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ABSTRACT 
 Infections by chlamydial species are of significant impact to global public health, 
causing sexually transmitted infections, blinding trachoma and pneumonia.  Despite its 
importance, there are many aspects of chlamydial biology that are not completely 
understood, including the mechanisms by which it infects, persists and replicates in its 
host cells.  The reason for this ignorance of basic chlamydial biological processes is 
because there is an abundance of Open Reading Frames (ORFs) of unknown function 
present in chlamydial genomes, almost 30% of the entire genome in many species.  This 
is likely due to the relatively large phylogenetic distance between Chlamydiae and better-
understood bacteria such as E. coli and B. subtilis.  Current strategies of genome 
annotation rely on the presence of homology to genes of known function and these 
approaches have not been effective in annotating chlamydial genomes. 
 In an effort gain insight into the function of these chlamydial ORFs of unknown 
function, I utilized structural information (both computational and experimentally 
derived) about three proteins of interest.  Based on these structural studies, hypotheses 
concerning the functions of these proteins were formed and then tested.  Together, my 
findings not only provide valuable information about these proteins of unknown function, 
but they also serve to demonstrate both the strengths and shortcomings of the overall 
approach of utilizing structural information for functional prediction. 
 One example of this approach is my work on the chlamydial ORF CT296.  
Although this protein was annotated as having an unknown function (due to insignificant 
homology to proteins of known function), it had been experimentally characterized as an 
iron-dependent transcription factor.  Having an experimentally characterized function 
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allowed me to test my approach of utilizing structural information to predict function on a 
protein with a relatively well-understood function.  Surprisingly, structural information of 
this protein suggested that it functions as a Fe(II) 2-oxoglutarate-dependent enzyme and 
not as a transcription factor.  Subsequent functional analyses of the protein were unable 
to reproduce previous reports of its DNA binding.  Together, my findings suggest that 
this protein may not function as a transcription factor. 
 A second example of my structure-function approach was applied to the 
chlamydial protein CT584.  This protein was first experimentally described as interacting 
with the chlamydial Type Three Secretion System (T3SS) needle protein in an 
interactome study.  This observation, combined with a subsequent biophysical 
characterization of the protein lead to an initial hypothesis that the protein may be a 
chlamydial T3SS needle tip protein.  However, results of structural studies on the protein 
reveal a structure that is not similar to any of the known T3SS needle tip proteins.  
Additionally, functional studies on the protein focusing on identifying its localization on 
chlamydial organisms revealed localization patterns not consistent with its proposed role 
as a T3SS needle protein.  Together, my studies suggest that this protein may not function 
as a needle tip protein. 
 A final example of the utility of structural information for informing function 
concerns chlamydial ORF CT009.  This protein was annotated in many chlamydial 
species as a protein of unknown function; however, bioinformatics analyses had 
identified it as a helix-turn-helix containing transcription factor.  Results of 
computational and experimental structures of this protein show structural similarity to the 
protein RodZ, a key component of the bacterial morphogenic complex.  Subsequent 
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functional analyses of CT009 demonstrate that this protein has the characteristics of a 
chlamydial homolog to RodZ. 
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Chapter I. General Introduction 
 
Public Health Impact of Chlamydia 
 
 Human infections by species of Chlamydia have been recorded since antiquity 
and the relationship between humans and Chlamydia likely predates civilization (Taylor, 
2008).  Human disease caused by species of Chlamydia is caused primarily by the 
chlamydial species Chlamydia trachomatis and Chlamydia pneumoniae.  C. trachomatis 
can cause ocular infections that can lead to blindness and genital infections that can lead 
to infertility and/or complications in pregnancy; C. pneumonia can cause lung infections 
that lead to pneumonia (Centers, 2010, Hammerschlag, 2000, Resnikoff et al., 2004). 
 Members of the species Chlamydia trachomatis can be further subdivided into 
serovars, based on differences in the sequence of their Major Outer Membrane Protein 
(MOMP) (Choroszy-Krol et al., 2012).  These serovar groupings also determine what 
tissue these organisms are most able to infect.  Serovars A, B and C of Chlamydia 
trachomatis infect the ocular epithelium and can lead to blinding trachoma (Hu et al., 
2010, Hvidsten et al., 2009).  It has been estimated that in 2002 and 2003, approximately 
40.6 million individuals worldwide had ocular C. trachomatis infections, 8.2 million of 
which had early symptoms of trachoma and 3.2 million of which were blind due to 
trachoma (Mariotti et al., 2009, Resnikoff et al., 2004).  This makes infection by these 
serovars of C. trachomatis the leading cause of infectious blindness in the world (Hu et 
al., 2010).  Successful treatment and curing of ocular infection by C. trachomatis can be 
achieved by a single dose of azithromycin (Bailey et al., 1993).  However, for this to 
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prevent blindness, it must take place in the relatively early stages of disease, before 
inversion of the eyelid (trichiasis) occurs. 
 Serovars D through K of Chlamydia trachomatis are responsible for sexually 
transmitted genital infections (Bosnjak et al., 2012).  In 2009, 1.2 million cases of C. 
trachomatis genital infection were reported in the United States, making this infection the 
number one most reported infection in the U.S. (Centers, 2010).  Numbers of unreported 
infections are likely even higher because genital infection by C. trachomatis is 
asymptomatic in ~50% of men and ~70% of women (Cecil et al., 2001, Falk et al., 2005).  
When symptoms are present, they include dysuria and nongonococcal urethritis in men 
and pelvic inflammatory disease (which may lead to ectopic pregnancy or involuntary 
infertility) in women (Centers, 2010).  Treatment of infection with azithromycin or 
doxycycline is 92-98% effective (Lau & Qureshi, 2002, Batteiger et al., 2010).  However, 
a major problem with this treatment is that infection is so frequently asymptomatic and 
therefore is not diagnosed or treated (Cecil et al., 2001, Falk et al., 2005). 
  Serovars L1, L2 and L3 of Chlamydia trachomatis also cause genital infections 
but are also capable of a more severe infection (Kapoor, 2008).  These 
Lymphogranuloma Venereum (LGV) strains are also capable of infecting macrophages, 
leading to invasive lymphangitis/lymphadenitis (Spaargaren et al., 2005).  Clinically, 
infection by these serovars is rare and infection can be treated with doxycycline, similarly 
to other C. trachomatis genital infections (Workowski & Berman, 2010). 
 Infection by Chlamydia pneumoniae is responsible for an estimated 6-22% of 
cases of community-acquired pneumonia (Hammerschlag, 2000, Kumar & 
Hammerschlag, 2007).  Importantly, the seroprevalence of this organism is very high; 70-
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80% of individuals are exposed to this organism within their lifetimes (Grayston, 1992).  
Fortunately, C. pneumoniae is susceptible to the common antibiotics prescribed for 
atypical pneumonia: azithromycin, beta-lactam antibiotics and/or levofloxacin. 
  Finally, there are several species of Chlamydia that are primarily animal 
pathogens.  These include C. muridarum (infects mice; (Carey et al., 2013)), C. suis 
(infects pigs; (Englund et al., 2012)), C. felis (infects cats; (Laroucau et al., 2012)), C. 
pecorum (infects sheep, cattle and horses; (Fukushi & Hirai, 1993)), C. caviae (infects 
guinea pigs; (Read et al., 2003)) and C. psittaci (infects birds; (Voigt et al., 2012)).  
Among these, C. psittaci is of the most importance from a public health standpoint; this 
zoonotic pathogen can also spread to humans, causing psittacosis (Harkinezhad et al., 
2009).  Although incidence of this disease is rare, it is difficult to diagnose due to its 
broad range of symptoms and is potentially fatal (Rohde et al., 2010).  Due to its high 
rates of infectivity and its ability to be aerosolized, the CDC has classified C. psittaci as a 
category B bioterrorism agent (CDC, 2007). 
  All infections by species of Chlamydia can be successfully treated with antibiotics 
(Hammerschlag & Kohlhoff, 2012).  Despite the relative availability of antibiotics, the 
threat and damage caused by chlamydial species has clearly not been eradicated.  
Particularly with genital infections, infection is often asymptomatic; therefore, treatment 
is often not administered until long-term damage has already been done.  Additionally, 
re-infection by both ocular and genital serovars of C. trachomatis is common, requiring a 
continued administration of antibiotics (Cooksey et al., 2010).  An effective vaccine 
against C. trachomatis could remedy these problems.  Such a vaccine does not yet exist 
but its development is a high priority (Cochrane et al., 2010). 
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Basic Biology of Chlamydia 
 
  Despite their differences in tissue tropism and disease pathology, all chlamydial 
species share an obligate intracellular lifestyle and a unique biphasic developmental cycle 
(Abdelrahman & Belland, 2005).  As obligate intracellular parasites, chlamydial species 
do not grow or replicate outside of host cells.  These species therefore rely on infection 
for their survival.  Infection, growth and replication take place as part of a developmental 
cycle.  In this cycle, chlamydial organisms alternate between two distinct forms termed 
Elementary Bodies (EBs) and Reticulate Bodies (RBs) (Abdelrahman & Belland, 2005).  
EBs are metabolically inactive and are capable of initiating infection while RBs are 
metabolically active but cannot infect cells (Abdelrahman & Belland, 2005). 
  Initiation of the developmental growth cycle begins with attachment of an EB to a 
suitable host cell.  One example attachment factor is the heparan sulfate (HS) 
polysaccharide, which has been proposed to be involved in a trimolecular interaction 
between OmcB, a chlamydial outer membrane protein, and a host cell receptor, thereby 
linking the two cells together (Zhang & Stephens, 1992).  However, multiple factors on 
both the surface of chlamydial EBs and the host cell are likely involved in attachment. 
  Now attached to the host cell, chlamydial EBs are taken up by a process termed 
“parasite-specific endocytosis” (Byrne & Moulder, 1978).  This process is induced 
primarily through a chlamydial Type III Secretion System (T3SS; discussed in more 
detail later in this chapter) via the secreted effector protein Tarp, a Translocated actin 
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recruiting phosphoprotein (Clifton et al., 2004).  Once internalized in the host cell, Tarp 
induces actin polymerization, leading to endocytosis of the EB (Jewett et al., 2006). 
  Having entered the host cell within a vacuole, chlamydial EBs respond to an 
unknown signal and begin their conversion to metabolically active RBs.  This process 
takes place at approximately 2-6 hours post infection (HPI) and involves a disruption in 
the EBs of the interactions between histone-like proteins and their chromosomes that 
prevent active transcription (Perara et al., 1992).  This conversion process also involves 
reduction of the highly crosslinked outer membrane that serves to protect EBs in the 
extracellular environment.  Additionally, the endocytic vacuole is modified by 
chlamydia-expressed Inc proteins, which prevent fusion to lysosomes and lead to the 
interception of Golgi-derived vesicles for energy (Fields & Hackstadt, 2002).  Modified 
thusly, the vacuole is termed an inclusion. 
  At approximately 6 HPI, RBs begin to grow and replicate by binary fission with a 
doubling time of approximately 3 hours (Mathews et al., 1999).  Also during this time, 
proteins are secreted by RBs into the inclusion and into the host cell cytoplasm, in order 
to continue their subversion of host cell processes.  For example, one such secreted 
protein is named CPAF (Chlamydial Protease-like Activity Factor) and is secreted into 
the host cell cytoplasm where it degrades many different proteins, ultimately leading 
toward an inhibition of apoptosis and an evasion of immune system recognition (Zhong, 
2009). 
  At approximately 18-24 HPI, RBs begin to asynchronously convert to EBs.  The 
signals that trigger this conversion are not well understood but the process involves 
condensation of the genome by histone-like proteins and disulfide crosslinking of the 
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outer membrane.  By 48 HPI, the developmental cycle is complete and chlamydiae are 
released from the host cell by either lysis or a process called extrusion (Hybiske & 
Stephens, 2007).  Because conversion of RB to EB is an asynchronous process, both EBs 
and RBs are present in the inclusion upon release.  Released RBs are non-infectious but 
released EBs proceed to infect neighboring cells, starting a new round of the 
developmental cycle. 
  Despite its importance and conservation among chlamydial species, there are 
many aspects of this complex developmental cycle that are poorly understood.  These 
include the precise factors involved in EB attachment to host cells and their order of 
events.  Additionally, the events that trigger conversion from EB to RB and conversely 
RB to EB are not completely understood. 
 
Protein Structure-Function Relationships 
 
 As discussed above, there are many key aspects of chlamydial biology that are not 
fully understood, including its ability to invade cells, evade immune function and regulate 
its complex developmental cycle.  One reason for our current lack of understanding is 
that species of chlamydia encode an abundance of hypothetical proteins, also known as 
Open Reading Frames (ORFS) of unknown function or proteins of unknown function.  
Depending on the species, these ORFs of unknown function total approximately 25-35% 
of the total number of genes in the genomes (Carlson et al., 2005, Stephens et al., 1998, 
Thomson et al., 2008, Unemo et al., 2010, Van Lent et al., 2012). 
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  The reason a function cannot be assigned to these proteins has to do with the 
method by which these (and most) genomes are annotated.  All chlamydial genomes were 
annotated by using primary sequence homology to assign function.  This means that an 
ORF with a sequence that is similar to a different ORF (from another organism) of 
known function will be annotated as having the function of that similar ORF.  Conversely, 
proteins without significant sequence similarity to proteins of known function will be 
annotated as having an unknown function.  This annotation method results in an 
abundance of proteins of unknown function for chlamydial genomes because of the 
phylogenetic distance between chlamydial species and other, better-characterized 
bacterial systems.  Most proteins with experimentally characterized function come from 
model bacterial systems, such as E. coli and B. subtilis.  Due to genetic drift, even 
chlamydial proteins with a conserved function have evolved a primary sequence that is 
significantly different from their E. coli orthologs.  Because current genome annotation 
strategies only take into account sequence information, the functions of such proteins 
were not be identified and they were annotated as having an unknown function. 
  The Protein Structure Initiative (PSI) is a concerted effort by several major 
institutions with many goals, all of which concern protein structure and function.  One of 
the goals of this program is to utilize structural information of proteins annotated as 
having an unknown function to infer a molecular function.  The fruits of this labor have 
resulted in numerous discoveries and publications and have been reviewed elsewhere 
(Shin et al., 2007).  In short, ~60% of the solved protein structures of proteins of 
unknown function lead to testable hypotheses regarding their molecular functions.  These 
structures of proteins of unknown function fell into five distinct categories, based on how 
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an inference of function was achieved.  The largest of these categories contained proteins 
of unknown function (with no close homologs by primary sequence), which possessed a 
structure that clearly resembled the structure of a protein of known function.  This 
allowed for clear assignment of a functional annotation.  Based on this previous success, 
it is therefore anticipated that a similar strategy would prove effective in elucidating the 
function of the many proteins of unknown function encoded by chlamydial species, 
thereby giving insight into the molecular processes of chlamydial species that are poorly 
understood. 
 
The Role of Iron in Chlamydial Biology 
 
  In almost all bacteria, iron is required for life.  This is due to the critical role that 
this micronutrient plays in catalysis for numerous enzymes involved in numerous cellular 
processes, including ribonucleotide reductase, superoxide dismutase and amino acid 
hydroxylases, to name a few (Andrews, 2000).  Despite its critical importance in these 
metabolic processes, levels of iron must be tightly controlled because free iron is capable 
of reacting with oxygen, generating free radicals that are capable of causing damage to 
lipids, proteins and DNA (Kehrer, 2000).  Therefore, bacteria have evolved regulatory 
networks that ensure that cellular iron levels remain in a concentration that is high 
enough to support the enzymes that require it as a cofactor, but low enough as to not 
cause damage to cellular components. 
  Species of chlamydia do not appear to be an exception for this common need for 
iron; the genome of C. trachomatis clearly shows the presence of several enzymes that 
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are predicted to require an iron cofactor (Stephens et al., 1998).  Additionally, when 
deprived of iron by treatment with an iron chelating agent, chlamydia enter a persistent 
state, characterized by a halting of cell division, a halting of RB to EB conversion and a 
transition of RBs into large, non-dividing cells called aberrant bodies (Raulston, 1997b, 
Schoborg, 2011).  Replacement of iron reverses this transition and chlamydial organisms 
resume their normal development.  This response to iron deprivation suggests a strong 
requirement for iron in the progression of the chlamydial developmental cycle.  
Examination of the effects of iron-induced persistence at the transcriptional and 
translational levels has revealed several proteins that are up or down-regulated by this 
response (Timms et al., 2009, Raulston, 1997b).  However, the mechanisms for 
controlling this response are still poorly understood. 
  Regulation of iron homeostasis in bacteria is most frequently carried out by an 
iron-dependent transcriptional repressor.  The two best studied of these repressors are 
named Fur and DtxR, originally characterized from E. coli and Corynebacterium 
diptheriae, respectively.  These proteins repress expression of target genes by binding to 
a region of DNA overlapping the promoters of these genes (Schmitt et al., 1992, de 
Lorenzo et al., 1987).  However, these proteins are only able to bind DNA and repress 
transcription if they have an iron cofactor bound, thereby only allowing transcription of 
the genes they repress under iron-limiting conditions (Pennella & Giedroc, 2005). 
  To date, two iron-responsive transcription factors have identified in Chlamydiae.  
DcrA (encoded by C. trachomatis ORF CT296) possesses distant sequence homology to 
Fur but was shown to functionally complement the Fur protein in E. coli and was able to 
bind to an E. coli Fur binding sequence (Wyllie & Raulston, 2001).  Additionally, several 
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promoter regions of chlamydial ORFs were found to be bound by E. coli Fur, an 
interaction that was confirmed in vitro using purified recombinant DcrA (Rau et al., 
2005).  More recently, a second iron-responsive transcriptional repressor was identified 
in chlamydia: the two-domain protein named YtgCR (encoded by C. trachomatis ORF 
CT069).  The C-terminal domain of this protein (termed YtgR) has sequence homology 
to DtxR and was shown to repress the expression of a reporter gene in the heterologous 
system of E. coli by binding to an operator sequence from its own promoter (Thompson 
et al., 2012). 
  Despite these recent findings, there are still many unanswered questions regarding 
the transcriptional response of chlamydial species in response to iron limitation.  Gene 
targets for YtgC, other than itself, have yet to be identified and a consensus sequence for 
DcrA binding has yet to be established.  Additionally, the relationship between these to 
repressors is also unknown; having ostensibly similar functions, it is not clear how these 
two proteins serve non-redundant roles.  Clearly, additional research on these 
transcriptional repressors is needed to better understand their roles in the biology of 
chlamydiae. 
 
Type Three Secretion in Chlamydia 
 
  As described in detail above, at several stages of the chlamydial developmental 
cycle, these organisms secrete proteins into the host to subvert normal host cell functions.  
To achieve this, several different secretion systems are employed.  Type II and Type V 
secretion systems, which secrete proteins outside of the cell from the periplasm, are 
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employed to secrete proteins such as CPAF (Saier, 2006).  Chlamydiae also possess a 
Type III secretion system (Hsia et al., 1997, Stephens et al., 1998).  This system is most 
distinct from other secretion systems in that it allows for translocation of proteins directly 
from the bacterial cytoplasm across both bacterial membranes and then across the host 
cell membrane directly into the host cell cytoplasm. 
 The Type III secretion system (T3SS) is an essential factor for virulence in many 
other Gram negative bacterial pathogens, including species of Yersinia, Salmonella, and 
Shigella flexneri (Hueck, 1998).  In other species, the T3SS secretion apparatus is 
referred to as the injectisome and is composed of approximately 25 different protein 
components (Beeckman & Vanrompay, 2010).  A cartoon representation of this secretion 
system is diagrammed in FIG 1.1.  The Basal Apparatus (BA), also referred to as a 
multipartite core secretory apparatus, is made up of a number of integral and non-integral 
membrane proteins that together span the inner and outer membranes of the bacterium, 
forming a hollow pore through which proteins may be secreted.  Also part of the BA is an 
ATPase that powers secretion.  Attached to this apparatus and located completely outside 
of the bacterial cell is the Needle Complex (NC), composed of 100-150 copies of a 
needle protein, forming a 40-80 µm long, hollow needle, through which partially folded 
proteins may be passed (Blocker et al., 2008).  Atop this needle lies the Tip Complex, 
composed of a multimer of a needle tip protein.  This protein is typically responsible for 
sensing contact with the host cell and activation of the secretion system.  The first 
proteins to be secreted following contact with host cell surface are the hydrophobic 
components of the Translocon Pore (TP), which embed themselves in the host cell 
membrane and complete the hollow connection between bacterium and host (Ghosh, 
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2004).  In addition to the structural components of the injectisome, the T3SS also 
involves proteins called effectors that are translocated from the bacterial cytoplasm 
through the injectisome and into the host cell and the chaperone proteins that are 
frequently involved in stabilizing these effectors within the bacterial cell. 
  The injectisome apparatus and its components are well conserved among bacteria 
that possess a T3SS.  Chlamydial species are no exception and the majority of T3SS 
structural genes were identified by homology (Stephens et al., 1998).  Interestingly, in 
most bacteria that encode the components of a T3SS, the genes for this system are 
localized to a single pathogenicity island or plasmid (Hueck, 1998).  However, in species 
of Chlamydia, components of the T3SS are spread across the genome; five main loci can 
be identified but some components are even more disperse (Stephens et al., 1998).  While 
functionally related proteins seem to be located close to one another on the genome, the 
reason for this atypical gene arrangement (if there is one) is not clear. 
  While the structural components of the T3SS tend to be well conserved among 
Gram-negative bacteria, the actual effector proteins tend to be less well conserved.  
Importantly, due to the relative phylogenetic distance between chlamydial species and 
other more thoroughly studied bacteria, the identification of these effector proteins has 
been challenging and it is likely that more effectors remain to be discovered (Valdivia, 
2008).  Despite these challenges, several chlamydial T3SS effector proteins have been 
identified and characterized, together emphasizing the importance of the T3SS in the 
biology and pathology of chlamydial species. 
  One such effector protein is Tarp, which is prepackaged into EBs and is 
translocated into host cells at the early stages of infection.  Tarp acts as a nucleation site  
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FIG. 1.1.  Model of the Chlamydial Type III Secretion System (T3SS) apparatus.  
The components of the chlamydial T3SS apparatus can be organized into several 
different apparatuses and complexes.  Anchored in both the inner and outer membranes 
of the bacterium, the Basal Apparatus forms a hollow pore through these membranes.   
Attached to this is the Needle Complex, a hollow needle through which secreted proteins 
may pass.  At the tip of the Needle Complex is the Tip Complex, which is responsible for 
sensing contact with the host cell. 
  Once in contact with the host, the components of the Translocon Pore are 
transported through the secretion system and embed themselves in the host cell 
membrane.  In the context of secretion through the inclusion, this pore would form in the 
inclusion membrane.  Now, effector proteins (stabilized within the bacterium by 
chaperone proteins) can be translocated into the host cell.  Adapted from Betts-
Hampikian and Fields (Betts-Hampikian & Fields, 2010). 
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for actin and is a major driving force behind the cytoskeletal rearrangement that occurs 
during chlamydial entry into the host cell (Jewett et al., 2006).  Additional T3SS effectors 
include various Inc proteins that are involved in modification of the inclusion membrane, 
giving stability to the inclusion and allowing for subversion of host cell processes (Fields 
& Hackstadt, 2002, Wolf et al., 2009, Betts et al., 2008).  A final example of T3SS 
effectors involves the proteins ChlaDub1 and ChlaDub2.  These two proteins are cysteine 
proteases and appear to prevent ubiquitination of NF-κB, thereby leading to a suppression 
of pro-inflammatory signaling (Misaghi et al., 2006).  Although these are only a few 
examples of the many translocated effector proteins employed by Chlamydiae, they 
illustrate the variety of functions that these proteins have and they emphasize the 
importance of the T3SS throughout the chlamydial developmental cycle. 
 
Cell Division in Chlamydia 
 
  The process of cell division is incredibly well conserved among bacterial species, 
likely due to its indispensible role in the propagation of life.  This process involves a 
large number of different proteins that are responsible for coordinating the process such 
that the division septum is formed in the correct location and with the correct shape 
(Weiss, 2004).  Among the proteins involved in this process, perhaps the most important 
is the protein FtsZ.  FtsZ is structurally similar to tubulin and polymerizes into 
protofilaments inside the bacterial cell in a shape the forms a ring at the division septum 
(Erickson et al., 2010).  This ring of FtsZ polymer is called a Z ring and marks the site for 
septation by recruiting all other proteins involved in this process (Adams & Errington, 
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2009).  Other key players in this process include (but are not limited to) the proteins ZipA 
and FtsA, which are responsible for tethering the Z ring polymer to the inner membrane, 
and the MinCDE system, which is responsible for ensuring proper Z ring assembly at 
midcell by inhibiting FtsZ polymerization at the cell poles (Adams & Errington, 2009).  
Importantly, no motor molecules have been identified in the process of cell division and 
data support the hypothesis that it is the FtsZ protein itself that powers the process of 
septation by forming curved filaments as it polymerizes (Li et al., 2007). 
  In spite of its strict conservation among bacterial species, chlamydial species do 
not have an FtsZ ortholog that is apparent by sequence homology, following sequencing 
of the genome (Stephens et al., 1998).  Due to their phylogenetic distance from other, 
more thoroughly studied bacteria, it is possible that an FtsZ ortholog may exist in 
chlamydial species but cannot be identified in the genomes due to sequence divergence.  
However, FtsZ is not the only conserved component of cell division that cannot be 
identified in the genome sequences of chlamydial species: virtually all FtsZ interaction 
partners, components of the cell divisome and their regulatory proteins (including FtsA, 
ZipA, ZapA, MinCDE and UgtP) are absent from chlamydial genomes, suggesting that 
these species employ a novel mechanism for cell division (Stephens et al., 1998). 
  The absence of these highly conserved cell division proteins is not the only point 
of interest regarding proteins encoded by chlamydial species: these organisms also 
encode several proteins involved in rod cell shape maintenance even though they have 
coccoid (round) morphology (Stephens et al., 1998).  These proteins include RodA and 
MreB, both of which have been shown in other species to guide the peptidoglycan 
machinery in such a way that it creates cell wall in a distinct rod shape (White et al., 
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2010).  These proteins are typically found only in rod or crescent shaped bacteria and 
their presence in the coccoid chlamydial species was surprising. 
  Another interesting feature of chlamydial species is their lack of peptidoglycan.  
While there are examples of bacteria without peptidoglycan cell walls, chlamydiae are 
unique for several reasons.  No peptidoglycan could be detected in chlamydial species by 
any of the methods used (Chopra et al., 1998).  However, these organisms are sensitive to 
antibiotics like penicillin that target peptidoglycan synthesis; these compounds are not 
bactericidal but put chlamydia in a so-called persistent state of infection characterized by 
large, aberrant RBs (Wyrick, 2010).  Additionally, the first sequenced genome of 
Chlamydia trachomatis revealed that these organisms encode almost all of the genes 
necessary for peptidoglycan production, with the notable exception of the 
transglycosylase enzymes, which connect the N-acetylglucosamine and N-acetylmuramic 
acid disaccharides to one another (Stephens et al., 1998).  Together, these findings have 
lead to several hypotheses, most recently reviewed in 2007 (Pavelka, 2007).  These 
hypotheses include suppositions that chlamydial species might employ extremely low 
amounts of peptidoglycan (explaining their inability to be detected) or that an atypical 
(perhaps glycan-less) form of peptidoglycan is utilized.  A third hypothesis is that this 
peptidoglycan, regardless of its precise structure, is only used in a specific, transitory 
process, thereby explaining its undetectable levels. 
  All of these anomalies regarding chlamydial cell division, rod shape and 
peptidoglycan can be united by a hypothesis in which the rod shape determining proteins 
functionally replace FtsZ by guiding peptidoglycan-mediated septation at midcell 
(Ouellette et al., 2012).  A non-proteinaceous antigen termed SEP was identified at the 
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site of septation in dividing chlamydia and was proposed to be a form of peptidoglycan 
due to its cross-reactivity with a component of the cell walls of other bacteria (Brown & 
Rockey, 2000).  Furthermore, inhibition of the cell shape determining protein MreB lead 
to a phenotype in which cell division was arrested in cells, implicating it and other rod-
shape determining proteins in the process of cell division (Ouellette et al., 2012).  While 
additional support for this hypothesis is needed, it does neatly explain many of the 
anomalies of chlamydial biology together in a unique mechanism for cell division. 
	   19	  
Collaborator’s Contributions 
  The crystal structure of CT296 in Table 2.2 and Fig. 2.1B was solved by Dr. John 
Hickey (Department of Pharmaceutical Chemistry, University of Kansas), with assistance 
from Dr. Scott Lovell (Del Shankel Structural Biology Center, University of Kansas) and 
Dr. Kevin Battaile (IMCA-CAT Hauptman-Woodward Medical Research Institute).  The 
sequence and secondary structure alignment in Fig. 2.1C was generated by Dr. John 
Hickey (Department of Pharmaceutical Chemistry, University of Kansas).  Confocal 
microscopy in Fig. 3.3 was performed with guidance from Heather Shinogle (Microscopy 
and Analytical Imaging Laboratory, University of Kansas).  The crystal structure of 
CT009 in Table 4.3 and Fig. 4.8 was solved with the guidance of Dr. Scott Lovell (Del 
Shankel Structural Biology Center, University of Kansas).  Sedimentation velocity profile 
of purified recombinant CT009 in Fig. 4.11 was performed by Lei Hu (Department of 
Molecular Biosciences, University of Kansas). 
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Chapter II.  Ab initio structural modeling of and experimental validation for 
Chlamydia trachomatis protein CT296 reveal structural similarity to Fe(II) 2-
oxoglutarate-dependent enzymes 
 
Abstract 
 
  Chlamydia trachomatis is a medically important pathogen that encodes a 
relatively high percentage of proteins with unknown function. The three-dimensional 
structure of a protein can be very informative regarding the protein's functional 
characteristics; however, determining protein structures experimentally can be very 
challenging. Computational methods that model protein structures with sufficient 
accuracy to facilitate functional studies have had notable successes. To evaluate the 
accuracy and potential impact of computational protein structure modeling of 
hypothetical proteins encoded by Chlamydia, a successful computational method termed 
I-TASSER was utilized to model the three-dimensional structure of a hypothetical protein 
encoded by open reading frame (ORF) CT296. CT296 has been reported to exhibit 
functional properties of a divalent cation transcription repressor (DcrA), with similarity to 
the Escherichia coli iron-responsive transcriptional repressor, Fur. Unexpectedly, the I-
TASSER model of CT296 exhibited no structural similarity to any DNA-interacting 
proteins or motifs. To validate the I-TASSER-generated model, the structure of CT296 
was solved experimentally using X-ray crystallography. Impressively, the ab initio I-
TASSER-generated model closely matched (2.72-Å C(α) root mean square deviation 
[RMSD]) the high-resolution (1.8-Å) crystal structure of CT296. Modeled and 
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experimentally determined structures of CT296 share structural characteristics of non-
heme Fe(II) 2-oxoglutarate-dependent enzymes, although key enzymatic residues are not 
conserved, suggesting a unique biochemical process is likely associated with CT296 
function. Additionally, functional analyses did not support prior reports that CT296 has 
properties shared with divalent cation repressors such as Fur. 
 
Introduction 
 
 Progress toward better understanding key aspects of chlamydial biology is 
hindered by the inherent restraint presented by the phylogenetic distance between C. 
trachomatis and better-characterized bacterial systems, such as E. coli and B. subtilis. 
This distance dramatically reduces the utility of protein function assignments as inferred 
by sequence similarity. As a result, Chlamydia trachomatis encodes a relative 
overabundance (~25%) of proteins with little or no sequence similarity to functionally 
defined proteins (i.e. hypothetical proteins) (Carlson et al., 2005, Unemo et al., 2010, 
Thomson et al., 2008, Stephens et al., 1998). 
 For proteins where the only known characteristics are their primary sequence, the 
three dimensional structure of a protein can be very informative and useful in regards to 
understanding functional characteristics. Importantly, protein structure provides the 
precise molecular details that often facilitate experimental characterization of an expected 
function. Similarly, the structure of a protein can also be useful in facilitating functional 
predictions as a search template for better-characterized proteins that share regions of 
structural similarity. While there are many cases of structural information playing a 
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productive role in predicting putative function (Yakunin et al., 2004), there are 
limitations with this approach. For instance, proteins can share very similar global folds 
but have contrasting functions (Thornton et al., 2000). However, local structural 
similarities, as well as certain well-defined structural motifs (e.g. helix-turn-helix, 
catalytic triad) can be much more predictive of function than global fold alone (Hvidsten 
et al., 2009). Thus, while the three-dimensional structure of a protein may not be 
completely revealing regarding function, there are many examples to support that it will 
be very informative regarding numerous functional aspects. 
 Obtaining high resolution, three-dimensional structural information can be 
challenging in certain cases and this proves to be a major constraint to using protein 
structure to facilitate functional studies. The development of computational methods that 
can predict protein structure to a relatively high level of accuracy and thereby facilitate 
functional annotation, biochemical analyses, and biological characterization is a high 
priority (Zhang, 2008). There are three different categories of methods for computational 
protein structure modeling.  Comparative modeling, or homology modeling, uses the 
structures of close homologs to generate a structural model. This method is typically only 
effective when the modeled protein shares relatively high primary sequence similarity 
with proteins with determined structures (Qu et al., 2009). A second approach is termed 
threading, which uses smaller regions of sequence homology between the query sequence 
and sequences of solved structures to build a model. As with homology modeling, 
threading is only effective if the modeled protein has primary sequence homology to a 
protein or proteins of known structure. These two methods are less capable of modeling 
the structure for a protein with no close homologs and no significant sequence homology.  
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The third method of computational modeling is ab initio, or free modeling (Lee et al., 
2009).  This method builds a structure from scratch and is not dependent on the existence 
of homologs. Because this method is the most technically challenging method for protein 
structure modeling, it is a particular challenge to accurately model structures for proteins 
with very little or no shared similarity evident by their primary sequence. 
 I-TASSER (Iterative Threading ASSEmbly Refinement) is a computational 
method that has been successful in accurately modeling protein structures. I-TASSER 
uses a combinatorial approach, employing all three conventional methods for structure 
modeling: comparative modeling, threading, and ab initio modeling (Roy et al., 2010). In 
large blind benchmarking experiments conducted over the past several years (Critical 
Assessment of protein Structure Prediction: CASP), I-TASSER has consistently been 
ranked among the most accurate modeling program for automated protein structure 
predictions (Battey et al., 2007, Cozzetto et al., 2009). Importantly, I-TASSER has also 
proven to be particularly effective in ab initio modeling of small proteins with low 
primary sequence similarity (Wu et al., 2007). 
 To provide further support for the utility of protein structure analyses to facilitate 
functional characterization of hypothetical proteins encoded by Chlamydia, both 
computational and experimental approaches were applied to a chlamydial hypothetical 
protein for which experimental information regarding the function of the protein had been 
previously obtained. Chlamydia trachomatis open reading frame CT296 has very limited 
sequence homology to any proteins outside of Chlamydiae and was initially annotated as 
a protein with unknown function (Stephens et al., 1998). Subsequent functional studies 
indicated that CT296 exhibits properties of a Divalent cation transcription repressor 
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(DcrA), with functional similarity to the Fur repressor (Rau et al., 2005, Wyllie & 
Raulston, 2001). Fur (short for Ferric uptake regulator) is an iron-responsive 
transcriptional repressor that regulates genes involved in iron acquisition in an iron-
dependent fashion (Escolar et al., 1999). Iron concentrations have been demonstrated to 
have a profound effect on the growth of Chlamydia by inducing a persistent growth 
phenotype that is expected to be clinically relevant (Raulston, 1997a). As such, it was 
anticipated that structural studies on CT296 would also be instrumental in understanding 
the molecular mechanisms critical for a transcription factor associated with chlamydial 
pathogenesis. 
 In this study, the structure of CT296 was determined computationally, using I-
TASSER, and experimentally, using X-ray crystallography. These two structures were 
compared to assess the ability of I-TASSER to model CT296 ab initio with a relatively 
high level of accuracy. Each of the structures was used as a search template to identify 
proteins with shared structural features. The functional properties of the proteins with 
structural similarity to CT296 were compared to the previous experimental observations 
of CT296. As subsequently described, given the structural observations and potential 
functional disparity, oligomerization and DNA binding capabilities were analyzed. 
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Chapter II 
Materials and Methods 
 
  Cloning, Expression, and Purification of CT296- The open reading frame 
encoding CT296 (GenBank Accession #: CAP03988.1) was PCR amplified with Phusion 
high fidelity DNA polymerase (Finnzymes, Lafayette, CO), using Chlamydia trachomatis 
LGV (L2/484/Bu) genomic DNA and primers 5’- 
CTGTACTTCCAATCGCGAATGAGGGCAGTTTTACACCTAGAG-3’ and 5’- 
GAATTCGGATCCTCGCGATTAGTTAGGAAATCCCGCTGAGGAG-3’. The 
amplified DNA was inserted into a modified pET21b (Novagen, San Diego, CA) vector 
at the EcoR1 restriction site, using the In-Fusion Advantage kit (Clontech, 
MountainView, CA), following the manufacturer’s protocol. The resulting plasmid 
contained the CT296 gene downstream of DNA encoding a polyhistidine tag and a TEV 
protease recognition sequence. The plasmid insert was sequenced (ACGT, Wheeling, IL) 
and confirmed to be completely present and without mutation. The plasmid was then 
transformed into E. coli Acella cells (EdgeBio, Gaithersburg, MD). For native CT296 
over-expression, the cells were grown in LB medium supplemented with 100 µg/mL 
ampicillin to an OD600 of 0.8 before the addition of 1 mM IPTG. For selenomethionine 
(SeMet)-labeled CT296, the cells were grown and labeled using a previously described 
method (Doublie, 2007). The cells were harvested after an overnight growth at 15°C 
through centrifugation (10 min at 5,000 x g; 4°C). The resulting pellet was resuspended 
in purification buffer (50 mM Na2HPO4 pH 7.0, 300 mM NaCl) and disrupted by 
sonication. Cell debris was removed through centrifugation (30 min at 14,000 x g; 4°C). 
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CT296 was purified using Co2+-affinity chromatography (Clontech), following the 
manufacturer’s protocol. The eluted fractions containing CT296 were pooled and a 
polyhistidine-tagged Tobacco Etch Virus (TEV) protease was added to a final 
concentration of 0.6 µM in order to cleave the polyhistidine tag from the protein. 
Following an overnight dialysis in the purification buffer, the protein mixture was added 
to a Co2+ column to remove the polyhistidine tagged TEV protease and the cleaved 
polyhistidine fragments. 
 
  Size Exclusion Chromatography- Purified recombinant CT296 at concentrations 
of 1000, 100 and 10 µM were analyzed by size exclusion chromatography using a 
BioLogic DuoFlow system (Bio-Rad). 1 mL of protein solution was applied to a 
Sephacryl S-200 HR column (GE Healthcare), equilibrated with 50 mM Na2HPO4 (pH 
7.0) and 300 mM NaCl. A protein standard mixture containing bovine γ-globulin (158 
kDa), chicken ovalbumin (44 kDa), horse myoglobin (17 kDa) and vitamin B12 (1.4 kDa) 
(Bio-Rad) was used to generate a standard curve. 
 
  Electrophoretic Mobility Shift Assay (EMSA)- Chlamydia trachomatis LGV 
(L2/484/Bu) genomic DNA was used as a template to amplify ~400 base pair fragments 
of DNA by PCR. These fragments consist of a region spanning ~100 base pairs upstream 
of the transcription start site and ~300 base pairs downstream of the transcriptional start 
site. These putative promoter regions of DNA were amplified for the genes CT248 and 
CT709 using the IR800-labled primers (Integrated DNA Technologies); CT248 5’-
GATGCCGATTGAGGAGTCTG-3’ and 5’-GCAACTTTTGCTGTACATTCC-3’or 
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CT709 5’-CTTAGTTTCTTTAAAAGCTGGAG-3’ and 5’-
GGAAAAAAAATTAAATACACGATC-3’. These genes were previously identified as 
DNA binding targets of CT296 (Rau et al., 2005). To serve as a negative control in the 
EMSA reaction, ~400 bases from the region of DNA between the two converging genes 
CT032 and CT033 was amplified using IR800 labeled primers; 5’-
ACATTCCTTAGATCTAGGTTCCC-3’ and 5’-
GCTATTGCTGTTCGTAATAATAAGG-3’). 
 EMSA reactions were prepared with a total volume of 20 µL each, using the 
methods and buffers previously described (Rau et al., 2005). Reactions contained EMSA 
buffer, DNA fragments (48 pmol) and purified recombinant CT296 (at DNA:protein 
molar ratios of 1:100, 1:500 and 1:2500). Reactions without protein were used as a 
negative control. Once protein was added, the solution was gently mixed and incubated 
for 30 minutes at room temperature. 5 µL of 5x DNA dye (90 mM Tris, 90 mM boric 
acid, 2 mM EDTA, 20% glycerol, 1% xylene cyanol, 1% bromphenol blue) was added to 
the reactions and mixed gently. 20 µL of each reaction was loaded on a precast 6% TBE 
gel (Invitrogen) and run at 150V for 75 minutes. Bands were visualized using an Odyssey 
infrared imaging system (Li-Cor Biosciences). 
 
  Target Selection and I-TASSER Structure Modeling Method- The following 
amino acid sequence from the genome of Chlamydia trachomatis LGV (L2/484/Bu) was 
selected as the target: 
MRAVLHLEHKRYFQNHGHILFEGLAPVSDCKQLEAELKLFLKEVAVVKDRHLQ
RWRENVHRTLPGVQMIVKRVRLDHLAAELTHRSRVALVRDLWVQKQEEILFDD
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CDCSVLLCLSGEKAGWGLFFSGEYPQDVFDWGAGDTAIILRFSSAGFPN. Using 
the nomenclature of the L2 genome, the name of this protein is CTLon_0544. However, 
in this report the more widely used nomenclature of the serovar D genome is used and the 
protein is referred to as CT296. 
 The I-TASSER server has been described previously (Zhang, 2009, Roy et al., 
2010). Briefly, the target sequence is first threaded through a representative PDB library 
by LOMETS, a locally installed meta-threading program (Wu & Zhang, 2007). The 
continuous fragments (>5 residues) are excised from the LOMETS alignments and used 
to reassemble the structure by replica-exchange Monte Carlo simulations (Wu & Zhang, 
2007). The simulation trajectories are then clustered by SPICKER (Zhang & Skolnick, 
2004) which are used as the starting state of the second round I-TASSER assembly 
simulation. Finally, the structures of the lowest energy are selected, which are then 
refined by a fragment guided molecular dynamics procedure, with the purpose of 
optimizing the hydrogen-binding network and removing steric clashes. 
 The computationally determined protein structure of CT296 was analyzed for 
putative DNA binding regions using PreDs (Tsuchiya et al., 2005) and HTHQuery 
(Ferrer-Costa et al., 2005). 
 
  CT296 Crystallization- Purified recombinant CT296 was concentrated to 6.3 
mg/ml in 50 mM Na2HPO4 pH 7.0, 300 mM NaCl and screened for crystallization with 
commercially available sparse matrix screens. 1 µl of the protein was mixed with 1 µl of 
the crystallization solution in Compact Jr. (Emerald Biosystems, Bainbridge Island, WA) 
sitting drop vapor diffusion plates and equilibrated against 100 µl of the crystallization 
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solution.  CT296 crystals were observed after 3 days at 20°C from the Wizard 4 screen 
condition #48 (Emerald Biosystems) (100 mM HEPES pH 7.0, 15% (w/v) PEG 20,000). 
Single crystals were transferred to a cryoprotectant solution containing the crystallization 
condition supplemented with 20% PEG 400.  
 Co-crystallization was attempted with purified CT296 at 8.6 mg/ml and 5 mM α-
ketoglutarate (Sigma-Aldrich, St. Louis, MO) and/or 5 mM FeCl2 (Sigma-Aldrich). The 
resulting mixture was screened for crystallization as described above; however no 
crystals were obtained. Additionally, apo CT296 crystals were soaked in the 
crystallization solution supplemented with 50, 5, 1, or 0.1 mM α-ketoglutarate and/or 
FeCl2. The crystals dissolved within seconds-to-minutes of exposure to either compound 
or combination. 
 
  Data Collection and Processing- Data sets for the native and SeMet-labeled 
CT296 crystals were collected at 100K at the Advanced Photon Source (APS) IMCA-
CAT, sector 17ID. Data for the native and the SeMet-labeled crystals were collected 
using an ADSC Quantum 210r CCD detector and Dectris Pilatus 6M pixel array detector, 
respectively. Native diffraction data were processed with HKL2000 and SeMet data were 
integrated and scaled using XDS (Kabsch, 1993) and SCALA (Evans, 2006), respectively, 
via the AUTOPROC (Vonrhein et al., 2011) software package. Structure solution using 
the SAD phasing method and preliminary model building were performed using 
AUTOSOLVE (Terwilliger et al., 2009), contained within the PHENIX suite (Adams et 
al., 2010). Automated model building was performed using AUTOBUILD (Terwilliger et 
al., 2008). The SeMet derived CT296 model was used as the search model for molecular 
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replacement against the native data set using PHASER (McCoy et al., 2007a). Manual 
model building and subsequent refinement of the models was performed using COOT 
(Emsley & Cowtan, 2004) and PHENIX (Adams et al., 2010) respectively. 
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Chapter II 
Results 
 
The I-TASSER Modeled Structure of CT296 Shows No Significant Structural 
Similarity to Fur Family Members and Has No Apparent DNA-Binding Motifs. 
  The protein encoded by ORF CT296 has been reported to contain very limited 
sequence similarity to the Fur protein but exhibits metal-dependent DNA binding 
properties comparable to Fur (Rau et al., 2005, Wyllie & Raulston, 2001). To better 
understand the molecular basis for its metal and DNA binding functions as well as test 
the accuracy and impact of I-TASSER protein structure modeling, both computational 
and experimental structural analyses were performed on CT296.  
Initially, computational modeling of the structure of CT296 using I-TASSER was 
performed. Five models of CT296 were computationally generated using the I-TASSER 
algorithm with C-scores ranging from -5 to -2.25. The C-score is a confidence score and 
ranges from -5 to 2, with higher scores representing higher confidence in the model (Roy 
et al., 2010). Although -1.5 has been used previously as a cutoff for confidence in models, 
there can still be significant modeling accuracy in models with C-scores below this limit 
(Roy et al., 2010). Model 1 (C-score of -2.25) was used for all analyses described (Fig. 
2.1A) as the remaining models had C-scores of -5. The overall structure of CT296 model 
1 is primarily α-helical (5 helices; 46%), a significant number of loops (48%), and two 
relatively short β-strands (6%). The topology of the CT296 model is (residue number); 
α1 (H6-H16) – α2 (V27-V47) – α3 (H51-R61) – α4 (P64-K71) – α5  
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FIG. 2.1.  Tertiary and secondary structure comparisons of the I-TASSER model 
and the experimentally determined structure of CT296. (A) Ribbon depiction of the I-
TASSER model of CT296. Topology of the CT296 model is (residue number); α1 (H6-
H16) – α2 (V27-V47) – α3 (H51-R61) – α4 (P64-K71) – α5 (R74-L82) – α6 (R87-W95) 
– β1 (D105-D106) – β2 (S110-C114) – β3 (A143-F148). (B) The experimentally 
determined structure of CT296. Topology of the crystal structure of CT296 is (residue 
number); α1 (L7-H16) – β1 (H18-F21) – α2 (V27-F40) – α3 (G65-V73) – α4 (L75-T83) 
– β2 (A89-V96) – β3 (D108-C114) – β4 (W122-F126) – β5 (A143-S149). Secondary 
structure elements that are conserved between the two structures (four α-helices and two 
β-sheets) are labeled and highlighted in red. (C) Secondary structure topology 
comparison of I-TASSER model and experimentally determined structure of CT296. 
 
	   33	  
 
 
 
 
 
 
	   34	  
(R74-L82) – α6 (R87-W95) – β1 (D105-D106) – β2 (S110-C114) – β3 (A143-F148) (Fig. 
2.1A). 
 Despite the low overall primary sequence similarity between CT296 and Fur, it 
was anticipated that the two would share significant structural characteristics, largely 
based on the previously reported ability of CT296 to functionally complement Fur in E. 
coli (Wyllie & Raulston, 2001). However, the I-TASSER generated model of CT296 
bears little resemblance to the structures of Fur family members (PDB#: 2W57, 2O03, 
2FU4 and 1MZB) as no significant similarity was identified using DaliLite pairwise 
comparisons (with a Z-score of >2 used as a cutoff for significance; data not shown) 
(Holm & Park, 2000). Additionally, no DNA binding motifs (e.g. helix-turn-helix, a 
leucine zipper, a zinc finger, winged helix-turn-helix, etc.) were apparent in the I-
TASSER model of CT296. To identify potential regions of DNA-binding sites based on 
electrostatics and curvatures on the protein surface, the model of CT296 was subjected to 
computational analysis by PreDs (Tsuchiya et al., 2005). These protein characteristics are 
summarized as a P score, the value of which ranges from 0.0 to 1.0 and is predictive of a 
protein with the necessary structural characteristics to bind to DNA. The results of this 
analysis give a P score of 0.03 to the model of CT296. A P score of 0.12 is typically used 
as a cutoff point, because DNA-binding proteins almost always have P scores above this 
threshold. As a control, the effector domain of ChxR, a well-characterized chlamydial 
DNA binding protein, was subjected to the same analysis (Koo et al., 2006, Hickey et al., 
2011). It was given a P score of 0.22, correctly predicting that it is capable of binding to 
DNA. All together, the I-TASSER generated model of CT296 is in contrast with the 
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previous observations that CT296 is a DNA-binding protein with structural similarity to 
Fur. 
 
Homology Searches Using The I-TASSER Generated Model of CT296 Support Its 
Functional Prediction as a Non-Heme Fe(II) 2-oxoglutarate Dependent Enzyme.
 The model of CT296 generated by I-TASSER was used to search for proteins 
with regions of structural homology within the PDB (Table 2.1). This assessment was 
carried out using both the PSFloger server 
(http://zhanglab.ccmb.med.umich.edu/PSFloger/), and the DALI server 
(http://ekhidna.biocenter.helsinki.fi/dali_server/). PSFloger was developed in part to 
complement I-TASSER; it detects the structural and functional analogs from a 
representative PDB library by the global structural alignment algorithm, TM-align 
(Zhang & Skolnick, 2005), assisted with local motif matches (Zhang & Skolnick, 2005).  
DALI is a well-established, widely utilized server for protein structure alignment (Holm 
& Sander, 1993). Although the overall goal of the PSFloger and the DALI servers is to 
identify structural homologs, both servers were employed in order to give a deeper 
insight into the relationship between the modeled structure of CT296 and other proteins 
of known structure. 
 The PSFloger search indicated that the 10 proteins the share structural similarity 
to the CT296 model are from diverse sources (e.g. H. sapiens [mammal], P. syringae 
[bacteria], and A. thaliana [plant]) but have similar functions as non-heme Fe(II) and 2-
oxoglutarate dependent enzymes. The closest structural match (2OPW) is the enzyme 
PHYHD1 from Homo sapiens, which carries out a hydroxylation reaction using a non-
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Table 2.1. Top 10 structures with homology to the CT296 I-TASSER model as 
measured by PSFloger and DALI 
 
    PSFloger       DALI    
Rank TM-Score1 PDB File Protein Name Classification  Z Score2 PDB File Protein Name Classification 
1 0.6619 2OPW PHYHD1 Hydroxylase (Mihalik et al., 1997) 6.3 2G1M PHD23 Hydroxylase (McDonough et al., 2006) 
2 0.6564 2HBT PHD2 Hydroxylase (Warshakoon et al., 2006) 5.7 3GJB CytC33 Halogenase (Wong et al., 2009) 
3 0.6365 2CSG YbiU Putative oxioreductase 5.5 3EMR ECTD Dioxygenase (Reuter et al., 2010) 
4 0.6131 2FCU SyrB2 Halogenase (Blasiak et al., 2006) 5.3 3KT7 Tpa13 Hydroxylase (Kim et al., 2010) 
5 0.6063 1GP6 ANS Dioxygenase (Wilmouth et al., 2002) 5.1 3OBZ PHYHD13 Hydroxylase 
6 0.6060 1UNB DAOCS Oxioreductase (Valegard et al., 2004) 5.1 3NN1 Hal3 Halogenase (Khare et al., 2010) 
7 0.6019 2DBN JW0805 Unknown Function 4.5 2RG4 Q2CBJ1 Unknown Function 
8 0.5998 2A1X PHYHD1 Hydroxylase (McDonough et al., 2005) 4.4 3DKQ Sbal_36343 Putative Hydroxylase 
9 0.5917 1W3X IPNS Oxioreductase (Daruzzaman et al., 2006) 4.2 3BVC Ism_017803 Unknown Function 
10 0.5820 2RDN PtlH Hydroxylase (You et al., 2007) 4.0 2FCU SyrB2 Halogenase (Blasiak et al., 2006) 
              
 
1TM-score is a measurement of similarity between two protein structures and it varies from 0 to 1, with 1 indicating a perfect alignment.  A score of 0.5 or higher indicates significant  
similarity (Xu & Zhang, 2010). 
2Structures with Z-scores above 2 are considered to be significant matches (Holm et al., 2008). 
3This protein was listed multiple times on the DALI output, with various minor differences (ligands, etc.); these redundant structures are not listed here. 
 
	   37	  
heme Fe(II) cofactor and a 2-oxoglutarate co-substrate (Mihalik et al., 1997, Warshakoon 
et al., 2006). The next closest match (2HBT) is also from Homo sapiens and is called 
PHD2. PHD2 is a prolyl hydroxylase and likewise makes use of non-heme Fe(II) and 2-
oxoglutarate (McDonough et al., 2006). The third structural match to the model of CT296 
(2CSG) is the protein YbiU from the bacterium Salmonella typhimurium and is a putative 
oxidoreductase with iron bound in the crystal structure. As a final example, the fourth 
closest structural match to CT296 (2FCU) is the halogenase SyrB2 from Pseudomonas 
syringae; like the first two matches, it requires non-heme Fe(II) and 2-oxoglutarate 
(Blasiak et al., 2006). Although these structural homologs differ in their classes of 
enzymatic function (e.g. hydroxylase or oxidoreductase), the similarities among them 
predict that CT296 is an enzyme that utilizes iron as a co-factor and may bind 2-
oxoglutarate. 
 Like PSFloger, the DALI server also identified structural homologs from diverse 
sources (e.g. H. sapiens [mammal], S. cerevisciae [fungus] and S. salexigens [bacteria]).  
Also similar to the PSFloger results, all matches made by DALI function as non-heme 
Fe(II) and 2-oxoglutarate dependent enzymes. Despite the similar functional 
characteristics of the PSFloger and DALI matches, only three of the top ten structures 
identified as homologous to the CT296 model by PSFloger were also identified by DALI.  
This is partly because PSFloger uses a non-redundant PDB library (with pair-wise 
sequence identity <95%) while DALI search utilizes all available PDB structures. The 
top ranked DALI structure (2G1M) is the protein PHD2, the same protein that was listed 
as the second highest ranked homolog by PSFloger (PDB file 2HBT; same protein, 
different ligands bound). The second closest structural match (3GJB) is the halogenase 
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CytC3 from Streptomyces sp. and was not ranked in the top ten structure homologs by 
PSFloger. This enzyme also uses Fe(II) and 2-oxoglutarate for catalysis (Wong et al., 
2009). The third match (3EMR) is ECTD from Salibacillus salexigens and is a non-heme 
Fe(II)-dependant dioxygenase (Reuter et al., 2010). As a final example, the number four 
structural match to the CT296 model by DALI is PDB code 3KT7. It is the protein Tpa1 
from Saccharomyces cerevisiae, a hydroxylase that binds iron and 2-oxoglutarate (Kim et 
al., 2010). Overall, the observations of the two alignment programs support the prediction 
of CT296 as an Fe(II) 2-oxoglutarate dependant enzyme. 
 A relatively conserved feature of the non-heme Fe(II) 2-oxoglutarate dependent 
enzymes is the presence of a Double-Stranded Beta Helix (DSBH) core in which the 
catalytic events typically occur (Clifton et al., 2006). This DSBH fold is formed by two 
opposing β-sheets, composed of at least four β-strands each (Clifton et al., 2006). The 
CT296 model appears to contain an incomplete DSBH core with only one relatively 
small β-sheet present containing 3 β-strands (Fig. 2.1A and Fig. 2.2A). In order to 
examine the conserved structural characteristics of the CT296 model and its homologs, 
the model was aligned with three homologous structures (2OPW, 2FCU, and 2HBT) 
from the PDB using the CCP4 Molecular Graphics program (Potterton et al., 2004) (Fig. 
2.2). The three models selected for alignment represent proteins that were identified as 
homologs to CT296 by both PSFloger and DALI. There are five (2HBT) or six (2OPW 
and 2FCU) secondary structures that are present and similarly oriented among the three 
models: three or four α-helices and two β-strands. The three or four conserved α-helices 
are oriented immediately adjacent to one of the β-sheets that forms the canonical DSBH  
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FIG 2.2. Ribbon depiction of I-TASSER model for CT296 aligned with three 
proteins exhibiting the highest structural homology. Regions of structure that are 
conserved between all four structures are highlighted in red. (A) I-TASSER model of 
CT296. Four α-helices are highlighted, α1 (L7-H16), α2 (V27-F40), α3 (G65-V73) and 
α4 (L75-T83).  Two β-strands are highlighted, β3 (D108-C114) and β4 (W122-F126). (B) 
Crystal structure of H. sapien PHYD1 (PDB 2OPW). Four α-helices, (similarly oriented 
to α1, α2, α3 and α4 from the I-TASSER model of CT296) and two β-strands (similar to 
β3 and β4 of CT296) are highlighted. (C) Crystal Structure of P. syringae SyrB2 (PDB 
2FCU). Four α-helices, (similarly oriented to α1, α2, α3 and α4 from the I-TASSER 
model of CT296) and two β-strands (similar to β3 and β4 of CT296) are highlighted. (D) 
Crystal structure of H. sapien PHD2 (PDB 2HBT). Three α-helices, (similarly oriented to 
α1, α2, and α3+4 from the I-TASSER model of CT296) and two β-strands (similar to β3 
and β4 of CT296) are highlighted. 
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core containing the known (2FCU; (Blasiak et al., 2006) and 2HBT; (McDonough et al., 
2006)) and proposed (2OPW; (Mihalik et al., 1997)) ligand-binding and catalytic site. 
There are two β-strands in the CT296 model that are immediately adjacent to the 
structurally conserved α-helices. These β-strands are oriented similar to the β-sheet that 
comprise the typical DSBH in Fe(II), 2-oxoglutarate dependent enzymes. It was also 
apparent that the structures of the three proteins used for this comparison (2HBT, 2OPW, 
and 2FCU) have only minimal opposing β-strands that compose the canonical DSBH 
typical of this family of non-heme Fe(II) 2-oxoglutarate dependent enzymes (4, 3 and 6 
short sheets, respectively). 
 
The Crystal Structure of CT296 Shows No Significant Structural Similarity to Fur 
Family Members and Has No Apparent DNA-Binding Motifs. 
 In addition to computational prediction of the structure of CT296, recombinant 
CT296 was expressed, purified and crystallized. A data set was collected and processed 
to a resolution of 1.8 Å, with one molecule of CT296 in the asymmetric unit within the 
crystal lattice (Table II). The structure of CT296 was solved using SAD phasing with 
selenomethionine-labeled recombinant protein. The crystal structure of CT296 is 
composed of a single 5-stranded antiparallel β-sheet, supported by 4 α-helices (Fig. 2.1B). 
The molecular topology of CT296 is (residue number); α1 (L7-H16) – β1 (H18-F21) – α2 
(V27-F40) – α3 (G65-V73) – α4 (L75-T83) – β2 (A89-V96) – β3 (D108-C114) – β4 
(W122-F126) – β5 (A143-S149) (Fig. 2.1C). The region between α2-α3 (E43-R54) was 
not modeled due to the lack of electron density, indicating that this region is flexible.  
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Table 2.2. Data collection and refinement statistics for CT296 
 
             
 
Data Collection   Apo CT296   SeMet-CT296 
Unit-cell parameters (Å) a = 51.2 b =64.0 c = 46.3 a = 50.8 b = 63.7 c = 46.3 
Space group    P21212    P21212 
Resolution (Å)1    30.0-1.8 (1.86-1.8)  63.66-2.5 (2.5-2.5) 
Wavelength (Å)    1.000    0.979 
Observed reflections   101642    65969 
Unique reflections   14832    5585 
<I>/σ<I>1     25.4 (2.3)    18.0 (6.1) 
Completeness (%)1   99.8 (99.9)    99.9 (99.8) 
Redundancy1    6.8 (6.2)    11.8 (12.3) 
Rmerge (%)1, 2    10.2 (59.4)    11.8 (48.0) 
Refinement 
Resolution (Å)   23.1-1.8    39.7-2.5 
Rfactor / Rfree (%)3   20.5/23.8    20.4/25.7 
No. atoms (protein / water) 1212/68    1147/20 
Model Quality 
Bond lengths (Å)   0.015    0.011 
Bond angles (o)   1.423    1.159 
Average B factor (Å2) 
Protein     28.6     35.7 
Water     31.7     32.1 
Coordinate error based on  0.19     0.26 
Maximum Likelihood (Å) 
Ramachandran Plot 
Favored (%)    98.5     97.8 
Allowed (%)    1.5     2.2 
Outliers (%)   0.0     0.0 
PDB ID    3QH6    3QH7 
 
             
 
1 Values in parenthesis are for the highest resolution shell.  
2 Rmerge = ΣhklΣi |Ii(hkl) - <I(hkl)>| / ΣhklΣi Ii(hkl), where Ii(hkl) is the intensity measured 
for the ith reflection and <I(hkl)> is the average intensity of all reflections with indices 
hkl.  
3 Rfactor = Σhkl ||Fobs (hkl) | - |Fcalc (hkl) || / Σhkl |Fobs (hkl)|; Rfree is calculated in an identical 
manner using 5% of randomly selected reflections that were not included in the 
refinement. 
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Overall, the structure is 19% β-sheet, 32% α-helix, and 49% random coil. No additional 
non-water molecules, such as divalent cations, were evident in the crystallized protein. 
 As observed for the I-TASSER model of CT296, the experimentally determined 
crystal structure does not contain similarity to Fur family members as indicated by a 
DaliLite pairwise comparison (data not shown). Additionally, the structure of CT296 
contains no apparent DNA binding motifs, such as a helix-turn-helix, a leucine zipper, a 
zinc finger, or a winged helix-turn helix. As before, the structure of CT296 was subjected 
to analysis by PreDs resulting in a P score of 0.06, well below the typical cutoff point for 
DNA-binding proteins (0.12). Together, these analyses of the crystal structure of CT296 
are in contrast with the precious observations that CT296 is a DNA-binding protein with 
structural similarity to Fur. 
 
The Structure of CT296 Predicted by I-TASSER is Similar (Cα r.m.s.d. 2.72 Å) to the 
CT296 High-Resolution Structure Solved Using X-ray Crystallography. 
  Because CT296 lacks homologs by primary sequence, template-based homology 
modeling cannot be used to generate a model of the structure of CT296.  Therefore, ab 
initio modeling must be employed. This type of modeling is a particular challenge in the 
field of protein structure prediction (Lee et al., 2009).  Impressively, the I-TASSER 
generated model of CT296 has significant overall structural similarity (Cα r.m.s.d. 2.72 Å 
for 101/137 Cα) to the experimentally determined structure of CT296 (Fig. 2.1). The 
model and experimentally determined structure of CT296 are primarily α-helical (46% vs. 
32%, respectively) but almost 50% of the protein is random coil. In total, there are six 
secondary structure elements in the experimentally determined structure (α1, α2, α3, α4, 
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β3, and β5) that are equivalent in the model of CT296 (Fig. 2.1). A notable difference 
between the two structures is a helix (α3; H51-R94) modeled by I-TASSER that is 
unstructured in the experimentally determined structure. The most prominent difference 
between the two structures is the presence of a five-stranded β-sheet (β1-5) in the 
experimentally determined structure whereas I-TASSER modeled only two β-strands (β2 
and β3). 
 
Structural Homology Searches Using the High-Resolution X-ray Crystallography 
CT296 Structure Yield Almost Identical Results as the CT296 I-TASSER Model.
 To determine the impact on functional predictions due to the structural differences 
between experimentally determined and modeled CT296, the crystal structure of CT296 
was used to search for structural homologs in the PDB using PSFloger and DALI (Table 
III). As expected, the scores for top matches improved dramatically (TM-Score range 
0.7806-0.6764 and DALI Z-score range 10.5-8.7). Strikingly, all of the top 10 PSFloger 
and all but one (PutA – PDB 3ITG) of the DALI homologs are retained in the comparable 
homology search of the I-TASSER model for CT296 (Table I), reinforcing the prediction 
that CT296 has a structural scaffold similar to non-heme Fe(II) 2-oxoglutarate enzymes. 
The top hit for both PSFloger and DALI was PHYHD1 (2OPW), an enzyme from H. 
sapiens. Similar to the I-TASSER CT296 model homology search, only three of the 
proteins (PHYD1, PHD2, and SyrB2) were shared between the top CT296 structure 
homology matches of PSFloger and DALI.  
 Based upon the conservation of proteins with structural homology identified 
between the two search processes and increase in homology scores, it was expected that 
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Table 2.3. Top 10 homologous structures to the crystal structure of CT296 as 
measured by PSFloger and DALI 
 
    PSFloger             DALI                       
Rank TM-Score1 PDB File Protein Name Classification  Z Score2 PDB File Protein Name Classification   
1 0.7806 2OPW PHYHD1 Hydroxylase (Mihalik et al., 1997) 10.5 2OPW PHYHD13 Hydroxylase (Mihalik et al., 1997) 
2 0.7537 2FCU SyrB2 Halogenase (Blasiak et al., 2006) 10.5 3GJB CytC3 Halogenase (Wong et al., 2009) 
3 0.7473 2A1X PHYHD1 Hydroxylase (McDonough et al., 2005) 10.3 3NN1 Hal Halogenase (Khare et al., 2010) 
4 0.7221 2CSG YbiU Putative oxioreductase 9.9 3EMR ECTD Dioxygenase (Reuter et al., 2010) 
5 0.7138 2DBN JW0805 Unknown Function 9.7 3HQU PHD23 Hydroxylase (Chowdhury et al., 2009) 
6 0.7113 2HBT PHD2 Hydroxylase (Warshakoon et al., 2006) 9.4 2FCU SyrB2 Halogenase (Blasiak et al., 2006) 
7 0.6905 1UNB DAOCS Oxioreductase (Valegard et al., 2004) 9.1 3GZE P4H3 Hydroxylase (Koski et al., 2009) 
8 0.6802 2RDN PtlH Hydroxylase (You et al., 2007) 9.0 2RG4 Q2CBJ1 Unknown Function 
9 0.6793 3GJB CytC3  Halogenase (Wong et al., 2009) 8.8 3MGU Tpa1 Hydroxylase (Kim et al., 2010) 
10 0.6764 1GP6 ANS Dioxygenase (Wilmouth et al., 2002) 8.7 3ITG PutA Oxioreductase (Srivastava et al., 2010) 
              
1TM-score is a measurement of similarity between two protein structures and it varies from 0 to 1, with 1 indicating a perfect alignment.  A score of  
0.5 or higher indicates significant similarity (Zhang & Skolnick, 2005). 
2Structures with Z-scores above 2 are considered to be significant matches (Holm et al., 2008). 
3This protein was listed multiple times on the DALI output, with various minor differences (ligands, etc.); the redundant structures are not listed here.  
	   46	  
 
 
 
 
 
FIG 2.3. Ribbon depiction of experimentally determined structure of CT296 aligned 
with three proteins exhibiting the highest structural homology. Regions of structure 
that are conserved between all four structures are highlighted in red. (A) Crystal structure 
of CT296. Four α-helices are highlighted, α1 (L7-H16), α2 (V27-F40), α3 (G65-V73) and 
α4 (L75-T83).  Three β-strands are highlighted, β3 (D108-C114), β4 (W122-F126) and 
β5 (A143-S149). (B) Crystal structure of H. sapien PHYD1 (PDB 2OPW). Four α-
helices, (similarly oriented to α1, α2, α3 and α4 from the I-TASSER model of CT296) 
and three β-strands (similar to β3, β4 and β5 of CT296) are highlighted. (C) Crystal 
Structure of P. syringae SyrB2 (PDB 2FCU). Four α-helices, (similarly oriented to α1, α2, 
α3 and α4 from the I-TASSER model of CT296) and three β-strands (similar to β3, β4 
and β5 of CT296) are highlighted. (D) Crystal structure of H. sapien PHD2 (PDB 2HBT). 
Three α-helices, (similarly oriented to α1, α2, and α3+4 from the I-TASSER model of 
CT296) and three β-strands (similar to β3, β4 and β5 of CT296) are highlighted. 
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additional structural elements would be shared. The experimentally determined structure 
of CT296 was aligned with three of its structural homologs from the PDB, in order to 
determine which structural regions are similar (Fig. 2.3). The three structural homologs 
selected are the same three that were aligned to the I-TASSER model of CT296 (Fig. 2.1; 
2OPW, 2FCU, and 2HBT); these proteins can be found on the PSFloger and the DALI 
lists of both the model and the experimental structure of CT296. A total of seven 
secondary structure elements are equivalent between CT296 and the three selected 
homologs, three α-helices (α1, α2, α3, and α4) and three β-sheets (β3-5). Importantly, six 
(α1, α2, α4, α5, β2, and β3) of these seven structural elements were also found to be 
equivalent between the model of CT296 and the homologs. This suggests that these 
elements are the underlying reason for the large number of proteins that contain structural 
homology to both the model and the experimental structure of CT296. 
 
CT296 does not possess the molecular capabilities to bind to Fe(II) or 2-oxoglutarate 
  Despite the overall global structural similarity between CT296 and many Fe(II) 
and 2-oxoglutarate containing enzymes, CT296 lacks the appropriate residues to properly 
coordinate these molecules.  For example, CT296 shares structural homology to the 
prolyl hydroxylase PHD2 from Homo sapiens (Table 2.1 and 2.3).  The enzymatic 
function of PHD2 requires Fe(II) and 2-oxoglutarate, which are coordinated by four 
residues (His313, Asp315, His 374, Arg383) (Chowdhury et al., 2009).  The coordination 
of these molecules can be seen in the crystal structure (Fig 2.4A).  However, these 
residues critical to the enzymatic function of PHD2 do not appear to be retained in 
CT296. The corresponding residues in CT296 (Leu103, Asp105, Pro131, Asp141) would 
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FIG. 2.4.  CT296 does not have the conserved residues nor their proper orientation 
for the coordination of Fe(II) or 2-oxoglutarate.  (A) A structural homolog to CT296, 
PHD2 (PDB ID: 2HBT) coordinates an Fe(II) atom and a 2-oxoglutarate molecule using 
the amino acid sidechains His313, Asp315, His 374, Arg383.  (B) CT296 did not 
crystallize with either Fe(II) or 2-oxoglutarate bound, but a superposition of CT296 onto 
the structure of PHD2 reveals where these molecules would rest in the structure of CT296.  
The amino acid sidechains that correspond to those of PHD2 that coordinate these 
molecules are labeled (Leu103, Asp105, Pro131, Asp141); none of these residues are in 
an appropriate orientation to coordinate these molecules. 
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 likely not coordinate an iron atom or a 2-oxoglutarate molecule (Fig. 2.4). Similar 
comparisons have been made for EctD from Virgibacillus salexigens (Reuter et al., 2010) 
and CytC3 from Streptomyces (Wong et al., 2009) with the same conclusion as PHD2. 
 
Recombinant CT296 is Predominantly Monomeric at Physiological Concentrations. 
  Recombinant Fur has been shown to exist predominantly as a homodimer in 
solution (D'Autreaux et al., 2007, Michaud-Soret et al., 1997). At high protein 
concentrations, Fur has been shown to form other higher-order structures, but the 
predominant species present at physiological concentrations (1-17 µM) of the protein is 
that of a dimer (D'Autreaux et al., 2007). Likewise, recombinant CT296 has previously 
been reported to form homodimers (Wyllie & Raulston, 2001). Given the structure of 
CT296 and its lack of similarity to Fur, the quaternary structure of recombinant CT296 
was reassessed, including a study of the effects of protein concentration. To accomplish 
this, recombinant CT296 was purified and subjected to size exclusion chromatography 
(SEC). Although SEC is not an appropriate technique for precise quantification of 
molecular weight, a standard curve can be constructed based on the elution of profiles of 
proteins of known molecular weight. A protein standard solution containing γ-globulin 
(158 kDa), ovalbumin (44 kDa), myoglobin (17 kDa) and vitamin B12 (1.4 kDa) was used 
to approximate the molecular weights of CT296 at varying concentrations. The molecular 
weight of CT296 is 17.9 kDa and so a dimer of CT296 would be 35.8 kDa. 
 At high protein concentration, (1000 µM) a predominant peak that corresponds to 
the approximate molecular weight of a CT296 dimer was observed (48.0 kDa; Fig. 2.5A). 
Other peaks that correspond to even higher order structures were also observed at this 
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FIG. 2.5. Size exclusion chromatograms of recombinant CT296 at varying 
concentrations. The molecular weight of monomeric CT296 is 17.9 kDa. The molecular 
weight of a CT296 dimer would be 35.8 kDa. The components of a molecular weight 
ladder are marked at their respective elution volumes on a line above the chromatograms. 
(A) At a concentration of 1000 µM, CT296 is predominantly present in a peak that 
approximately corresponds to the molecular weight of a dimer. Other, even higher order, 
structures can also be seen, in lower abundance. (B) At a concentration of 100 µM, 
CT296 elutes within fractions that correspond to the molecular weight of a monomer.  
(C) At a concentration of 10 µM, CT296 elutes as a peak that corresponds to the 
molecular weight of a monomer. 
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concentration (109 kDa; Fig. 2.5A). At a lower protein concentration, (100 µM), there 
was a single peak which corresponds to the molecular weight of a monomer of CT296 
(17.0 kDa; Fig. 2.5B). At the lowest concentration tested (10 µM), an approximate 
monomer of CT296 was observed (12.1 kDa; Fig. 2.5C). The physiological concentration 
for CT296 is not known, but physiological concentrations for Fur have been reported to 
be between 1 and 17 µM (D'Autreaux et al., 2007). These data show that, unlike Fur, 
CT296 exists predominantly as a monomer in solution at concentrations of 10-100 µM. 
This suggests that CT296 may lack other functional properties of Fur or other Fur-like 
repressors. 
 
CT296 Does Not Bind to Previously Reported Chlamydial Promoter DNA by 
Electrophoretic Mobility Shift Assay. 
  In previous reports, CT296 was shown to bind to DNA in the context of an 
Electrophoretic Mobility Shift Assay (EMSA) (Rau et al., 2005, Wyllie & Raulston, 
2001). Given the apparent absence of DNA-binding motifs in both the modeled and the 
experimentally determined structures of CT296, the DNA binding properties of CT296 
were reexamined. The promoters of two genes that were previously shown to bind to 
CT296 by EMSA were selected for analysis (Rau et al., 2005); namely, CT248 and 
CT709. The exact sequences of DNA from these promoters that were used in the previous 
study were not reported. However, the recent determination of the transcription start site 
(TSS) for these genes (Albrecht et al., 2010) allowed for the design of ~400 base pair 
regions that include at least 150 bases upstream and downstream of the TSS. To serve as 
a negative control, ~400 base pairs from the region of DNA between the two converging  
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FIG. 2.6. Electrophoretic Mobility Shift Assay (EMSA) using recombinant CT296.  
Three different promoter regions of DNA were tested with varying DNA:protein molar 
ratios; 1:100, 1:500 and 1:2500 (- indicates the absence of protein). CT032/033 is an 
intergenic region between two converging genes and is used as a negative control. CT248 
and CT709 had been previously reported to be bound by recombinant CT296 in the 
context of an EMSA. 
 
 
 
	   56	  
 
 
 
 
 
 
 
 
	   57	  
genes CT032 and CT033 was used. No shifts in DNA were detected with any of the 
promoter regions analyzed at any of the DNA:protein molar ratios used, even at the 
highest ratio of 1:2500 (Fig. 2.6). These findings are in direct contrast with the previous 
observations that CT296 binds to chlamydial promoter DNA. 
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Chapter II 
Discussion 
 
 One of the major observations of this study is that the experimentally determined 
properties of CT296 are not consistent with previous reports regarding the function of 
this protein. CT296 had been characterized previously (Rau et al., 2005, Wyllie & 
Raulston, 2001) as a chlamydial homolog to the E. coli Fur protein—a metal-responsive 
transcriptional repressor, termed DcrA (Divalent cation-dependent regulator A). The 
evidence for this functional assignment came primarily from E. coli Fur cross-reactive 
antibodies, the ability of CT296 to functionally complement Fur in E. coli, and the ability 
CT296 to bind to chlamydial promoter DNA sequences via EMSA. However, the 
experimentally determined structure of CT296 bears no structural similarity to Fur, does 
not contain an identifiable DNA binding motif, and putative regions for DNA binding 
were not identified using PreDs. No divalent cations were observed in the crystal 
structure and a metal-binding site could not be identified. Additionally, attempts to 
demonstrate that CT296 can bind to the chlamydial DNA targets reported previously 
(Rau et al., 2005) were unsuccessful (Fig. 2.5).  In the previous analysis, EMSA was used 
to validate targets isolated from a screen designed to find regions of chlamydial DNA that 
bound E. coli Fur.  In that analysis, the variable-sized regions of chlamydial DNA 
directly from a screen were analyzed for CT296 binding. Importantly, the molar ratio of 
DNA:protein in reaction mixtures were not stated and precise regions of the chlamydial 
genome tested were not reported.  In this report, analyses used regions of DNA designed 
based on the recently reported transcription start sites for these genes (Albrecht et al., 
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2010).  At a wide range of DNA:protein ratios and with the inclusion of different divalent 
cations (data not shown), DNA binding by CT296 could not be detected. Finally, CT296 
was previously reported to form dimers that are resistant to denaturation by SDS-PAGE 
(Wyllie & Raulston, 2001). During protein purification, only monomers of CT296 were 
observed by SDS-PAGE. Using gel filtration chromatography, higher order structures 
corresponding roughly to the molecular weight of a dimer can be seen, but this is only at 
very high concentrations (Fig. 2.4; 1000 µM) of protein where even higher order 
structures are observed. A direct explanation for these apparently discordant observations 
is not evident but not without significant efforts. 
One of the primary purposes for elucidating the structure (experimentally or 
computationally) of a protein of unknown function is to enable functional prediction and 
facilitate further analyses to confirm the predicted function. Functional assignment 
typically begins by searching for structural homologs to the protein of unknown function 
(Adams et al., 2007). In the case of CT296, this search yielded many structures, all with 
significant structural similarity (Table 2.1 and 2.3). According to the protein family 
database, all of the proteins with structural similarity are members of the cupin 
superfamily of proteins. This superfamily is functionally diverse, but all members share a 
characteristic β-barrel (Dunwell et al., 2004, Khuri et al., 2001). The proteins with 
structural similarity to CT296 have relatively different enzymatic functions (hydroxylase, 
halogenase, dioxygenase, reductase.) but all are members of the predominant cupin 
subclass of 2-oxoglutarate-Fe(II) dependent enzymes (Dunwell et al., 2004). These 
proteins have a well-defined fold termed a double stranded β-helix (DSBH) in which the 
	   60	  
enzymatic processes typically occur, including the binding site of the enzymatic co-
factors Fe(II) and 2-oxoglutarate. 
 Despite the correlation of protein function and structural similarity, there are 
many observations that do not support functional annotation of CT296 as a 2-
oxoglutarate-Fe(II) dependent enzyme in the cupin superfamily. Firstly, the structure of 
CT296 contains an incomplete DSBH fold, the structural motif that is characteristic of 
cupin superfamily proteins. The structure of CT296 contains one side of the β-helix 
consisting of five β strands; however, it lacks an opposing β-sheet that would form the 
typical DSBH fold. Secondly, no Fe(II) or 2-oxoglutarate were identified within the 
CT296 protein structure. Furthermore, attempts to soak CT296 protein crystals with these 
compounds (independently or in combination) or to generate new CT296 protein crystals 
in the presence of these compounds did not yield stable crystals (data not shown). Lastly, 
the vast majority of key residues that function in coordinating Fe(II) and 2-oxoglutarate 
for the proteins with structural homology are not conserved in CT296. 
 In contrast, there are many structural elements of CT296 that are remarkably 
similar to the arrangements of its structural homologs, as illustrated in Fig. 2.3. In fact, 
several secondary structure elements of CT296, four α-helices (α1-4) and three β-sheets 
(β2-4), are all localized together and similarly aligned with homologs. The four α-helices 
have not been shown to play a role in ligand binding or catalysis but appear to serve as 
structural support for the double stranded β-helix (Blasiak et al., 2006, McDonough et al., 
2005). While CT296 appears to contain an incomplete double stranded β helix, this 
region of structural homology may be stabilizing the β-sheet region of CT296. 
Additionally, CT296 could function as a part of a higher order structure and that the 
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conserved region of surface exposed α helices could stabilize an interaction interface to 
another protein(s). Importantly, additional experimental evidence is needed to 
appropriately define the function of CT296. 
  It is important to note that the structural information regarding CT296 was, on its 
own, somewhat misleading.  By examining only global structural similarity, one might 
have concluded that CT296 in an Fe(II) and 2-oxoglutarate-dependent enzyme.  However, 
by examining the structure and the primary sequence more closely and by attempting to 
identify the conserved features of its predicted function (the cofactor coordinating 
residues), it was concluded that CT296 likely does not function as an Fe(II) and 2-
oxoglutarate-dependent enzyme.  This illustrates that point that, when utilizing structural 
information to inform function, the structure must be examined for salient features 
instead of simply being classified based on global similarity. 
 Another of the observations of this study was the ability of I-TASSER to 
accurately model the three-dimensional structure and aid in the prediction of function of a 
protein encoded by C. trachomatis that does not share primary sequence homology with 
any proteins with functional assignment. While accuracy can be a subjective 
measurement, the Cα r.m.s.d. (2.72 Å) between the CT296 model and experimentally 
determined structure provides a relative measurement that the model generated by I-
TASSER is a very close representation of the physical structure of the protein. It is 
especially encouraging that none of the templates used in the I-TASSER modeling had 
sequence identity to the target higher than 25%. Proteins with such low similarity to any 
of the templates represent a ‘twilight zone’ in the structural genome, which is one of the 
most challenging categories of targets for protein structure prediction. 
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 As typically performed, the Chlamydia trachomatis genomes were annotated 
using primary sequence homology to assign function. After applying this strategy, 
chlamydial genomes have an abundance of ORFs of unknown function – approximately 
25% of encoded proteins (Carlson et al., 2005, Unemo et al., 2010, Thomson et al., 2008, 
Stephens et al., 1998). For Chlamydia pneumoniae, another chlamydial species with an 
immense impact on public health, the situation is worse with approximately 35% of 
encoded proteins characterized as hypothetical. In addition to this report, there are limited 
data in Chlamydia to demonstrate the utility of protein structure to facilitate functional 
assignment for uncharacterized proteins. However, a highly supportive and recent 
example is an analysis on protein encoded by open reading frame CT670. CT670 has 
very limited primary sequence similarity to any other protein, but the X-ray crystal 
structure supports this protein functions in the chlamydial type three secretion system and 
is homologous to YscO from Yersinia pestis (Lorenzini et al., 2010). Furthermore, this 
protein was demonstrated to interact in vivo with many other type III secretion 
components in Chlamydia (Lorenzini et al., 2010) and functional prediction of CT670 is 
supported by the inclusion of the encoding gene in an operon that contains type three 
secretion system homologs (Hefty & Stephens, 2007). Outside of Chlamydia, there is an 
abundance of reports on hypothetical proteins having function assigned based on 
structure (Janowski et al., 2009, Sim et al., 2009, van Staalduinen et al.). Therefore, more 
thorough annotations of bacterial genomes (and the chlamydial genome in particular) 
would benefit greatly from the incorporation of computation and/or experimentally 
determined structural information. 
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 The studies presented here have shown that I-TASSER is effective at predicting 
the structures of proteins that have no function homologs by primary sequence and would 
be very effective as a complement to primary sequence annotation. While this study also 
highlights the limitations of structural based functional annotation, the structural 
information provides a wealth of molecular information that can be leveraged to elucidate 
the biochemical function and biological role of a given protein – for which relatively little 
is previously known. 
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Chapter III.  Localization studies of the Chlamydia trachomatis protein CT584, a 
potential type III secretion needle tip protein 
 
Abstract 
 
 Chlamydia species use a Type Three Secretion System (T3SS) to facilitate entry 
into the host cell, maintain their parasitophorous vacuole within the host, and possibly to 
exit host cells. Key in the ability of the T3SS to operate is the T3SS needle tip protein 
that, in other bacteria, sense environmental conditions to initiate T3SS dependent 
translocation. These proteins have been demonstrated to have at least some portion of the 
protein exposed to the extracellular environment. A putative T3SS needle tip protein in 
Chlamydia trachomatis, CT584, was recently reported. This identification was based on 
the protein’s computationally predicted structure and experimentally determined 
biophysical characteristics, both of which were similar to other T3SS needle tip proteins.  
It was also recently reported that CT584 is associated with the chlamydial T3SS needle 
protein in the context of a yeast two-hybrid screen. To further test the hypothesis that 
CT584 is a surface-exposed T3SS needle tip protein, protease protection assays were 
employed. This analysis indicated that undetectable levels of CT584 are surface exposed 
on EBs. Similarly, antibodies against CT584 do not bind to the protein on the surface of 
EBs as demonstrated by direct IFA. Additionally, confocal microscopy was employed to 
analyze infected cells; these studies suggest that CT584 is primarily localized to the 
cytoplasm in RBs. Together, these data do not support the role of CT584 as a surface 
exposed T3SS needle tip protein. 
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Introduction 
 
  Human infections by species of Chlamydia have a significant impact on public 
health worldwide.  Different strains of the bacterium Chlamydia trachomatis are capable 
of infecting the ocular epithelium, causing blinding trachoma, or infecting the genital 
tract, causing sexually transmitted disease (Cecil et al., 2001, Falk et al., 2005, Mariotti et 
al., 2009, Resnikoff et al., 2004).  All chlamydial organisms are obligate intracellular 
parasites and their pathogenesis is intimately linked to their unique biphasic 
developmental cycle.  During this cycle, metabolically inactive, infectious forms of the 
bacteria referred to as Elementary Bodies (EBs) bind to and enter host cells.  Once inside 
the host cells, chlamydial organisms convert to non-infectious metabolically active forms 
termed Reticulate Bodies (RBs) and replicate within a parasitophorous vacuole termed an 
inclusion, evading immune response and apoptosis as they divide (Zhong, 2009).  Finally, 
RBs begin to asynchronously convert back to EBs, which are released from the host cell 
by lysis or extrusion at about 48 hours post infection (Hybiske & Stephens, 2007). 
  The genome of Chlamydia trachomatis contains almost all of the components for 
a functional Type III Secretion System (T3SS) (Stephens et al., 1998).  This secretion 
system is composed of a large multi-protein apparatus termed an injectisome and is 
widely used by pathogenic Gram negative bacteria to translocate effector proteins from 
the bacterial cytoplasm directly into their host cells.  At several points during their 
developmental cycle, Chlamydiae employ a Type III Secretion System (T3SS) to allow 
infection and to subvert normal cell processes.  Notably, T3SS effector proteins have 
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been implicated in playing vital roles in invasion (by EBs), inclusion biogenesis and 
manipulation of the host immune system (by RBs).  The protein components involved in 
this process are typically well conserved among bacterial species that possess T3SS, 
including species of Yersinia, Salmonella, and Shigella flexneri (Hueck, 1998).  However, 
homologs to many of these proteins are not apparent in chlamydial genomes, especially 
effector proteins.  Efforts to identify these proteins through a variety of experimental and 
computational methods has been fairly successful (Peters et al., 2007). 
  Among these T3SS proteins that are conserved among other bacteria but not 
apparent within chlamydial species is the needle tip protein.  This protein sits atop the 40-
80 µm long, extracellular needle and has been shown to regulate the secretion process by 
sensing contact with the host cell (Espina et al., 2006).  Additionally, this protein is of 
interest because the Yersinia pestis homolog has been shown to an effective component 
of a vaccine against this pathogenic bacterium (Overheim et al., 2005).  Importantly, by 
primary sequence homology, there is no apparent homolog by to needle tip protein in any 
chlamydial genome. 
  Experimental evidence suggests that the protein CT584 (to use the nomenclature 
of C. trachomatis) may be the chlamydial needle tip protein.  In a study utilizing the 
yeast-two hybrid assay, the interactions between known components of the chlamydial 
T3SS and chlamydial proteins of unknown function were examined (Spaeth et al., 2009).  
Among the proteins of unknown function was CT584, which was shown to interact with 
CdsF, the T3SS needle protein, a property consistent with the function of CT584 as a 
needle tip protein.  Additionally, the biophysical properties of the CT584 protein, as 
assessed by a battery of different tests (including circular dichroism, Fourier transformed 
	   67	  
infrared spectroscopy and UV absorbance spectroscopy) showed that this protein has 
structural properties akin to similarly characterized, known needle tip proteins (Markham 
et al., 2009). 
  All of the evidence that supports the role of CT584 as the chlamydial needle tip 
protein is indirect; based on the behavior of the protein in vitro or in a heterologous 
system.  In order to more confidently identify the function of CT584 as a needle tip 
protein, more direct methods of experimentation must be employed.  Therefore, we 
sought to employ various techniques to examine the cellular localization of the CT584 
protein.  This approach takes advantage of the uncommon localization of needle tip 
proteins; namely, that they localize extracellularly on the ends of the T3SS needles.  
Ultimately, these studies indicate that CT584 is not localized primarily to the outside of 
chlamydial cells (either EB or RB). 
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Chapter III 
Materials and Methods 
 
Proteinase K protection assay- For each condition, 100 µL of highly purified EBs were 
diluted 1:4 in 1x PBS.  EBs were purified using a 30% Renografin density gradient, as 
described previously (Scidmore, 2005).  Conditions with soluble CT584 protein were 
supplemented with 0.1 µg of purified recombinant CT584, purified as described 
previously (Markham et al., 2009).  Conditions without recombinant CT584 received an 
equal volume of CT584 buffer (40 mM tris, pH 8.0, 500 mM NaCl, 5% glycerol).  
Conditions with proteinase K were supplemented with 40 µg of purified proteinase K 
(Sigma-Aldritch); conditions not treated with proteinase K were supplemented with an 
equal volume of proteinase K buffer (50 mM Tris pH 8.0, 10 mM CaCl2).  Following 
proteinase K addition, tubes were incubated for 30 minutes at 37 °C, after which PMSF 
(Thermo Pierce) was added to a final concentration of 5 mM.  Samples were vortexed, 
supplemented with final sample buffer, boiled for 10 minutes and then loaded onto a 15% 
SDS-PAGE gel. 
 
Immunofluorescence of EBs- Highly purified EBs from C. trachomatis (serovar L2 / 434 / 
Bu) were diluted 1:17 in 1x PBS and were incubated on glass coverslips for one hour at 
room temperature, to allow EBs to adhere to the glass.  EBs were then fixed by the 
addition of 1 mL of methanol and incubated for 10 minutes at room temperature.  Fixed 
EBs were blocked in a solution of 1x PBS containing 5% BSA for 1 hour at room 
temperature.  All slides were stained using a commercially available kit, which labels 
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EBs green (Trinity Biotech) for 1 hour at room temperature.  Each slide was probed with 
a different primary antibody, anti-MOMP (ViroStat), anti-RopA or anti-CT584, for 1 
hour at room temperature.  Anti-RopA and anti-CT584 antibodies had been purified from 
sera using AminoLink Plus coupling resin (Thermo Scientiic), as per manufacturer’s 
protocol.  Finally, slides were probed with fluorescently conjugated secondary antibodies 
that label the protein of interest (MOMP, RpoA or CT584; Invitrogen) in red for 1 hour at 
room temperature.  Coverslips were mounted on glass slides using mounting medium 
(Vector Labs) and then visualized using an IX71 inverted microscope (Olympus). 
 
Confocal microscopy of infected cells- A monolayer of L929 cells on an 8-well µ-slide 
plate (Ibidi) was infected with C. trachomatis to a multiplicity of infection of 1.0.  At 24 
hours post infection, cells were fixed with methanol and washed.  Fixed cells were 
probed with primary antibodies, anti-CT584 and anti-MOMP (ViroStat) for 1 hour at 
room temperature.  Cells were washed with 1x PBS and probed with secondary 
antibodies (Invitrogen) for 1 hour at room temperature.  Cells were mounted and 
visualized using a spinning disk confocal microscope (Olympus).  Images were de-
convolved using the nearest-neighbor method. 
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Chapter III 
Results 
 
CT584 is not primarily surface exposed on EBs 
  A distinctive property Type III Secretion System (T3SS) needle tip proteins is 
their extracellular localization.  As a proposed chlamydial T3SS needle tip protein CT584 
should therefore likely also be localized extracellularly.  In order to examine the 
localization of CT584, several different methods were employed.  Initially, a proteinase 
K protection assay was used.  In this assay, whole cells (in working with chlamydia, EBs) 
are exposed to the broad-specificity protease Proteinase K (PK).  This protease is capable 
is digesting nearly any protein, based on its preferred cleavage site at the carboxyl end of 
aliphatic or aromatic amino acids, which are common in virtually all proteins (Kraus & 
Femfert, 1976).  Because the integrity of the outer membrane of the cells is not 
compromised in this assay, proteins that are surface exposed will be digested by the 
protease while proteins not exposed to the surface will be unaffected. 
  To ensure that the protease was digesting only surface-exposed proteins, the 
protein levels of the major outer membrane protein MOMP were examined.  Although 
this integral membrane protein has minimal surface exposure, this was sufficient 
exposure and the protein was digested thoroughly in the presence of PK (Fig. 3.1).  
Additionally, protein levels of the alpha subunit of RNA polymerase (RpoA) were 
examined.  This protein functions in the cytoplasm and therefore should not be digested.  
Following PK treatment, RpoA levels are unaffected, demonstrating that EB membrane  
	   71	  
 
 
 
 
 
 
FIG 3.1.  Proteinase K protection Assay.  Highly purified EBs were either treated or 
mock treated with Proteinase K, a highly active broad-specificity protease.  Following 
treatment, protease activity was inhibited and EBs were lysed, run on an SDS-PAGE gel, 
subjected to western blot, and then probed with antibodies.  Blots were probed again 
RpoA, a subunit of RNA polymerase, known to have cytoplasmic localization, MOMP, 
also known as OmpA, the major outer membrane proteins and against CT584.  Although 
it has very broad specificity for cleavage, the ability of proteinase K to digest CT584 
protein was confirmed by the addition of purified recombinant CT584 to the EBs prior to 
digestion. 
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integrity was not compromised (Fig. 3.1).  Finally, levels of CT584 were analyzed.  
Following treatment by PK, CT584 protein levels were not significantly affected (Fig. 
3.1).  This indicates that the majority of CT584 in the cells it not surface exposed. 
  Although the specificity of Proteinase K is very broad and the primary sequence 
of the CT584 protein confirms the presence of over 50 potential PK recognition sites, it is 
possible that the CT584 protein in not digestible by PK.  To confirm the susceptibility of 
CT584 to PK, EBs were supplemented with purified recombinant CT584.  This protein 
runs at a slightly higher molecular weight than endogenous CT584 due to a polyhistidine 
tag utilized for purification of the recombinant protein.  Following PK treatment, this 
supplementary extracellular CT584 was digested by PK, confirming that the protein is 
susceptible to digestion, if properly exposed (Fig 3.1). 
  Importantly, this result does not preclude surface exposure for this protein.  It is 
possible that the majority of CT584 in the cell remains in the cytoplasm with a minority 
of the protein localizes to the surface.  In this case, PK would digest the surface-exposed 
subpopulation of protein but since total protein levels are assessed, its absence would not 
be detected. 
 
CT584 could not be detected on the surface of EBs by immunofluorescence 
  In order to more precisely elucidate the localization qualities of CT584, direct 
immunofluorescence of EBs was employed.  If a small sub-population of CT584 is 
localized to the membrane, then this technique should be successful in detecting it.  In 
this experiment, EBs were attached to a glass coverslip, fixed, blocked and then probed 
with a fluorescently conjugated antibody that binds to the MOMP protein on the outer  
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FIG. 3.2.  CT584 is not detected on the surface of EBs by immunofluorescence.  EBs 
were fixed on glass coverslips and then blocked.  In all conditions (A-C), EBs were 
labeled with a fluorescently-labeled primary antibody that binds to EBs and fluoresces 
green.  (A) EBs were also probed with an anti-MOMP antibody, followed by a secondary 
antibody that fluoresces red.  (B) EBs were also probed with an anti-RpoA antibody, 
followed by a secondary antibody that fluoresces red.  (A) EBs were also probed with an 
anti-CT584 antibody, followed by a secondary antibody that fluoresces red. 
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surface of chlamydial organisms and fluoresces green; therefore, all conditions tested 
have green fluorescing EBs (Fig. 3.2).  As a control to ensure that the secondary antibody 
is functioning properly, in one condition, EBs were probed with a primary anti-MOMP 
antibody followed by a secondary antibody that fluoresces red.  Therefore, in this 
condition, EBs were labeled with both green and red, producing yellow colored EBs (Fig. 
3.2A).  To ensure that the fixing procedure was not compromising the integrity of the EB 
membrane, in another condition, EBs were probed with a primary against RpoA (the 
chlamydial alpha subunit of RNA polymerase, a protein that should not have surface 
localization) followed by a secondary antibody that fluoresces red.  This produced EBs 
that fluoresce green but not red, illustrating that internally localized proteins are not 
available for antibody binding (Fig. 3.2B).  In the final condition, EBs were probed with 
antibodies against CT584.  EBs were not labeled in red in this condition, indicating that 
CT584 is not available for antibody binding on EBs. 
 
CT584 does not exhibit primarily surface localization in RBs 
  In order to examine the localization properties of CT584 in the context of RBs, 
infected cells were examined at 24 hours post infection by confocal microscopy (Fig. 3.3).  
CT584 has a localization pattern that is consistent with primary cytoplasmic localization 
(Fig. 3.3A).  As a control for a known membrane localized protein, the localization of 
MOMP was also examined, in the same inclusions.  MOMP displays a characteristic 
localization to the RB membrane, resulting in bacteria with ring-like fluorescence (Fig 
3.3B).  Because the two proteins were fluorescently labeled in the same sample, a merged 
image showing localization of both together was constructed; this image shows clearly  
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FIG 3.3.  CT584 is not primarily localized to the surface of RBs.  L929 cells were 
infected with C. trachomatis and fixed at 24 hours post infection, probed with antibodies 
and then visualized by confocal microscopy.  Cells were then probed with antibodies 
against CT584 (A) and against MOMP (B).  A merged image showing both CT584 and 
MOMP fluorescence shows their contrasting localizations (C).  Host cell nuclei are 
stained in each image in blue. 
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how the localization of CT584 does not resemble the ring-like localization of MOMP 
(Fig. 3.3 C).  This analysis shows that in the context of RBs, CT584 does not have a 
localization pattern consistent with primary membrane localization. 
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Chapter III 
Discussion 
 
  Levels of CT584 in EBs were not significantly affected by treatment with the 
protease Proteinase K.  This indicates that the majority of CT584 present in EBs is not 
available for digestion by the protease.  This does not preclude its surface localization for 
two reasons: first, it remains possible that CT584 has two roles in the cell, as both a 
needle tip protein and serving another function in the cytoplasm of the chlamydial cell.  If 
the number of CT584 proteins serving an extracellular role is significantly less than the 
number of proteins functioning in the cytoplasm, then their destruction by the protease 
would not significantly affect the total overall levels of CT584 protein in the EBs.  An 
examination of this ambiguity is handled by the examination of EBs by 
immunofluorescence, discussed below.  Another possible explanation for the lack of 
CT584 destruction is that CT584 may have surface localization but plays its role in RBs, 
not EBs.  This is plausible because it is known that the T3SS plays a role in both EBs and 
in RBs.  EBs were used in this assay because the purification of RBs while maintaining 
the integrity of their membranes is challenging.  This possibility served as justification 
for the following experiments examining CT584 localization in RBs. 
  CT584 could not be detected on the surface of EBs by immunofluorescence.  One 
interpretation of these data is that CT584 is not localized to the surface of chlamydia and 
is therefore not likely to be the T3SS needle tip protein.  However, these are a few 
alternate explanations to these findings.  The positive control for surface localization 
(MOMP) was easily detected in this assay.  However, MOMP is, as its name implies, the 
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major protein component of the chlamydial outer membrane, making up ~60% of the 
total protein of the outer membrane (Caldwell et al., 1981).  It is possible that CT584 is 
localized to the surface of EBs but in quantities that are below the levels for detection by 
this assay.  In order to eliminate this doubt, more sensitive, higher resolution techniques 
must be employed in the future to examine CT584 localization, including transmission 
electron micrograph (TEM) immunogold labeling, which has been used in the past to 
detect the needle tip protein on Shigella flexneri (Espina et al., 2006).  As discussed 
above, another potential interpretation of these results is that CT584’s role as a needle tip 
protein is not involved in attachment or entry of the EB to the cell but rather serves a 
purpose in the RBs in maintaining the inclusion integrity and evading the immune system.  
It is this possibility that provoked localization studies on RBs. 
  Supporting the possibility that chlamydial species employ non-redundant sets of 
proteins for type three secretion is the expression patterns of the translocon pore proteins.  
The proteins CopB and CopD have been shown to have properties consistent with the 
function of the T3SS transposon pore proteins.  These proteins are among the first to be 
secreted and form a hollow pore in the host cell membrane through which effectors 
proteins are translocated.  As discussed previously, for Chlamydiae, the T3SS apparatus 
translocates proteins across the host cell membrane during initial stages of infection but 
also translocates effectors across the inclusion membrane (and into the host cytoplasm) at 
later timepoints.  Despite the presence of a functional T3SS throughout the 
developmental cycle, levels of CopB transcript become undetectable after 8 hours post 
infection (Chellas-Gery et al., 2011).  This suggests the presence of an alternate 
translocon pore that functions during the times when CopB is absent.  The use of 
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alternate components of a T3SS is not a novel concept; Salmonella spp. use two distinct 
T3SS apparatuses that have both common and unique components (Ochman & Groisman, 
1996).  Therefore, it would not be surprising if CT584 functioned as a needle tip protein 
in the later stages of infection, translocating proteins across the inclusion membrane 
rather than across the host cell membrane. 
  In order to examine localization of CT584 in the late stages of infection, 
localization studies on RBs (in the context of infected host cells) were performed.  These 
showed a primarily cytoplasmic localization for CT584.  This does not rule out the 
possibility of CT584 playing a role as a needle tip.  As discussed above, CT584 may have 
dual roles in the cell, functioning as a needle tip on the surface and playing a different 
role in the cytoplasm of the cell.  If the majority of CT584 in RBs has an undetermined 
function in the cytoplasm, then its surface localization in these studies would not be 
apparent.  This is a limitation of the resolution obtainable by confocal microscopy, 
compounded with the relatively small size of chlamydial RBs.  More sensitive 
visualization techniques, such as TEM immunogold labeling could be employed to 
resolve this issue. 
  CT584 is well conserved in all species of Chlamydia with sequenced genomes.  
Recently, the structure of the CT584 ortholog from Chlamydia pneumoniae (Cpn0803) 
was solved and analyzed (Stone et al., 2012).  Overall, the protein structure bore little 
resemblance to other T3SS needle tip proteins, such as LcrV or IpaD.  Additionally, the 
protein exists as a hexamer in solution and in the crystal structure.  Analysis of this 
higher order structure revealed that this protein complex lacked the inner pore diameter 
required for proteins to pass through and therefore was not consistent with the proposed 
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function of this protein as a needle tip protein.  Importantly, both the overall global fold 
of the protein and its salient features (inner pore diameter) were examined in this study 
and both analyses concluded the same thing: that the protein lacks features consistent 
with the function of a T3SS needle tip protein. 
  Ultimately, the evidence that CT584 is a chlamydial needle tip protein comes 
exclusively from indirect assays; biophysical characterization of the protein’s unfolding 
properties and on its interaction with the needle tip protein in a heterologous system 
(Spaeth et al., 2009, Markham et al., 2009).  While impossible to fully rule out its 
possible function as a needle tip protein, experimental localization patterns of the protein 
do not support this role.  While the evidence for CT584 as a needle tip protein weakens 
with these findings, another protein with a better-characterized role as the T3SS needle 
tip has yet to be identified.  Therefore, CT584 can still be looked on as a putative needle 
tip protein, but one that does not exhibit primary surface localization on either EBs or 
RBs. 
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Chapter IV.  Structural and functional analyses support that Chlamydia trachomatis 
protein CT009 is a homolog to the key morphogenesis component RodZ 
 
Abstract 
 
 Cell division in Chlamydiae is poorly understood as apparent homologs to most 
conserved bacterial cell division proteins are lacking and, as recent evidence suggests, 
non-canonical mechanisms may be employed for these processes. Specifically, the rod-
cell shape determining protein MreB may be playing a role in chlamydial cell division. In 
other organisms, MreB is part of a morphogenic complex that requires RodZ for proper 
morphogenesis. A RodZ homolog was not evident in the chlamydial genomes; however, 
computational structure modeling (I-TASSER) indicated that uncharacterized ORF 
CT009 shares structural similarity to RodZ. The X-ray crystal structure of CT009 was 
solved and validated the accuracy of the I-TASSER predicted structure as well as 
similarity to RodZ. CT009 and MreB were demonstrated to interact and require two 
conserved residues in CT009. CT009 expressed in a rodZ deficient E. coli strain restored 
wild-type rod shaped morphology, also dependent on these key residues. These 
observations demonstrate that CT009 is a RodZ homolog in Chlamydia and expected to 
be involved in cell division and septum formation processes in chlamydial species. 
Furthermore, CT009 sequence similarity analysis supports that many other 
uncharacterized proteins are likely RodZ homologs. 
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Introduction 
 
 In the vast majority of bacterial species, cell division is mediated primarily by a 
structure called the Z ring, which directs the location of the division septum (Erickson et 
al., 2010).  The Z ring is made up of a polymer of the protein FtsZ and serves as a 
scaffold for the recruitment of all other proteins involved in septation and cytokinesis 
(Adams & Errington, 2009).  However, no homolog to FtsZ is apparent in any chlamydial 
genome.  In addition, many other well-conserved proteins that are involved in Z-ring 
assembly, such as FtsA and ZipA, are also not apparent in chlamydial genomes.  
Together, this suggests that either homologs to these proteins are present in chlamydial 
species but are not apparent by sequence similarity or that chlamydial cell division is 
mediated by a novel mechanism.  Along these lines, it was recently proposed that (in 
Chlamydiae) the protein MreB functions as a central coordinator of cell division in 
replacement of FtsZ (Ouellette et al., 2012).  MreB is a bacterial protein that is 
structurally similar to actin but, unlike actin, is predominately associated with the 
regulation of non-cocci cell shape.  Chlamydiae are an exception to this trend as they 
have coccoid morphology and yet encode MreB (Stephens et al., 1998).  In fact, 
Chlamydiae encode several rod-shape determining proteins, including MrdA/Pbp2 
(CT682), which is involved in sidewall peptidoglycan synthesis (peptidoglycan synthesis 
in the lateral direction) and MrdB/RodA (CT726), a predicted flippase (aiding in the 
movement of membrane-localized proteins between leaflets of the membrane). 
 If MreB is utilized for cell division in Chlamydiae, then it is likely that other 
proteins associated with MreB may also play a role in this process.  In other bacteria, 
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MreB does not function alone; rather, it is part of a large morphogenic complex and has 
been shown to interact with several other proteins including MreC, MreD, RodA, and 
RodZ (Kleinschnitz et al., 2011, Kruse et al., 2005, White et al., 2010).  While RodA is 
predicted to be a flippase, the precise functions of MreC, MreD and RodZ are not well 
understood and they are thought to play scaffolding roles in the morphogenic complex.  
RodZ is of particular importance because its interactions with MreB are better defined, 
due to a co-crystal structure with these two proteins (PDBid: 2WUS; (van den Ent et al., 
2010)).  Importantly, while there is an annotated chlamydial RodA homolog (CT726), the 
other MreB interaction partners do not appear to be present in chlamydial species.	    A 
better understanding of the presence or absence of these MreB interaction partners in 
chlamydial species could give insight into the unique mechanisms for cell division 
employed by these species. 
Open Reading Frame (ORF) CT009 is conserved in all species of Chlamydiae 
with sequenced genomes.  Interestingly, this protein contains a predicted helix-turn-helix 
motif within a conserved XRE (xenobiotic response element) domain superfamily of 
DNA binding transcription factors.  As such, our initial studies with this protein tested the 
hypothesis that CT009 functioned as a DNA binding protein and had a role in chlamydial 
gene regulation.  However, as described in this report, computational and experimental 
structural analyses indicated that CT009 has highest similarity to RodZ, the MreB-
interacting protein that plays a key role in morphogenesis.  Functional complementation 
and bacterial two-hybrid analyses support the structural observations providing evidence 
for CT009’s function as a homolog to RodZ. 
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Chapter IV 
Materials and Methods 
 
Identification of CT009 homologs and their conservation- CT009 protein sequence was 
used as input for a BLAST search (Altschul et al., 1997).  Orthologous proteins from 
other chlamydial species were identified.  Sequences were aligned using ClustalW2 
(Thompson et al., 2002). 
 
Protein expression profile of CT009- T150 flasks confluent with L929 mouse fibroblast 
cells were infected with Chlamydia trachomatis serovar L2 434/Bu at an MOI of 1.  As a 
control, a T150 flask was mock infected.  At 12 or 30 hours post infection (mock infected 
at 30 hours post mock-infection), cells were trypsinized and harvested by centrifugation.  
Protein was isolated from other cellular material using the Qproteome Mammalian 
Protein Prep Kit (QIAGEN), as per manufacturer’s instructions.  Protein was further 
processed by ethanol precipitation.  Briefly, 9 volumes of cold 100% ethanol was added 
to samples and incubated at -20 °C overnight.  Precipitated protein was harvested by 
centrifugation at 15,000 xg got 15 minutes, pellets were air dried and resuspended in a 
volume of 90% cold ethanol equal to the starting volume.  Samples were centrifuged and 
dried again, as previously described.  Finally, each pellet was resuspended in 100 µL of 
1x SDS PAGE final sample buffer.  Samples were boiled for 10 minutes at 94 °C, loaded 
and run on an SDS PAGE gel (15% acrylamide).  Proteins were transferred to a 
nitrocellulose membrane by western blot.  The membrane was stained by Ponceau S and 
cut horizontally at the 25 kDa molecular weight marker.  The membrane was blocked for 
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45 minutes in a 5% w/v non-fat dry milk solution in PBS + 0.1% Tween-20 and probed 
with either a polyclonal affinity-purified anti-CT009 antibody (lower half of membrane; 
1/500) or a polyclonal affinity-purified anti-RpoA antibody (upper half of membrane; 
1/1000) overnight at 4 °C.  Membranes were washed in PBS-Tween and probed with 
anti-rabbit IR700 secondary antibodies (LI-COR Biosciences) at 1/5000 for 1 hour at 
room temperature.  Membranes were washed in PBS-Tween and visualized using an 
Odyssey infrared imaging system (LI-COR Biosciences). 
 
Systematic Evolution of Ligands by Exponential Enrichment (SELEX)- Single-stranded 
template DNA was obtained (Integrated DNA Technologies, Coralville IA) with the 
following sequence: 5’ 
CGGGATCCAAGCTTCTGCAGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
GGTACCGTCGACGAATTCCG 3’.  This template was then amplified using the 
following primers: 
5’ primer: 5’ CGGGATCCAAGCTTCTGCAG 3’ 
3’ primer: 5’ CCATGGCAGCTGCTTAAGGC 3’ 
Buffer and ions were removed from the reaction using QIAquick nucleotide removal kit 
(QIAGEN).  Protein (ChxR, CT009_FL or no protein) was allowed to bind to SELEX 
template DNA by incubation for 1 hour at room temperature while on a circular rotator in 
a 500 µL reaction in DNA binding buffer (40 mM Tris, 0.1 mM EDTA, 100 mM NaCl, 
250 mM KCl, 1 mM DTT, 10% glycerol, pH 7.5) containing 170 pmol of DNA and 1000 
pmol of protein.  To crosslink protein to DNA, formaldehyde was added to a final 
concentration of 1.7% to each tube and incubated for 20 minutes at room temperature.  
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To neutralize unreacted formaldehyde, glycine was added to a final concentration of 143 
mM.  10 µg of antibodies (to either CT009 or ChxR) or DNA binding buffer was added 
to each tube.  Tubes were incubated at 4 °C overnight.  To bind the DNA-protein-
antibody complex to beads, to each reaction added 25 µL of resuspended Dynabeads 
(Invitrogen) that had been washed 2x in RIPA buffer (10 mM Tris, 1 mM EDTA, 1% 
Triton X-100, 0.1% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 140 mM NaCl, 
5 mM DTT, pH 8.0).  Tubes were rotated at 4 °C overnight.  Using a MagnaRack 
(Invitrogen), unbound solution was removed and beads were washed 4x with RIPA 
buffer.  To elute bound DNA, 30 µL of TE buffer (100 mM Tris, 10 mM EDTA, pH 7.4) 
was added to beads and incubated at 94 °C for 5 minutes.  Eluted DNA was removed by 
MagnaRack.  PCR was performed using eluted DNA as template for each reaction and 
the primers listed above. 
 
Electromobility Shift Assays (EMSA) using CT009 and select chlamydial promoter 
regions- Chlamydia trachomatis LGV (L2/484/Bu) genomic DNA was used as a 
template to amplify ∼400-bp fragments of DNA by PCR.  These fragments consist of a 
region spanning ∼100 bp upstream of the transcription start site and ∼300 bp downstream 
of the transcriptional start site. These putative promoter regions of DNA were amplified 
for the genes listed in Table 4.1 using primers listed in Table 4.1 (Integrated DNA 
Technologies).  To serve as a negative control in the EMSA reaction, a ∼400 bases region 
of DNA between the two converging genes CT032 and CT033 was also amplified.  
EMSA reactions were carried out in a total volume of 20 µL with poly DIC (1 ug), 
respective DNA regions (400 ng) and purified recombinant CT009FL at a DNA/Protein 
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molar ratio of either 1:10 or 1:100 in DNA binding buffer (40 mM Tris, 0.1 mM EDTA, 
100 mM NaCl, 250 mM KCl, 1 mM DTT, 10% glycerol, pH 7.5).  In addition, an EMSA 
reaction with promoter region CT241 was also carried out with no protein.  Once protein 
was added, the solution was gently mixed and incubated for 20 min at room temperature.  
Five microliters of 5× DNA dye (90 mM Tris, 90 mM boric acid, 2 mM EDTA, 20% 
glycerol, 1% xylene cyanol, 1% bromphenol blue) was added to the reaction mixtures 
and mixed gently.  Twenty microliters of each reaction mixture was loaded on a precast 
6% Tris-borate-EDTA (TBE) gel (Invitrogen) and run at 150 V for 75 min.  Gels were 
stained in a SYTO 60 DNA stain solution (Invitrogen) as per manufacturer’s protocol for 
30 minutes and were visualized using an Odyssey infrared imaging system (Li-Cor 
Biosciences). 
 
Table 4.1.  Primers used in CT009 EMSAs 
Name Sequence 
CT043 promoter 5’ 5’-CTCTTTAGCAAAATTTTTTAGATTTTC-3’ 
CT043 promoter 3’ 5’-CGAAACTAAAGCGTGTTTTAGAAG-3’ 
CT230 promoter 5’ 5’-CCTGAATTAATATTAGAACAGCTC-3’ 
CT230 promoter 3’ 5’-GCCAAGCATCATATTGCTTTTTTC-3’ 
CT239 promoter 5’ 5’-GTCAAAATTTTCTTAGGCAAATACG-3’ 
CT239 promoter 3’ 5’-GGATCCCATTCTAATAATTCAAAAG-3’ 
CT241 promoter 5’ 5’-GCTTTTCGGGCTTTTTTTCGTTG-3’ 
CT241 promoter 3’ 5’-GCAACAGTAAAACAGCGAGTTG-3’ 
CT259 promoter 5’ 5’-GCCTAACTAAACCAACATCACTC-3’ 
CT259 promoter 3’ 5’-GGCAGAGTAAAATACTTCTGTTTG-3’ 
CT344 promoter 5’ 5’-CAAAAATTAATTCGCTGTCGCC-3’ 
CT344 promoter 3’ 5’-CCTCTGAAGCATTTGGATCTAG-3’ 
CT386 promoter 5’ 5’-CGTGAAAAGAACCATCATGTGTG-3’ 
CT386 promoter 3’ 5’-GAAAAATTTTTAAAAAGAGAGTTTAAAG-3’ 
CT432 promoter 5’ 5’-GCCAAATTTTGCTGACTTTTGTC-3’ 
CT432 promoter 3’ 5’-CTGAAGCTGCAATGGTATTAAAG-3’ 
CT635 promoter 5’ 5’-GTTTTATAGAATCTATAATTTTTTGAG-3’ 
CT635 promoter 3’ 5’-CTTGATTTTTTCCAGTAAGACAAC-3’ 
CT708 promoter 5’ 5’-CGCGAGAAGAAGAGCATTCTAG-3’ 
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CT708 promoter 3’ 5’-GCAGTATGTTAGCTGTAAAATCTC-3’ 
CT827 promoter 5’ 5’-GCTCTCGAAAAGAAATTTTTCATC-3’ 
CT827 promoter 3’ 5’-CTTAACAATTGTGCATTGCTTTTC-3’ 
CT874 promoter 5’ 5’-GGATGACAAAATAGCAGCACATAG-3’ 
CT874 promoter 3’ 5’-CAAAATTAAAAAAATCGATAATAAAATAAG-3’ 
CT032/CT033 5’ 5′-ACATTCCTTAGATCTAGGTTCCC-3′ 
CT032/CT033 3’ 5′-GCTATTGCTGTTCGTAATAATAAGG-3′ 
 
Fluorophore-Linked Immunosorbent Assay (FLISA)- A region of the ChxR promoter 
(~300 bp, from position -10 to -334) was amplified from Chlamydia trachomatis LGV 
(L2/484/Bu) genomic DNA using the following primers: forward 5' 
GCAGAAACATCAGCTGCATC 3' and reverse, 5' CCCATTGAACTATTAGATTACC 
3'.  A biotinylated forward primer was used (Integrated DNA Technologies, Coralville 
IA) to ensure that the DNA fragment had biotin attached to it.  A similarly sized molecule 
of DNA (with biotin attached) was amplified from the promoter region between the 
diverging genes CT870 and CT871 using the following primers: forward 5' 
CGCAGGTTAAAAGGGGGATG 3' and reverse 5' GGCAAAGCTGCAATAGAATTG 
3'.  A similarly sized molecule of DNA (with biotin attached) was amplified from the 
non-promoter genome region between the converging genes CT870 and CT871 using the 
following primers: forward 5' ACATTCCTTAGATCTAGGTTCCC 3' and reverse 5' 
GCTATTGCTGTTCGTAATAATAAGG 3'. 
  2 µg of these DNA molecules (~10 pmol) in DNA binding buffer (5 mM Tris, 0.5 
mM EDTA, 50 mM KCl, pH 7.8) was loaded onto a well of a clear NeutrAvadin coated 
polystyrene plate (Thermo Scientific) and was allowed to bind for 2 hours at room 
temperature.  Wells were washed three times with Wash Buffer (140 mM NaCl, 3 mM 
KCl, 4 mM Na2PO4, 0.1% Tween-20) and either full-length ChxR protein (6.3 ug, ~100 
pmol in DNA binding buffer) or DNA binding buffer was loaded into wells and 
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incubated for 30 minutes at room temperature.  Wells were washed three times with 
Wash Buffer.  3 µg of anti-ChxR antibody in DNA binding buffer (or DNA binding 
buffer alone for controls) was applied to each well and incubated for 1 hour at room 
temperature.  Wells were washed three times with Wash Buffer.  Finally, anti-rabbit 
IR700 fluorescently labeled secondary antibodies (Rockland Immunochemicals, 
Gilbertsville PA) were added to each well at a dilution of 1/1000 in DNA binding buffer 
and were incubated for 1.5 hours at room temperature.  Wells were washed three times 
with Wash Buffer and visualized using an Odyssey infrared imaging system (LI-COR 
Biosciences). 
 
Bacterial one hybrid assays- Single-stranded template DNA was obtained (Integrated 
DNA Technologies, Coralville IA) with the following sequence: 5’ 
AAAGTGTAAAGAATTCGNNNNNNNNNNNNNNNNNNNNNNNNNAATTCGGCG
CGCCTC 3’.  Library template was extended using the following primer: 5’ 
GAGGCGCGCCGAATT 3’.  Library vector (pH3U3) was digested with EcoRI-HF 
(New England Biosciences) and isolated by gel extraction (QIAGEN).  Library insert was 
treated with Cloning Enhancer (Clontech) as per manufacturer’s protocol.  Library vector 
and insert were subjected to the In-Fusion reaction (Clontech) as per the manufacturer’s 
protocol.  5 µL of this reaction and 18 ng of pH3U3 plasmid were transformed into DH5α 
cells and plated onto 2xYT plates with 30 ug/mL kanamycin.  Colonies were counted 
manually and transformation efficiency was calculated. 
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I-TASSER Protein Structure Modeling- The I-TASSER server has been described 
previously (Roy et al., 2010, Zhang, 2009) as has its application in the modeling of 
chlamydial proteins (Kemege et al., 2011).  The following amino acid sequence from the 
genome of Chlamydia trachomatis LGV (L2/484/Bu) was selected as the target: 
GHMSEHVHKELLHLGEVFRSQREERALSLKDVEAATSIRLSALEAIEAGHLGKLI
SPVYAQGFMKKYAAFLDMDGDRLLKEHPYVLKIFQEFSDQNMDMLLDLESMG
GRNSPEKAIRS.  This proteins sequence represents amino acids 1-116 of CT009, the 
predicted cytoplasmic domain.  In addition, there are two extra amino acids added to the 
N-terminus of the sequence.  In our purification strategy for recombinant protein, these 
amino acids are the remnant of an N-terminal solubility tag.  In order to make a fair 
comparison between the modeled structure and the experimentally determined structure, 
the exact sequence of the recombinant protein used for crystallography was used for 
computational modeling.  In the nomenclature of the L2 genome, this protein is named 
CTLon_0264. However, in this report the more widely utilized serovar D genome is used 
and the protein is referred to as CT009. 
 
Cloning, Protein Expression and Purification of CT009 1-116- The putative cytoplasmic 
domain of CT009 (residues 1-116) was amplified by PCR using Chlamydia trachomatis 
LGV (L2/484/Bu) genomic DNA and the following primers: 5’-
GGGAATTCCATATGAGCGAACATGTCCACAAAG-3’ (forward, with an NdeI 
restriction site) and 5’-CGCGGATCCCTACTAACTACGGATCGCTTTCTCAGG-3’ 
(reverse, with a BamHI restriction site).  Both the CT009 insert and the vector (pDZ1) 
were digested with NdeI/BamHI and then ligated together.  The vector pDZ1 encodes a 
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His6-tagged GB1 protein (the B1 immunoglobulin domain of Protein G from 
Streptococcus sp., used as a solubility tag) and a Tobacco Etch Virus (TEV) protease 
cleavage site upstream of the cloning site (resulting in an N-terminally tagged protein) 
(Chatterjee et al., 2011).  These alterations greatly increased the solubility of the protein.  
However, following cleavage of the GB1 protein from CT0091-116 by TEV protease, the 
two proteins did not separate from one another, even under high salt conditions.  GB1 is a 
mildly acidic protein with a pI of 4.6.  It has been previously reported that three amino 
acids changes can be made to the GB1 protein (resulting in a protein termed “GB1basic”) 
that increase its pI to 8.0 but do not alter its efficacy as a solubility tag (Zhou & Wagner, 
2010).  This change in pI should prevent aggregation of the GB1 with CT0091-116 if their 
interaction is mediated by charge (Zhou & Wagner, 2010). 
 In order to obtain GB1basic-CT0091-116 recombinant protein, the CT0091-116 insert 
was cloned into the pDZ1b vector (generous gift from Dr. Susan Egan, University of 
Kansas), as described above. It was constructed by modifying the pDZ1 vector 
(Chatterjee et al., 2011) through six base pair substitutions, resulting in three amino acid 
changes.  The ligation reaction was then transformed into E. coli BL21-derivative Acella 
cells (Edge BioSystems).  Cells were grown at 37°C with shaking at 220 rpm in LB 
medium supplemented with 100 µg mL-1 ampicillin to an optical density (OD600) of 0.6.  
Expression of recombinant protein was induced by the addition of 0.1 mM isopropyl-β-
D-thiogalactopyranoside (IPTG) followed by shaking incubation at 15°C and 220 rpm for 
~16 hours.  Cells were harvested by centrifugation (10,000 x g, 20 min, 4°C) and frozen 
at -20°C. 
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 Cell pellets were resuspended in lysis/wash buffer (20 mM Tris pH 8.0, 500 mM 
NaCl), lysed by sonication and centrifuged at 16,000 x g, 20 min, 4°C.  The soluble 
fraction was filtered through a 0.45 µm filter before it was applied to TALON metal 
(Co2+) affinity resin (Clontech) as per the manufacturer’s guidelines.  The beads were 
washed with lysis/wash buffer and GB1basic-CT0091-116 was eluted with lysis/wash buffer 
supplemented with 500 mM imidazole.  Peak fractions were pooled and purity was 
assessed by SDS-PAGE, followed by staining with IRDye Blue protein stain (LI-COR) 
and visualization by an Odyssey infrared imaging system (LI-COR). 
 Purified GB1basic-CT0091-116 was treated with purified recombinant TEV protease 
as it was dialyzed into 50 mM Tris pH 8.0 at room temperature for ~16 hours.  Protein 
digest was filtered through a 0.22 µm filter and NaCl was added to a final concentration 
of 500 mM.  Protein solution was applied to fresh TALON metal (Co2+) affinity resin.  
Flowthrough and washes (with lysis/wash buffer) were collected and assessed for purity 
by immunoblot against polyhistidine and CT009.  Fractions with CT0091-116 but without 
the His6-tagged GB1basic were pooled and concentrated to 30.1 mg/mL, using an Amicon 
3,000 molecular weight cut-off centrifugal filtration device (Millipore).  Purity of 
CT0091-116 was assessed by SDS-PAGE, followed by stain and visualization, as described 
above. 
 
Crystallization and Data Collection- A purified sample of CT009 was concentrated to 
43.5 mg mL-1 in 20 mM Tris, 500 mM NaCl, pH 8.0 buffer for crystallization screening.  
All crystallization experiments were conducted using Compact Jr. (Emerald Biosystems) 
sitting drop vapor diffusion plates at 20 oC using equal volumes of protein and 
	   96	  
crystallization solution equilibrated against 75 µL of the latter.  For X-ray data collection, 
samples were transferred to a fresh drop composed of 80% crystallization solution and 
20% PEG 400 before flash cooling in liquid nitrogen.  Initial crystals, which formed as 
clusters of needles in 1-2 days, were obtained from the Crystal Screen HT screen 
(Hampton Research) condition A6 (30% PEG 4000, 100 mM Tris pH 8.5, 200 mM 
MgCl2).  Initial X-ray diffraction data were collected in-house at 93K using a Rigaku 
RU-H3R rotating anode generator (Cu-Ka) equipped with Osmic Blue focusing mirrors 
and an R-Axis IV++ image plate detector.  Subsequent crystals, which were used for high-
resolution data collection, were obtained from a custom PEG Screen, with the final buffer 
composition being 100 mM Tris, 200 mM magnesium chloride, 30% w/v polyethylene 
glycol 5,000, pH 8.5.  Data were collected at the Advanced Photon Source beamline 17-
ID using a Dectris Pilatus 6M pixel array detector. 
 
Structure Solution and Refinement- Intensities for the in-house diffraction data were 
integrated using XDS (Kabsch, 1988).  Synchrotron diffraction data were collected at 
frame width of 0.2° for a total of 120° (600 total frames).  For each frame, the exposure 
time was 0.2 seconds and the crystal-to-detector distance was 175 mm.  Synchrotron data 
were integrated using XDS via the XDSAPP interface (Krug et al., 2012).  The Laue 
class check and data scaling were performed with Aimless (Evans, 2011).  The highest 
probability Laue class was 4/mmm and space groups P41212 or P43212.  The Matthew’s 
coefficient (Matthews, 1968) (Vm=2.5 / 50.8 %) indicated that there was a single CT009 
molecule in the asymmetric unit.  Structure solution was conducted by molecular 
replacement with Phaser (McCoy et al., 2007b) via the Phenix (Adams et al., 2010) 
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interface using the in-house diffraction data scaled to 2.6Å resolution.  All space groups 
in the Laue class 4/mmm were tested.  The search model for molecular replacement was 
generated using the protein structure prediction program MODELLER (Eswar et al., 
2006).  The top solution was obtained in the space group P41212, which was used from 
this point forward.  The model was improved using the Autobuild suite via the Phenix 
interface which converged at R=25%, Rfree=33% following refinement.  This model was 
used for subsequent molecular replacement searches against synchrotron data that was 
scaled to a resolution of 1.25Å.  Structure refinement using anisotropic atomic 
displacement parameters and manual model building were conducted with Phenix and 
Coot (Emsley et al., 2010) respectively.  Structure validation was conducted with 
Molprobity (Chen et al., 2010).  Figures were prepared using the CCP4MG package 
(Potterton et al., 2004). 
  The final model of CT009 contains one monomer in the asymmetric unit.  
Residues Leu 84 to Met 97 in the C-terminal helix were disordered; however, recurring	  
positive	   difference	   (Fo-­‐Fc)	   electron	   density	   in	   the	   region,	   following	   refinement,	  
indicated	  that	  this	  portion	  of	  the	  helix	  adopted	  two	  distinct	  conformations	  and	  was	  
model	   as	   such.	   	  Therefore, all residues were modeled.  There is also density for 111 
water molecules. 
 
Protein-Protein Interactions by Bacterial Two-Hybrid- The full-length CT009 gene, the 
predicted cytoplasmic domain of CT009, and the mreB gene (CT709) were amplified by 
PCR using Chlamydia trachomatis LGV (L2/484/Bu) genomic DNA: 
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Table 4.2.  Primers used in cloning for BACTH 
Name Sequence 
CT009 FL into 
pUT18C 5’ 
5’-CGACTCTAGAGGATCCCATGAGCGAACATGTCCAC-3’ 
CT009 FL into 
pUT18C 3’ 
5’-ATGAATTCGAGCTCGGTACCTCACTAGAAAAGGTTGAATAGATTC-3’ 
CT009 FL into 
pKT25 5’ 
5’-CGACTCTAGAGGATCCCATGAGCGAACATGTCCAC-3’ 
CT009 FL into 
pKT25 3’ 
5’-TTCTTAGTTACTTAGGTACCTCACTAGAAAAGGTTGAATAGATTC-3’ 
CT009 cyt into 
pKT25 5’ 
5’-CGACTCTAGAGGATCCCATGAGCGAACATGTCCAC-3’ 
CT009 cyt into 
pKT25 3’ 
5’-TTCTTAGTTACTTAGGTACCTCACTAACTACGGATCGCTTTCTC-3’ 
MreBCT into 
pKT25 5’ 
5’-CGACTCTAGAGGATCCCATGAGCCCATACCGCAG-3’ 
MreBCT into 
pKT25 3’ 
5’-TTCTTAGTTACTTAGGTACCTTATCATACTAAACTCTCTTTTCG-3’ 
 
The gene encoding the CT009 Y57A, F61A mutant was amplified by PCR using 
pMLB1113-CT009 Y57A, F61A plasmid as a template.  Vector plasmids (pKT25, 
pKNT25, pUT18 and pUT18C; Euromedex) were digested with BamHI and KpnI 
enzymes.  Vector and inserts were processed using the In-Fusion HD ligation-
independent cloning system (Clontech) and were transformed into Alpha-Select Gold 
Efficiency cells (Bioline).  Plasmids were isolated from overnight culture and then co-
transformed into chemically competent BTH101 cells (Euromedex). 
 Interactions between proteins were assessed using the Bacterial Adenylate 
Cyclase Two Hybrid (BACTH) system, as described previously (Karimova et al., 1998); 
Euromedex).  Briefly, BTH101 cells (a Δcya strain of E. coli) with two plasmids, each 
encoding a different fragment of the adenylate cyclase gene fused to a chlamydial protein 
of interest, and plated onto LB plates containing 100 µg mL-1 ampicillin, 50 µg mL-1 
kanamycin, 0.5 mM IPTG and 50 µg mL-1 X-gal.  Plates were incubated at 30 °C for up 
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to 48 hours and single colonies were picked and grown in liquid culture at 30 °C.  
Expression of the β-galactosidase reporter gene by reconstituted adenylate cyclase was 
assessed using a β-galactosidase assay, as described previously (Miller, 1972).  Assays 
were performed in triplicate. 
 
Analytical Ultracentrifugation- Purified recombinant CT0091-116 was analyzed using a 
Beckman Coulter XL-I analytical ultracentrifuge in sedimentation velocity mode. In the 
experiments, the protein concentration was 2.0 mg mL-1.  Protein was loaded into a two-
channel, 12 mm optical path length cell.  A four hole An60 Ti rotor was used for housing 
the cell, which was run at 10 °C for 450 continuous scans, measured in duplicate. The 
speed of rotor was 45000 rpm.  Sedimentation velocity analysis was conducted using 
SEDFIT, version 12.1b (Schuck, 2000).  Continuous c (s) distribution analysis was 
performed using non-linear regression during the data fit.  In addition, viscosities and 
densities of the buffers were measured using the SVM 3000 viscometer (Anton Parr USA 
Inc.), in order to get accurate parameters, which were used in the AUC fitting process. 
 
RodZ Functional Complementation- Full length CT009 was amplified by PCR using 
Chlamydia trachomatis LGV (L2/484/Bu) genomic DNA and the following primers: 5’-
CCGGAATTCATGAGCGAACATGTCCACAAAG-3’ (forward, with an EcoRI 
restriction site) and 5’-TCCCCCGGGTCACTAGAAAAGGTTGAATAGATTCC-3’ 
(reverse, with a SmaI restriction site).  Both the CT009 insert and the vector (pMLB1113) 
were digested with EcoRI/SmaI and then ligated together.  The ligation reaction was 
transformed into E. coli BL21-derivative Acella cells (Edge BioSystems), successful 
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cloning was verified by sequencing of the CT009 gene and finally purified pNLB1113-
CT009 plasmid was transformed into FB60 cells.  FB60 is an E. coli cell line, derived 
from the TB28 cell line, which lacks the RodZ gene (Bendezu et al., 2009).  Both the 
pMLB1113 plasmid and the FB60 cell line were generous gifts from the laboratory of 
Piet de Boer (Case Western University). 
 A plasmid encoding full length CT009 Y57A, F61A was generated by subjecting 
the pMLB1113-CT009 plasmid to site directed mutagenesis using the QuikChange II XL 
site-directed mutagenesis kit according to the manufacturer’s protocol (Agilent 
Technologies). 
 For functional complementation assays, cells were grown overnight in flasks of 
FB60 media (M9 minimal media with 0.2% maltose, 0.2% casamino acids and 50 mM 
thiamine HCl) at 30 °C to an OD600 of 0.2-0.3.  Cells were prepared for fluorescence 
microscopy by resuspending the cells from 3 mL of culture (harvested by centrifugation 
for 1 minute at 16,000 x g in a benchtop centrifuge) in 1 mL of Fixative Solution (0.05 
mg mL-1 malachite green and 2.5% v/v glutaraldehyde.  Cells were fixed for 1 hour at 
room temperature and then were washed twice with 1 mL of 1x PBS before resuspension 
in 100 µL of 1x PBS.  Fixed cells were mounted on glass coverslips and visualized using 
an Axioplan-2 upright fluorescent microscope (Zeiss).  Images were captured with an 
ORCA-ER digital camera (Hamamatsu). 
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Chapter IV 
Results 
 
CT009 is conserved across chlamydial species. 
 Following sequencing of the Chlamydia trachomatis serovar D genome, CT009 
was annotated as a protein of unknown function, due to lack of homology to any proteins 
of known function.  Whether the role of CT009 is unique to the biology of C. trachomatis 
or can be found in other species of chlamydiae could be determined by searching for 
orthologs to CT009 among other species of chlamydia.  A BLAST search was conduced, 
using CT009 protein sequence as input (Fig. 4.1).  The results of this search show that 
CT009 is conserved across all species of chlamydia with sequenced genomes, suggesting 
that it plays a conserved role in the biology of chlamydiae. 
 
The protein expression profile of CT009 could not be detected by western blot. 
  Transcriptional profiling of the expression of CT009 by microarray showed a 
typical constitutive expression profile in which levels of transcription were first detected 
at 3 hours post infection (HPI), increased at 8 HPI and then remained steady throughout 
the developmental cycle until the final point of 40 HPI (Belland et al., 2003).  However, 
this expression profile is a transcriptional profile.  Mechanisms for post-transcriptional 
regulation may affect the ultimate levels of CT009 throughout the developmental cycle.  
Therefore, in order to gain additional insight into the function of CT009, (specifically 
how it plays a role in the overall biology of Chlamydia), an analysis of the protein 
expression profile of CT009 was attempted. 
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FIG. 4.1.  CT009 is conserved across all species of chlamydiae.  A BLAST search 
using CT009 protein sequence as input revealed the presence CT009 homologs in all 
sequenced species of chlamydiae.  Species CT_A is Chlamydia trachomatis serovar A 
(strain HAR-13 / ATCC VR-571B) and its homolog is CTA_0010.  Species CT_B is 
Chlamydia trachomatis serovar B (strain Jali20/OT) and its homolog is JALI_0091.  
Species CT_D is Chlamydia trachomatis serovar (strain D/UW-3/Cx) and it is the 
starting sequence, CT009.  Species CT_E is Chlamydia trachomatis serovar E (strain 
E/11023) and its homolog is E11023_00055.  Species CT_F is Chlamydia trachomatis 
serovar F (strain SW5) and its homolog is FSW5_0091.  Species CT_G is Chlamydia 
trachomatis serovar G (strain G/9301) and its homolog is CTG9301_00050.  Species 
CT_L2 is Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) and its 
homolog is CTL0264.  Species Cmur is Chlamydia muridarum (strain MoPn / Nigg) and 
its homolog is TC_0277.  Species Cpneumo is Chlamydia pneumoniae (strain LPCoLN) 
and its homolog is CPK_ORF00494.  Species Cpecorum is Chlamydia pecorum (strain 
ATCC VR-628 / E58) and its homolog is G5S_0635.  Species Cpsitt is Chlamydia 
psittaci (strain ATCC VR-125 / 6BC) and its homolog is CPSIT_0325.  Species Cabortus 
is Chlamydia abortus (strain S26/3) and its homolog is CAB292.  Species Cfelis is 
Chlamydia felis (strain Fe/C-56) and its homolog is CF0708.  Species Ccaviae is 
Chlamydia caviae (strain GPIC) and its homolog is CCA_00295.  The most dissimilar 
protein to CT009 (the C. caviae homolog CCA_00295) still aligns with a E value of 3e-
55. 
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CT_A      --------MSEHVHKELLHLGEVFRSQREERALSLKDVEAATSIRLSALEAIEAGHLGKL 52 
CT_B      --------MSEHVHKELLHLGEVFRSQREERALSLKDVEAATSIRLSALEAIEAGHLGKL 52 
CT_D      --------MSEHVHKELLHLGEVFRSQREERALSLKDVEAATSIRLSALEAIEAGHLGKL 52 
CT_E      --------MSEHVHKELLHLGEVFRSQREERALSLKDVEAATSIRLSALEAIEAGHLGKL 52 
CT_F      --------MSEHVHKELLHLGEVFRSQREERALSLKDVEAATSIRLSALEAIEAGHLGKL 52 
CT_G      --------MSEHVHKELLHLGEVFRSQREERALSLKDVEAATSIRLSALEAIEAGHLGKL 52 
CT_L2     --------MSEHVHKELLHLGEVFRSQREERALSLKDVEAATSIRLSALEAIEAGHLGKL 52 
Cmur      MGANKRNYMSEHVHKELLHLGGVFRSQREEKAISLKDVEAATSIRLSALEAIEAGHLGKL 60 
Cpneumo   --------MQEHVHKELLHLGEIFRSSREFQSLSLKDVEAATSIRYSCLEAIEQGCLGKL 52 
Cpecorum  --------MTEHVHKELLHLGEIFRSRREEQSLSLKDVEAATSIRCSCLEAIEQGYLGKL 52 
Cpsitt    --------MAEQIHKELLHLGEVFRTKREEQSLSLKDVEAATSIRYSCLEAIENGYLGKL 52 
Cabortus  --------MAEQIHKELLHLGEVFRTKREEQSLSLKDVEAATSIRYSCLEAIENGYLGKL 52 
Cfelis    --------MAEQIHKELVHLGEVFRTKREEQLLSLKDVEAATSIRYSCLEAIENGCLGKL 52 
Ccaviae   --------MAEQIHKELIHLGEVFRTKREEQLLSLKDVEAATSIRYSCLEAIENGCLGKL 52 
                  * *::****:*** :**: ** : :************ *.***** * **** 
 
CT_A      ISPVYAQGFMKKYAAFLDMDGDRLLKEHPYVLKIFQEFSDQNMDMLLDLESMGGRNSPEK 112 
CT_B      ISPVYAQGFMKKYAAFLDMDGDRLLKEHPYVLKIFQEFSDQNMDMLLDLESMGGRNSPEK 112 
CT_D      ISPVYAQGFMKKYAAFLDMDGDRLLKEHPYVLKIFQEFSDQNMDMLLDLESMGGRNSPEK 112 
CT_E      ISPVYAQGFMKKYAAFLDMDGDRLLKEHPYVLKIFQEFSDQNMDMLLDLESMGGRNSPEK 112 
CT_F      ISPVYAQGFMKKYAAFLDMDGDRLLKEHPYVLKIFQEFSDQNMDMLLDLESMGGRNSPEK 112 
CT_G      ISPVYAQGFMKKYAAFLDMDGDRLLKEHPYVLKIFQEFSDQNMDMLLDLESMGGRNSPEK 112 
CT_L2     ISPVYAQGFMKKYAAFLDMDGDRLLKEHPYVLKIFQEFSDQNMDMLLDLESMGGRNSPEK 112 
Cmur      ISPVYAQGFMKKYADFLGLDGDKLLKEHPYVLKIFQEFSDQNVDMLLDLESMEGRNSPEK 120 
Cpneumo   ISPVYAQGFIKKYATYLGLDGDSILQEHPYVMKIFKEFSDHNMEMLLDLESMGGRNSPER 112 
Cpecorum  ISPVYAQGFIKKYASYLGLNGEKLLQEHPYVVKLLKEFSEQNMEMLLDLESMGGRNSPEK 112 
Cpsitt    ISPIYAQGFIKKYAAYLGLDGERILQDHPYVMKIFKEFSEHNMEMLLDLESMGGRNSPEK 112 
Cabortus  ISPIYAQGFIKKYAAYLGLDGERILQDHPYVMKIFKEFSEHNMEMLLDLESMGGRNSPEK 112 
Cfelis    ISPIYAQGFIKKYAAYLGLDGERILQEHPYVMKIFKEFSEHNMEMLLDLESMGGRNSPEK 112 
Ccaviae   ISPIYAQGFIKKYAAYLGMDGERILQEYPYVMRIFKEFSEQNMEMLLDLESMGGRNSPEK 112 
          ***:*****:**** :*.::*: :*:::***:::::***::*::******** ******: 
 
CT_A      AIRSWLNLGWAGVFVVGAACIWWLGNLFNLF 143 
CT_B      AIRSWLNLGWAGVFVVGAACIWWLGNLFNLF 143 
CT_D      AIRSWLNLGWAGVFVVGAACIWWLGNLFNLF 143 
CT_E      AIRSWLNLGWAGVFVVGAACIWWLGNLFNLF 143 
CT_F      AIRSWLNLGWAGVFVVGAACIWWLGNLFNLF 143 
CT_G      AIRSWLNLGWAGVFVVGAACIWWLGNLFNLF 143 
CT_L2     AIRSWLNLGWAGVFVVGAACIWWLGNLFNLF 143 
Cmur      AIRSWLNLGWAGAFVLGVACIWWLGTLLHFF 151 
Cpneumo   AIHSWSNLWWAGLIIIGGIVVWWLGSLFSIF 143 
Cpecorum  AIHSWSYLGIAGAIILGGGLLWWLGSLFSIF 143 
Cpsitt    AIRSLSNLWWAALIVFSGIAIWWLGSLLSLF 143 
Cabortus  AIRSLSNLWWAGLIVFSGMAIWWLGSLLSLF 143 
Cfelis    AIRTWSNLWWVGLITISGMAIWWLGSLLSIF 143 
Ccaviae   AIRTWSNLWWVALITISGMAIWWLGSLLSIF 143 
          **::   *  .. : ..   :****.*: :* 
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 Host cells infected with Chlamydia trachomatis were lysed and protein was 
isolated from other cellular material.  This simple experiment was repeated many times 
with many slight variations in technique, including the use of ethanol, acetone or 
trichloroacetic acid to precipitate (and therefore concentrate) proteins.  Additionally, this 
experiment was repeated at many different timepoints after the initial infection.  However, 
the most persistent issue has been the detection of a cross-reactive protein of similar 
molecular weight in uninfected cells (Fig. 4.2).  In samples in which this contaminant 
was absent, CT009 was not present in detectable quantities. 
 
A computationally generated structure of the CT009 protein is most structurally similar 
to the transcription factor cI 
  As previously described, the primary sequence of CT009 indicates that it 
possesses a helix-turn-helix motif in its structure, a motif that is frequently utilized to 
bind to DNA.  However, this function is not very specific because proteins with many 
different roles (transcriptional repressors, transcriptional activators, nucleases and 
histone-like proteins, to name a few) have the capability to bind to DNA.  In order to 
better understand the biological role of CT009, a model of the structure of the protein was 
generated using I-TASSER (Figure 4.3A).  I-TASSER (Iterative Threading ASSEmbly 
Refinement) is a computational method that has been successful in accurately modeling 
protein structures, as detailed in Chapter II (Kemege et al., 2011, Roy et al., 2010).  
Several models were generated but the model with the highest C score was used to search 
for proteins with structural similarity, using the DALI server	  (Holm & Rosenstrom, 2010).  
The protein most structurally similar to the modeled structure of CT009 was a protein 
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FIG. 4.2.  The protein expression profile of CT009 could not be conclusively 
determined by western blot.  Cells infected with Chlamydia trachomatis were harvested, 
lysed and protein was isolated from other cellular material at two different timepoints 
post infection (Hours Post Infection; HPI), 12 and 30.  As a control, an equal amount of 
uninfected cells was prepared with the same methods.  Protein isolates from these cells 
were loaded on an SDS PAGE gel, run and then transferred to a nitrocellulose membrane 
by western blot.  Membranes were cut in half width-wise, blocked and then probed with 
anti-CT009 antibodies or anti-RpoA (a loading control) antibodies, followed by a 
fluorescently labeled secondary antibody and visualization. 
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named cI (Fig. 4.3B).  The two structures are shown superposed on one another (Fig. 
4.3C).  cI is a transcriptional repressor in lambda phage and this structural similarity 
therefore lead to the hypothesis that CT009 binds DNA as a transcriptional repressor. 
 
The findings of Systematic Evolution of Ligands by Exponential Enrichment (SELEX) 
were inconclusive in identifying CT009 DNA binding sequences. 
 Systematic Evolution of Ligands by Exponential Enrichment (SELEX) is a tool 
for the identification of sequences of DNA that a protein target can bind to (Chai et al., 
2011).  This technique utilizes purified recombinant protein and a pool of DNA 
containing a randomized sequence, used at a high enough concentration to represent 
diverse DNA sequences.  The protein of interest binds to specific sequences of DNA in 
vitro, which are then extracted from solution and amplified.  This amplification is 
necessary due to the potentially very low concentration of the targeted DNA sequence in 
the overall pool of DNA.  A second round then begins using this material (which the 
protein bound to in the first round) as the target DNA.  This process is repeated several 
times and with each round the molecules of DNA that are recognized most strongly by 
the protein of interest are enriched.  Following the final round of DNA binding, the 
sequences of DNA are cloned into plasmids and transformed into E. coli, which are then 
plated to isolate individual plasmids, each containing a single template DNA.  These 
isolated plasmids are sequenced and this data is leveraged to identify a consensus 
sequence that the protein of interest used to bind to these DNA over to several rounds of 
selection.
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FIG 4.3.  A computationally modeled structure of full length CT009 has structural 
similarity to the protein cI. 
A.  A model of CT009 structure was created using the I-TASSER server. 
B.  The cI protein (PDB ID: 1R69) 
C.  A superposition of the modeled structure of CT009 (dark blue) and the structure of cI 
(light blue). 
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 SELEX was employed in an attempt to ultimately identify chlamydial genes that 
are targets of genetic regulation by CT009.  This technique was used with the goal of 
identifying DNA sequences that CT009 binds to in vitro and then utilizing this 
information to form testable hypotheses about genes that it may regulate.  As a control in 
this experiment, ChxR protein (a well-characterized chlamydial transcription factor with 
a known DNA binding sequence; (Hickey et al., 2011, Koo et al., 2006, Thompson et al., 
2002)) was used.  Following incubation between protein and DNA, these molecules were 
removed from solution using an antibody against the protein that is bound to a large bead 
via protein G.  As a control for nonspecific binding, each experiment was also carried out 
with no antibody added; any DNA pulled out from this condition would therefore be the 
result of nonspecific binding between the DNA and the tube/bead/protein G.  DNA was 
eluted from the protein-protein G-bead complex, used as a template for PCR and run on 
an agarose gel (Fig. 4.4).  An amplifiable region of DNA could not be obtained in any of 
the conditions tested; this suggests that either CT009 is not capable of binding to DNA or 
that the conditions of the assay were not suitable for DNA binding by CT009. 
 
CT009 does not bind to the promoter regions of select chlamydial genes in the context 
of an Electromobility Shift Assay (EMSA). 
 In an extended effort to identify chlamydial genes regulated by CT009, potential 
targets for regulation were selected and the affinity of CT009 for the promoter regions of 
these genes was tested by EMSA (Fig. 4.5).  The genes selected were CT043, CT230, 
CT239, CT241, CT259, CT344, CT386, CT432, CT635, CT708, CT827, and CT874.   
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FIG. 4.4.  SELEX was not successful in identifying sequences of DNA that CT009 
binds to.  A template DNA containing 30 random base pairs flanked by 20 base pair of 
known sequence on each side was generated and incubated with purified recombinant 
CT009 or ChxR protein.  As a negative control, DNA was incubated with no protein (-).  
Protein was crosslinked to DNA and the protein-DNA complex was separated from 
solution using antibodies and protein G beads.  As a negative control, each reaction was 
performed in which one replicate did not receive antibodies (-).  DNA was eluted from 
beads and was used as a template for PCR.  Each condition was loaded into the gel in two 
different volumes. 
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These ORFs were selected because they all have clearly identifiable promoter regions and 
are differentially regulated within the chlamydial developmental cycle (Belland et al., 
2003).  As a positive control (PC) in this experiment, the ChxR protein and its promoter 
region were tested by EMSA (Hickey et al., 2011).  As a negative control (NC) the 
intergenic region of DNA between the two converging genes CT032 and CT033 was 
used as a DNA target for EMSA; this region of DNA does not contain the promoters for 
any gene and therefore makes a good negative control for promoter binding.  The results 
of this study show no definitive shifts in the DNA in any of the reactions in which CT009 
was used, despite the clear shifts in the positive control (PC).  The promoter region of 
ORF CT241 did display a higher molecular weight species, but that species is present 
even with no CT009 present and therefore is likely not a shift caused by CT009 but rather 
an artifact of PCR amplification.  Therefore, CT009 does not possess DNA binding 
properties, CT009 is unable to bind to DNA in the context of this assay or CT009 does 
not bind to the selected promoter regions.  In the absence of a positive control for CT009 
DNA binding, it was difficult to conclude what was the cause of these negative results. 
 
Fluorophore-Linked Immunosorbent Assay (FLISA) was not effective in identifying 
chlamydial genes regulated by CT009. 
 In an effort to identify gene targets of CT009 Fluorophore-Linked Immunosorbent 
Assays (FLISA) were performed.  In this assay, the promoter regions of potential gene 
targets of a DNA binding protein are amplified by PCR using a primer that has biotin 
covalently linked to it.  These amplified promoter regions are then applied to a 96 well 
plate in which each well had streptavidin covalently linked to the bottom.  The strong 
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FIG. 4.5.  CT009 does not bind to select chlamydial promoters by EMSA.  Double 
stranded DNA, amplified from a ~400 bp region spanning ∼100 bp upstream of the 
transcription start site and ∼300 bp downstream of the transcriptional start site of several 
genes of interest were used in an Electromobility Shift Assay (EMSA), along with 
purified recombinant full-length CT009 protein.  Promoter regions for CT043, CT230, 
CT239, CT241, CT259, CT344, CT386, CT432, CT635, CT708, CT827, and CT874 
were used because these genes all have clearly identifiable promoter regions and are 
differentially regulated within the chlamydial developmental cycle.  As a positive control 
(PC), the ChxR protein and its promoter region were tested.  As a negative control (NC) 
the intergenic region of DNA between the two converging genes CT032 and CT033 was 
used as a DNA target for EMSA.  DNA:Protein molar ratios were either 1:10 or 1:100.	   
To show that the higher molecular weight species observed in the CT241 promoter region 
are not due to CT009 binding, this region of DNA was also tested using no CT009 
protein, suggesting that this additional DNA band is likely not a shift caused by CT009 
but rather an artifact of PCR amplification. 
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biotin-streptavidin interaction keeps the DNA in the well throughout the procedure. 
Purified recombinant protein is applied to each well and then washed to remove non-
specific interactions.  Next, an antibody against the protein is added to each well, 
incubated and followed by incubation with a fluorescently tagged secondary antibody.  
The 96 well plate is visualized; theoretically, only wells containing DNA that specifically 
interacts with the protein applied will have fluorescence.  This technique has been 
utilized previously and has been successful in identifying protein-DNA interactions 
(Jagelska et al., 2002).  While, like EMSA, this technique relies on purified recombinant 
protein interacting with a small fragment of DNA in vitro, because it is performed in a 96 
well plate, it allows for the screening of many potential gene targets at once. 
 Before applying this technique to a full array of 96 different DNA targets, 
validation was attempted using a previously characterized transcription factor, ChxR, and 
its own promoter DNA, to which it binds (Koo et al., 2006).  As negative controls for this 
experiment, DNA from the diverging promoter regions of the CT870 and CT871 genes 
was used in addition to DNA from the non-promoter region between the converging 
genes CT032 and CT033; the converging region of DNA does not contain the promoters 
for any gene and therefore makes a good negative control for promoter binding while the 
diverging promoter region contains two promoters but these are not DNA regions that 
ChxR has been shown to bind to, making it a good negative control for non-specific DNA 
binding.  Surprisingly, ChxR bound to these negative control DNAs just as strongly as it 
did to its own promoter.  Multiple harsh washes did not abolish this presumably non-
specific binding and studies using CT009 were not carried out due to the inability to 
detect specific DNA binding by ChxR using this technique (Fig. 4.6). 
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FIG. 4.6.  Fluorescence-Linked Immunosorbent Assay (FLISA) was not effective in 
identifying the previously reported positive interaction between the protein ChxR 
and its promoter.  Wells, lined with streptavidin, were incubated in the presence of 2 µg 
of biotinylated promoter regions of DNA.  ChxR promoter is the region previously 
reported to bind ChxR. CT870/871 is a promoter region shared by the two diverging 
genes, CT870 and CT871.  ChxR is not expected to bind to this promoter region and 
therefore this served as a negative control.  CT032/033 is a region of DNA in between 
two converging genes, CT032 and CT033.  It does not contain the promoter of any gene 
and therefore was expected to serve as a negative control.  ChxR protein bound to the 
well containing its promoter DNA.  However, ChxR protein also bound to the two 
negative control DNAs.  Controls without protein, DNA or secondary antibody confirm a 
low level of background fluorescence. 
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Bacterial One-Hybrid Assay was not effective in identifying a CT009 DNA binding 
sequence. 
 In an effort to identify sequences of DNA bound by CT009 protein (and thereby 
facilitate identification of gene targets) a Bacterial one-Hybrid (B1H) system was utilized.  
This system is well characterized and has been utilized previously to identify DNA 
binding sequences of proteins (Meng et al., 2005, Meng et al., 2006, Meng & Wolfe, 
2006, Noyes et al., 2008).  The B1H system utilizes two plasmids: a vector expressing 
the protein of interest fused to the alpha subunit of RNA polymerase (bait) together with 
a library of reporter vectors, each with a different 25 base pair sequence of DNA 
upstream of the promoter for two reporter genes, HIS3 and URA3 (prey). 
 These reporters provide both positive selection and negative selection.  In any 
given transformed cell, the DNA sequence upstream of the promoter for the reporter 
genes will either be recognized and bound by the protein of interest or not.  If the protein 
of interest does not recognize the sequence, then the alpha subunit of RNA polymerase 
will not be stably held at the promoter and transcription of the reporter genes will not 
occur at a significant level.  If the protein of interest does recognize the sequence, then 
the alpha subunit of RNA polymerase will be held at the promoter, allowing for efficient 
transcription of the reporter genes.  The HIS3 reporter gene allows for growth of E. coli 
on plates containing the compound 3-amino-triazole, thereby allowing only transformants 
in which the protein-DNA interaction is a positive one to survive on plates containing this 
compound. 
  Because it is possible that a random sequence might activate transcription 
independently of the fusion protein, the library is first cleared of plasmids that activate in 
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the absence of fusion protein.  This is achieved by the action of the second reporter gene, 
URA3; the protein product of this gene converts 5-fluoro-orotic acid (5-FOA) to a toxic 
product, killing cells with activated promoters in the presence of 5-FOA.  Therefore, by 
pre-screening the library of prey DNA against self-activating sequences, sequences of 
DNA recognized specifically by the protein of interest can by identified. 
  This system is fundamentally different from previously attempted methods to 
identify CT009 DNA binding sequences because it does not require purified recombinant 
protein and instead relies on protein produced within the heterologous cell system of E. 
coli.  While it would not directly identify gene targets of CT009, after the identification 
of several DNA binding sequences, it could potentially allow for elucidation of a DNA 
binding consensus sequence, which could then be used to identify putative gene targets 
from the chlamydial genome sequence. 
  Difficulties in this approach came from problems in the construction of the prey 
library of plasmid DNA.  Ligation independent cloning of the randomized DNA binding 
site into a plasmid did not yield sufficient numbers of colonies to ensure the construction 
of a library with acceptable levels of diversity in the randomized sequence. 
 
A computationally generated protein structure (I-TASSER) of the cytoplasmic domain 
of CT009 is most structurally similar to the protein RodZ. 
  As previously described, CT009 possesses a predicted helix-turn-helix motif, as 
predicted by its primary sequence.  However, in contrast to many, but not all, protein 
sequences containing Xre DNA binding domain was the presence of a predicted carboxy-
terminal single transmembrane helix formed by amino acids 117-136 (Fig. 4.7) in CT009, 
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FIG. 4.7.  Predicted domain organization of RodZ and CT009.  The predicted domain 
architecture of RodZ has been described previously (Bendezu et al., 2009).  It appears to 
have an N-terminal cytoplasmic domain that contains a helix-turn-helix motif (HTH), a 
highly basic juxta-membrane domain (JM), a transmembrane helix (TM), a periplasmic 
domain rich in prolines and threonines (PT-rich) and a periplasmic domain with predicted 
β-sheets.  As predicted by HMMTOP, CT009 also possesses an N-terminal cytoplasmic 
domain (HTH; amino acids 1-116) and a transmembrane helix (TM; amino acids 117-
136).  However, it lacks a basic juxta-membrane domain and its predicted periplasmic 
region is only 7 amino acids long (amino acids 137-143). 
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as predicted by the HMMTOP server (Tusnady & Simon, 2001). 
 In order to gain more specific information regarding the function and possible 
biological role of CT009, a model of the structure of the cytoplasmic domain of the 
protein was generated using I-TASSER.  I-TASSER, as well as other protein modeling 
methods, is limited in the ability to accurately model membrane associated protein 
regions.  Therefore, the predicted N-terminal cytoplasmic domain of CT009 was 
analyzed (CT0091-116).  Several models were generated; the highest scored model had a 
C-score above the recommended cutoff (Fig. 4.8A; C-score of -0.92) and was used to 
search for proteins with structural similarity, using the DALI server (Holm & Rosenstrom, 
2010).  Interestingly, the top structure that aligned best with the I-TASSER model of 
CT0091-116 was not cI (which was most similar to the full length CT009; Fig. 4.3) but was 
the cytoplasmic domain of RodZ (chains R from PDBid: 2WUS), with Z-scores of 14.5 
and 13.2.  This RodZ structure aligns to Model 1 with an r.m.s.d. score of 0.9 Å (over 
86/87 residues), despite low sequence similarity to CT009 (BLAST E value >10;). 
 RodZ is a membrane-bound cell shape determining protein, a component of the 
bacterial cell morphogenic complex and an interaction partner of the bacterial actin 
homolog MreB (Alyahya et al., 2009, Bendezu et al., 2009, Shiomi et al., 2008, van den 
Ent et al., 2010).  In addition to possessing structural similarity to RodZ in their 
cytoplasmic domains, CT009 and RodZ also are predicted to share a similar membrane 
topology; a single transmembrane helix anchors both proteins in the inner membrane (Fig. 
4.7; (Bendezu et al., 2009)).  RodZ also possesses two MreB-interacting residues, 
conserved in RodZ homologs.  The only available structure of RodZ (from Thermatoga 
maritima) is a co-crystal with MreB.  In this crystal structure, several hydrophobic 
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FIG. 4.8.  A computationally modeled structure of the predicted cytoplasmic domain 
of CT009 has structural similarity to cytoplasmic domain of the protein RodZ. 
A.  The amino acid sequence of the predicted cytoplasmic domain of CT009 (amino acids 
1-116) was used to build a model of CT009 structure using the I-TASSER server. 
B.  The I-TASSER model of CT009 (purple) was aligned to the previously solved 
structure of RodZ (2WUS chain R; yellow) with an r.m.s.d. score of 0.89 Å over 86 
residues. 
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residues were identified at the interaction interface between RodZ and MreB, several of 
which are also required for proper interaction between RodZ and MreB (Fig. 4.9D; (van 
den Ent et al., 2010)).  Among these were residues Y53 and Y57, bulky hydrophobic 
amino acids in the fourth helix of the protein and correspond to F60 and Y64 in E. coli 
RodZ.  Importantly, despite overall low sequence similarity between RodZ and CT009, 
these residues are conserved in CT009 as Y57 and F61 are predicted to be similarly 
positioned in the helix 4 of CT009 (Fig. 4.10D), as analyzed by Clustal Omega and 
ESPript (Sievers et al., 2011, Gouet et al., 2003).  Therefore, based on both the overall 
predicted structural similarity and the presence of conserved residues critical for function, 
the I-TASSER generated model of CT0091-116 suggests that this protein may be a 
chlamydial RodZ homolog. 
 
The crystal structure of CT009 shows structural similarities to RodZ. 
  In addition to computational modeling, recombinant CT009 (cytoplasmic domain, 
residues 1-116) was expressed, purified and crystallized.  A data set was collected and 
processed to a resolution of 1.25 Å, with one molecule of CT009 in the asymmetric unit 
(Fig. 4.9A).  Curiously, the protein appears to be crystallized in a flat “open” 
conformation.  The physiological relevance of this form is dubious; proteins in solution 
typically adopt a more compact fold, minimizing the hydrophobic surface area exposed to 
solvent.  However, analysis of the crystal packing revealed that a molecule related by a 
crystallographic 2-fold operator (Y, X, -Z) results in the positioning of the C-terminal 
region near the N-terminal region.  Together, these crystallographic dimer partners form a 
“folded” conformation that one might expect, particularly when compared to a 
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homologous protein RodZ (Fig. 4.9C).  This phenomenon, in which two polypeptide 
chains exchange subdomains, is an uncommon (but not unheard of) occurrence and is 
most frequently observed in structural studies that utilize x-ray crystallography (Bennett 
et al., 1994).  This swapping of subdomains can be an artifact of crystal packing but 
sometimes the subdomain-swapped form exists in solution as well (Barrientos et al., 
2002).  Electron density at the “hinge” of this subdomain swapping, (Fig. 4.9B) 
demonstrates that the protein is indeed in a flat conformation.  This electron density is 
further highlighted (Fig. 4.9D).  A predicted structure of a CT009 monomer (from amino 
acids 1-54 of one monomer in the crystallographic dimer and amino acids 55-103 of the 
other crystal-mate) can be constructed (Fig. 4.9A).  Like the modeled structure of CT009, 
the conserved MreB-interacting residues (Y57 and F61) are apparent in the crystal 
structure, facing outward in a position capable of interaction with MreB and highlighted 
in red (Fig. 4.10A). 
 In addition to the subdomain-swapped crystallographic dimer, recurring positive 
difference (Fo-Fc) electron density at the C terminal helix, following refinement, 
indicated that this portion of the helix adopted two distinct conformations and was 
modeled as such.  Examples of the electron density in this helix can be seen in the 
backbone carbonyls of residues Lys 85 through Phe 87 (Fig. 4.9E) and in the sidechain of 
Phe 87 (Fig. 4.9F). 
  Superposition of RodZ onto the predicted monomer resulted in an r.m.s.d. of 1.02 
Å over 66/87 residues (Fig. 4.10C).  The major difference between the structure of 
CT009 and the structure of RodZ is in the orientation of their C-terminal helices.  In 
RodZ, this final helix (amino acids 69-86) is orientated straight up.  However, in the  
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Table 4.3.  Crystallographic data for CT009 refined to 1.25Å resolution. 
 
 CT009 
Data Collection  
Unit-cell parameters (Å, o) a=55.17, c=88.12 
Space group P41212 
Resolution (Å)1 46.76-1.25 (1.27-1.25) 
Wavelength (Å) 1.0000 
Temperature (K) 100 
Observed reflections 318,621 
Unique reflections 38,420 
<I/s(I)>1 25.1 (2.5) 
Completeness (%)1 99.9 (98.5) 
Multiplicity1 8.3 (7.5) 
Rmerge (%)1, 2 3.6 (82.4) 
Rmeas (%)1, 4 3.8 (88.5) 
Rpim (%)1, 4 1.3 (32.0) 
CC1/2 1, 5 
Phasing 
      Maximum LLG 
0.999 (0.816) 
 
2176 
Refinement  
Resolution (Å) 29.21-1.25 
Reflections (working/test) 36,417/1,921 
Rfactor / Rfree (%)3 15.9/17.3 
No. of atoms (Protein/Water) 1,007/111 
Model Quality  
R.m.s deviations   
Bond lengths (Å) 0.012 
Bond angles (o) 1.437 
Average B-factor (Å2)  
All Atoms 20.2 
Protein 18.8 
Water 32.9 
Coordinate error (maximum 
likelihood) (Å) 
0.13 
Ramachandran Plot   
Most favored (%) 99.2 
Additionally allowed (%) 0.8 
 
1) Values in parenthesis are for the highest resolution shell. 
2) Rmerge = ShklSi |Ii(hkl) - <I(hkl)>| / ShklSi Ii(hkl), where Ii(hkl) is the intensity 
measured for the ith reflection and <I(hkl)> is the average intensity of all reflections with indices hkl.  
3) Rfactor = Shkl ||Fobs (hkl) | - |Fcalc (hkl) || / Shkl |Fobs (hkl)|; Rfree is calculated in an  
identical manner using 5% of randomly selected reflections that were not included in the refinement. 
4) Rmeas = redundancy-independent (multiplicity-weighted) Rmerge(Evans, 2011, Evans, 2006).  Rpim = precision-indicating 
(multiplicity-weighted) Rmerge(Diederichs & Karplus, 1997, Weiss, 2001).  
5) CC1/2 is the correlation coefficient of the mean intensities between two random half-sets of data (Karplus & Diederichs, 2012, 
Evans, 2012). 
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FIG. 4.9.  A high-resolution structure of CT009 adopts an “open” fold as a result of 
crystal packing, resulting in a subdomain swap dimer. 
A.  The predicted cytoplasmic domain of CT009 (amino acids 1-116) was purified and 
crystallized.  A set of data at 1.25 Å was collected and a structure was modeled. 
B.  Electron density at the “hinge” of the subdomain swap (between amino acids I53 and 
A58). 
C.  A crystallographic dimer of the CT009 structure (green and cyan). 
D.  A closer view of the electron density at the “hinge” of the subdomain swap (between 
amino acids I53 and A58). 
 E.  Electron density highlighting the backbone carbonyls of the C-terminal helix, which 
was modeled as being in two conformations, contoured at 2 sigma (residues K85, I86 and 
F87 shown). 
F.  Electron density highlighting the alternate conformation of the C-terminal helix, 
showing the two conformations of the sidechain of F87. 
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structure of CT009, this helix is kinked sharply to the right and is broken into two distinct 
helices, one short (amino acids 73-78) and the other longer (amino acids 81-101).  The 
reason for this difference is not obvious, although it is possible that the final helix in 
CT009 is kinked so that it can make better crystal contacts with its crystal mates.  
Importantly, this helix is not directly involved in contacts with MreB and the MreB-
interacting surface appears to be structurally conserved in CT009.  Therefore, despite the 
unusual crystal packing of the CT009 subdomains, the crystal structure of the 
cytoplasmic domain of CT009 supports the hypothesis that it is a structural homolog to 
the protein RodZ. 
 
CT009 interacts with itself and with MreB. 
  As discussed previously, RodZ plays a role in rod-cell shape maintenance in other 
bacteria as part of a morphogenic complex with the bacterial actin homolog MreB.  
Although CT009 may be a functional homolog of RodZ, this does not explain what role 
this protein has in Chlamydiae, because these bacteria are coccoid in shape.  It was 
recently proposed that, in Chlamydiae, cell shape-determining proteins, including the 
MreB protein, are involved in chlamydial cell division (Brown & Rockey, 2000, 
Ouellette et al., 2012).  RodZ is thought to play a critical role in tethering MreB to the 
membrane and interacts with MreB through conserved amino acids at a well-defined 
interaction interface (van den Ent et al., 2010).  Given the structural similarity and 
conservation of these key MreB-interaction residues in CT009, we tested the hypothesis 
that CT009 interacts with chlamydial MreB and requires these interactive residues using  
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FIG. 4.10.  The crystallographic dimer of CT009 has structural similarity to RodZ, 
including a conservation of key MreB-interacting residues. 
A.  A theoretical structure of a CT009 monomer created by displaying amino acids 1-54 
of one monomer in the crystallographic dimer and amino acids 55-103 of the other 
crystal-mate; conserved MreB-interacting residues (Y59 and F61) are highlighted in red. 
B.  Crystal structure of RodZ (blue) and MreB (magenta) from Thermotoga maritima 
(PDBid: 2WUS); conserved MreB –interacting residues (Y53 and Y57) are highlighted in 
red. 
C.  A superposition of the theoretical monomer of CT009 (green and cyan) and the 
previously solved structure of RodZ (2WUS chain R; blue) with an r.m.s.d. score of 1.02 
Å over 66 residues. 
D.  A sequence alignment of CT009, RodZ from E. coli (RodZ_EC) and RodZ from T. 
maritima (RodZ_TM), illustrating conservation of MreB-interacting residues; the α-helix 
in which these amino acids lie is labeled. 
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the Bacterial Adenylate Cyclase Two Hybrid (BACTH) system (Fig. 4.11; (Karimova et 
al., 2005, Karimova et al., 1998)). 
 RodZ and MreB from a variety of species have been shown to interact in the 
context of a bacterial-two hybrid system and even co-crystallize together (Bendezu et al., 
2009, Kleinschnitz et al., 2011, van den Ent et al., 2010, White et al., 2010).  Our analysis 
shows a positive interaction between CT009 and chlamydial MreB proteins (Fig. 4.10, 
CT009-MreB).  All eight different possible combinations of interactions (with differing 
orientations of the fusion proteins on CT009 and MreB) were tested (data not shown).  
Any interactions in which the adenylate cyclase domain was fused to the C-terminus of 
CT009 failed to interact with MreB.  CT009 is predicted to be anchored to the inner 
membrane, with its N terminus in the cytoplasm and its C terminus in the periplasm (Fig. 
4.7).  It is expected that fusion proteins attached to the C terminus of CT009 might not 
function properly, as this domain is then likely localized in the periplasm.  All four 
interaction combinations using N-terminally tagged CT009 showed interaction between 
CT009 and MreB (data not shown). 
 As discussed previously, RodZ from Thermatoga maritima has been shown to 
interact with MreB and several residues that are critical for this process have been 
identified (van den Ent et al., 2010).  Two of these residues (Y53 and Y57 in T. 
maritima) are bulky hydrophobic amino acids that are positioned at the interface between 
RodZ and MreB; despite low overall sequence similarity between CT009 and RodZ, 
these residues are conserved in CT009 as Y57 and F61.  In order to test whether these 
large hydrophobic amino acids are directly involved in CT009-MreB interaction, CT009 
Y57A, F61A was analyzed by BACTH.  To ensure that these mutations have not altered 
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FIG. 4.11.  Interactions between CT009 and MreB by Bacterial Adenylate Cyclase 
Two Hybrid (BACTH).  Full length CT009, mutant CT009 Y57A, F61A, the predicted 
cytoplasmic domain of CT009 (residues 1-116), and chlamydial MreB interactions were 
analyzed.  As a positive control, self-interaction of the leucine zipper of the GCN4 
protein was tested.  Expression of the β-galactosidase reporter gene by reconstituted 
adenylate cyclase was assessed using a β-galactosidase assay.  Activities were calculated 
in Miller units.  Error bars represent standard deviations calculated from assays 
performed in triplicate. 
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the overall fold of the protein, dimerization interactions with CT009 Y57A, F61A were 
studied (Fig. 4.11, CT009 mut-CT009 mut).  CT009 with these two point mutations is 
still capable of interacting with itself, demonstrating that these mutations are likely not 
leading to a complete misfolding of the protein.  However, as expected, these mutations 
do lead to a loss of interaction with MreB (Fig. 4.11, CT009 mut-MreB). 
 In addition to interacting with MreB, RodZ has been shown to interact with itself, 
although the necessity of this self-interaction for function has not been explored 
(Bendezu et al., 2009, Kleinschnitz et al., 2011, White et al., 2010).  In our studies with 
recombinant protein, the cytoplasmic domain of CT009 did not form higher order 
structures in solution as analyzed by analytical ultracentrifugation (Fig. 4.12).  In order to 
assess the ability of full length CT009 to interact with itself, CT009 was expressed as a 
fusion with either the T25 or T18 domain of adenylate cyclase fused to either the N or C 
terminus.  All possible combinations of CT009 self-interaction (with differing orientation 
of the fusion proteins) were tested (data not shown) and one combination showed positive 
interaction (Fig. 4.11, CT009-CT009).  This was the condition in which both the T25 and 
T18 domains were fused to CT009 at its N terminus.  This is likely for the same reasons 
that C-terminal fusions to CT009 failed to interact with MreB (discussed above).  This 
suggests that, like RodZ, full length CT009 interacts with itself. 
 As mentioned previously, during purification of recombinant CT009 the predicted 
cytoplasmic domain did not form higher order structures with itself, as analyzed by 
analytical ultracentrifugation (Fig. 4.12).  This observation supported the hypothesis that 
the CT009 dimer seen in the crystal structure (Fig. 4.9C) was an artifact due to crystal 
packing and likely is not physiologically relevant.  To test this, self-interactions with the 
	   138	  
 
 
 
 
 
 
 
FIG. 4.12.  Sedimentation velocity profile of CT009 1-116 by analytical 
ultracentrifugation shows that its molecular weight is consistent with that of a 
monomer.  C(s) represents the relative concentration of each species.  The largest peak 
represents 90.01% of the total material and is centered at 1.057s, which corresponds to a 
molecular weight of 13.18 kDa.  The molecular weight of CT009 1-116 is 13.37 kDa. 
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cytoplasmic domain of CT009 were tested using BACTH (Fig. 4.11, CT009 cyt-CT009 
cyt).  In contrast to the full-length protein, the cytoplasmic domain of CT009 does not 
interact with itself.  Again, all possible combinations of interactions (with differing 
orientations of the fusion proteins) were tested, but no combination lead to a dimerization 
interaction (data not shown).  This suggests that the transmembrane helix and/or the short 
periplasmic tail may be involved in mediating or strengthening dimerization of CT009.  
Interaction between the cytoplasmic domain of CT009 and MreB was also tested (Fig. 
4.11, CT009 cyt-MreB).  No interactions between these two proteins were observed in 
any of the eight possible fusion protein configurations (data not shown).	   	  This suggests 
that either dimerization of the protein or its localization to the membrane may be required 
for MreB interaction. 
 
CT009 is able to functionally complement RodZ in vivo. 
  With the hypothesis that CT009 is a chlamydial RodZ homolog, its ability to 
complement the function of RodZ in the heterologous system of E. coli was tested.  RodZ 
is involved in directing cell shape and in rodZ knockout strains of E. coli there is a well-
defined phenotype: cells grow to be spherical instead of rod-shaped (Bendezu et al., 2009, 
Shiomi et al., 2008).  rodZ knockout cells (FB60) were transformed with plasmids that 
either encoded RodZ, CT009 or were empty.  As a control, a K-12 strain of E. coli 
(MC1000) was used as well.  In addition, a plasmid containing a mutant CT009 (CT009 
Y57A, F61A) was also transformed into FB60 cells.  This mutant protein has alterations 
at the MreB interaction interface and, unlike wild type protein, does not interact with 
MreB by BACTH. 
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 To test for complementation of the loss of RodZ phenotype, plasmid-containing 
FB60 cells and MC1000 cells were grown to exponential phase, fixed, stained with the 
dye malachite green and visualized by fluorescence microscopy (Fig. 4.13).  The images 
presented are representative of three independent experiments.  As expected for K-12 E. 
coli, MC1000 cells are rod shaped (Fig. 4.13A).  As previously described, rodZ deficient 
E. coli cells (FB60) with an empty vector have an aberrant morphology and are more 
spheroid with less of a defined rod shape (Bendezu et al., 2009) (Fig. 4.13B).  Also 
described previously, when FB60 cells are complemented with a plasmid expressing 
RodZ, wild type phenotype is restored and cells have rod morphology (Bendezu et al., 
2009) (Fig. 4.13C).  When FB60 cells are complemented with a plasmid expressing 
CT009, rod morphology is partially restored (Fig. 4.13D).  Although cells supplemented 
with CT009 are longer and more rod-like than RodZ knockout cells, they are also wider 
than cells complemented with RodZ.  This may be because CT009 does not possess a 
predicted periplasmic domain; a previous report in which RodZ knockout cells 
complemented with a truncated RodZ (lacking its periplasmic domain) showed 
complementation accompanied by widening of cells (Bendezu et al., 2009).  Additionally, 
when FB60 cells express a CT009 that contains mutations in the two conserved residues 
that mediate the interacting between RodZ and MreB (Y57A, F61A), cells fail to restore 
wild-type phenotype (Fig. 4.13E).  Together, these data suggest that CT009 is a 
functional homolog to RodZ in C. trachomatis. 
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FIG. 4.13.  CT009 is able to functionally complement RodZ in E. coli. 
A-E.  Representative images of E. coli cells that were fixed, stained with malachite green, 
and imaged by epifluorescent microscopy. Phenotypes of (A) wild type E. coli, (B) FB60; 
rodZ deficient E. coli (Bendezu et al., 2009), (C) FB60 cells ectopically expressing RodZ, 
(D) FB60 ectopically expressing CT009, and (E) FB60 cells ectopically expressing 
CT009 Y57A/F61A mutant. 
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Computational analyses identify potential RodZ homologs in other bacterial species. 
  At the time of its original annotation, CT009 contained a predicted helix-turn-
helix motif as well as a predicted XRE family DNA binding domain.  For this reason, it 
was annotated as a transcription factor.  However, our structural and functional studies on 
the protein now show that CT009 has properties of a homolog to RodZ, interacting with 
MreB and likely involved in chlamydial cell division.  Support for our initial exploration 
of CT009 as a homolog to RodZ rather than a transcription factor came from structural 
similarity and its possession of conserved residues involved in MreB interaction. Another 
key feature of RodZ that is conserved in CT009 is the presence of a C-terminal 
transmembrane helix.  Given the large number of proteins with high sequence similarity 
to CT009 that are annotated as Xre family DNA binding domain or not annotated 
functionally (hypothetical), we hypothesized that many of these are also RodZ homologs. 
 To support this hypothesis, the protein sequence of CT009 was used in a BLAST 
search (Altschul et al., 1997).  The top 20 proteins of similar sequence to CT009 (non-
chlamydial, from non-redundant genera) were first analyzed by the HMMTOP server, 
which predicts the presence of transmembrane helices and protein topology (Tusnady & 
Simon, 2001).  Fourteen of these proteins were found to have a single predicted 
transmembrane helix, with the N-terminus of the proteins oriented in the cytoplasm (like 
RodZ; Table 4.4).  These fourteen proteins were then analyzed further.  All of these 
proteins are either annotated as hypothetical proteins (HP) or as transcription factors, 
either helix-turn-helix containing proteins (HTH) or XRE-family members (XRE).  All of 
the species that produce these proteins are rod shaped in morphology and all encode an 
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MreB homolog (except for Carboxydibrachium pacificum), suggesting a need for a RodZ 
homolog.  Importantly, none of these species have an annotated homolog to RodZ. 
 Finally, the amino acid sequences of these proteins were aligned to that of E. coli 
RodZ and C. trachomatis CT009 using ClustalW2 (Larkin et al., 2007).  As mentioned 
previously, structural studies of RodZ and MreB revealed two bulky hydrophobic 
residues that are crucial for mediating interactions between RodZ and MreB (Fig. 4.8D).  
Conservation of these MreB-interacting residues was examined and all CT009 homologs, 
except for one, possess these key amino acids.  While the protein ANT_03850 from the 
filamentous thermophile Anaerolinea thermophile lacks these residues, its sequence 
homology to CT009 along with its predicted transmembrane helix suggest that it may be 
a RodZ homolog that mediates interactions with MreB through a novel mechanism.  
While this is not an exhaustive exploration of potential RodZ homologs among all 
bacterial species, it does showcase the power of going beyond sequence similarity to 
identify proteins of homologous function in other organisms. 
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Table 4.4.  Probable RodZ homologs based on CT009 homology 
           CT009  MreB-interacting 
Name  Annotation Organism       Transmembrane Helix  E value  Residues Present 
RodZ  RodZ Escherichia coli    112-131   0.004  Yes, F60, Y64 
CT009  HTH Chlamydia trachomatis   117-136   N/A  Yes, Y57, F61 
ALO_19967 XRE Acetonema longum   109-128   3e-14  Yes, F49, F53 
CYB_0195 HP Synechococcus sp.   110-129   1e-10  Yes, Y56, F60 
Moth_1073 XRE Moorella thermoacetica   100-117   1e-10  Yes, Y49, F53 
Thewi_1795 HP Thermoanaerobacter wiegelii  109-127   2e-10  Yes, Y49, F53 
Btus_1597 XRE Kyrpidia tusciae    107-125   2e-10  Yes, Y49, F53 
Thit_1638 HP Thermoanaerobacter italicus  110-128   4e-10  Yes, Y49, F53 
CDSM653_1192 HP Carboxydibrachium pacificum  107-126   5e-10  Yes, Y49, F53 
Daes_1731 HTH Desulfovibrio aespoeensis   115-133   6e-10  Yes, Y51, F55 
TC41_1408 XRE Alicyclobacillus acidocaldarius  157-181   7e-10  Yes, Y65, F53 
syc0492_c HP Synechococcus elongatus   112-134   1e-9  Yes, F57, F61 
ANT_03850 XRE Anaerolinea thermophila   241-260   2e-9  No, Q181, M185 
PTH_1295 HP Pelotomaculum thermopropionicum 105-122   3e-9  Yes, Y48, F52 
TM_1864 HP Thermotoga maritima   105-122   4e-9  Yes, Y53, Y57 
Thexy_0625 XRE Thermoanaerobacterium xylanolyticum 112-129   7e-9  Yes, Y49, F53 
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Chapter IV 
Discussion 
 
 A BLAST search using CT009 protein sequence as input revealed the presence of 
CT009 homologs in all species of Chlamydia with sequenced genomes, including all 
serovars of C. trachomatis, C. pneumoniae, C. psitacci, C. muridarum, C. abortus, C. 
pecorum, C. felis and C. caviae.  This suggests a conserved role for CT009 that is 
fundamental to the biology of chlamydiae. Interestingly, the CT009 ortholog in C. 
muridarum possesses a additional 8 amino acids at its N terminus.  The significance of 
these amino acids is not apparent. 
 Comparative sequence analyses with CT009 reveals a predicted helix-turn-helix 
motif within a conserved XRE (Xenobiotic Response Element)-family DNA binding 
domain (Altschul et al., 1997).  The Xre family (IPR001387) is expansive in regards to 
phylogenetic distribution and associated with many DNA regulatory functions including 
Lambda phage (cI/Cro) related transcription repressors (Aggarwal et al., 1988, Minezaki 
et al., 2005, Lewis et al., 1998).  Additionally, an initial computational model of the full 
length CT009 protein showed structural similarity to the transcriptional repressor cI.  
Therefore, initial studies on CT009 were aimed at the identification of its gene targets in 
Chlamydia. 
 In an effort to identify chlamydial genes regulated by CT009, several different 
techniques were employed.  An initially attempted method was Systematic Evolution of 
Ligands by Exponential Enrichment (SELEX).  This technique utilizes multiple rounds of 
DNA binding in order to enrich for sequences of DNA are most strongly recognized by 
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the protein.  However, in my analysis, after the first round of selection, DNA was present 
in the negative controls (conditions with no antibody to selectively remove the protein-
DNA complex from solution).  This indicates that the DNA was binding nonspecifically 
to the tubes, the beads or the protein G.  This experiment was repeated twice more with 
minor variations, but this nonspecific binding could not be eliminated (data not shown).  
Because of this negative result, other techniques were subsequently employed to 
elucidate CT009 DNA gene targets. 
 Electromobility Shift Assays (EMSA) have been previously used to identify and 
characterize interactions between chlamydial transcription factors and the promoters of 
the genes they regulate.  However, a weakness of this technique is that candidate genes 
must be chosen and tested one by one, making the identification of all potential gene 
targets impractical.  Twelve genes were selected as potentially regulated by CT009 based 
on the presence of an identifiable promoter regions and their differential regulation within 
the chlamydial developmental cycle.  However, no shifts were observed in any assays 
conducted using these promoter regions.  Another problem with this assay is the absence 
of a positive control for CT009; this is because no gene targets for CT009 have been 
previously identified.  Therefore, a failure to produce a shift in this assay might be due to 
problems with either the folding/stability of the recombinant protein and/or the buffer 
conditions used in the binding reaction.  Failure to produce shifts could also be due to 
CT009 not recognizing DNA sequence in those promoters; in this case, a method in 
which more promoter regions could be tested at the same time would be helpful. 
 In order to screen large numbers of promoter region DNAs for CT009 binding, 
Fluorophore-Linked Immunosorbent Assays (FLISA) was performed.  Like EMSA, this 
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technique relies on purified recombinant protein interacting with a small fragment of 
DNA in vitro, but because it is performed in a 96 well plate, it allows for the screening of 
many potential gene targets at once.  However, this technique did not prove helpful as 
negative controls failed to work properly, the reasons for which are not clear. 
 All three previously attempted techniques for identifying CT009 gene targets 
(SELEX, EMSA, FLISA) relied on properly folded purified recombinant protein.  
However, the quality of recombinant CT009 cannot be tested due to the lack of a reliable 
assay for function.  Therefore, a technique that does not rely on purified protein was 
employed: Bacterial one-Hybrid (B1H).  This assay system relies on protein-DNA 
interactions in vivo in the heterologous system of E. coli.  Despite its theoretical 
effectiveness, difficulties were encountered in the construction of the prey library of 
plasmid DNA.  Without a robust library of prey DNA sequences, this assay could not be 
effectively performed. 
 Concurrent with some of the investigations regarding CT009 gene target 
identification were ongoing structural studies of the CT009 protein, both computational 
and experimental.  As both of these structural studies suggested that CT009 might be a 
functional homolog to RodZ rather than a transcription factor, investigations of CT009’s 
DNA binding capabilities ceased. 
 Regarding the computational structure prediction of CT009, an important 
observation to highlight is the accuracy at which the I-TASSER server modeled the 
structure of CT009 and the importance of this structural information in the ultimate 
identification of this protein’s role.  The model generated was similar to the structure of 
RodZ with a r.m.s.d. value of 0.89 Å over 86 residues; this model lead to the initial 
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hypothesis that CT009 is a RodZ homolog.  The accuracy of this modeling is of note 
because of the extremely low sequence similarity between CT009 and RodZ protein 
sequences (BLAST E value >10) and particularly challenging category (i.e. ab initio) of 
computational protein structure modeling. 
  It should also be noted that the initial model of CT009, using the full protein 
sequence, was more similar to the transcription factors cI (Fig. 4.3). This predicted 
structure similarity, and the predominant association of helix-turn-helix domain with 
nucleic acid interactions, supported a hypothesis that CT009 functions as a transcription 
factor.  As highlighted previously, accurate modeling of membrane-associated regions of 
proteins is very difficult for many structural modeling servers (I-TASSER included).  
Only after the putative trans-membrane region of CT009 was identified and excluded was 
a confidently scored model (of the cytoplasmic domain) of the protein generated, leading 
to the hypothesis that CT009 functions as a RodZ homolog.  These observations with 
computational structural modeling of CT009 therefore demonstrate some of the strengths 
and weakness of a structure-based annotation of protein function.  However, it is clear 
that structural modeling can provide very valuable information regarding the function of 
a protein with otherwise ambiguous or unclear function. 
  The overall global structure similarities between both the computationally 
generated and the experimentally determined structures of the cytoplasmic domain of 
CT009 to RodZ leant support to the hypothesis that CT009 functions as a RodZ homolog.  
However, global fold of the protein alone did not strongly support this hypothesis: other 
proteins such as cI and cro were also structurally similar to the cytoplasmic domain of 
CT009.  The hypothesis of CT009 functioning as RodZ in chlamydiae was also supported 
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by the aforementioned presence of a single pass transmembrane helix (Fig. 4.6); this is a 
feature possessed by RodZ but not by cI or cro.  Additionally, upon examination of the 
primary sequence of CT009, two amino acids that are conserved in the function of RodZ 
were identified, despite the low overall sequence similarity between these two proteins 
(Fig. 4.10C and D).  The presence of these residues also leant support to the hypothesis 
that CT009 is a homolog to RodZ.  Importantly, all of these features (global structure, 
predicted membrane topology and conserved residues) were utilized together to strongly 
support that hypothesis that CT009 is a homolog to RodZ. 
 Although this is the first published study to focus on the chlamydial protein 
CT009, this protein has been analyzed before.  A recent search for additional 
transcription factors in chlamydial species, using a bioinformatics approach, identified 
CT009 as the number one strongest predicted DNA-binding protein (Akers et al., 2011).  
This is not surprising, as we have now experimentally shown that CT009 possesses a 
helix-turn-helix motif. Although this motif is most frequently utilized for DNA binding, 
there are examples of this motif functioning as an interface for protein-protein 
interactions (Aravind et al., 2005).  Importantly, RodZ also contains a helix-turn-helix 
motif; however, it utilizes this motif to stabilize protein-protein interactions, specifically 
with MreB (van den Ent et al., 2010).  Therefore, the helix-turn-helix motif of CT009 is 
also likely involved in interactions with MreB, based on its structural and functional 
homology to RodZ.  Interestingly, chlamydial species already encode a relatively low 
number of transcription factors and these data exclude CT009 as a candidate. Similarly, 
we previously reported that CT296 (Kemege et al., 2011), originally described as a 
divalent cation repressor (Rau et al., 2005, Wyllie & Raulston, 2001), does not contain 
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structural similarity to any transcription factor nor function as originally described. The 
search for additional factors involved in regulation of chlamydial gene expression will 
inevitably continue.  In the future it may be prudent to consider the possibility that not all 
proteins with a helix-turn-helix motif are necessarily utilizing this motif for the purposes 
of DNA binding. 
 Although the cytoplasmic domain of CT009 is structurally similar to RodZ and 
this membrane localized domain functionally complements RodZ in E. coli, the cells 
were wider than wild type (Fig. 4.10A vs 4.10D). This phenotype may be explained by 
the absence of a predicted periplasmic domain in CT009.  CT009 itself is significantly 
shorter than RodZ (Fig 4.6) although the cytoplasmic domains are of very similar size. 
The major difference is the presence of a large periplasmic domain in RodZ (199 amino 
acids) while the predicted periplasmic domain of CT009 is only 7 amino acids long. 
Deletion studies on the different domains of RodZ have demonstrated that the 
periplasmic domain of RodZ is not strictly required for the maintenance of cell shape. 
Importantly, deletion of this domain led to a widening of cells (Bendezu et al., 2009). 
Therefore, it is unsurprising that, in the absence of this domain, CT009 is still able to 
functionally complement RodZ by rendering rod shaped cells that are also wider than 
normal. 
 The precise function of the periplasmic portion of RodZ has not been defined, but 
there have been 16 RodZ homologs identified that lack this domain (Alyahya et al., 2009).  
These RodZ proteins with a periplasmic domain shorter than 10 amino acids were 
typically found in bacteria with reduced genomes or with round morphology (including 
but not limited to Rickettsia spp., Xanthamonas campestris and Staphylococcus spp.), 
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suggesting dispensability for this domain.  Unfortunately, RodZ homologs in these 
species have not, to date, been experimentally analyzed.  Being both coccoid in 
morphology and possessing a reduced genome, it is unsurprising that CT009 also lacks a 
predicted periplasmic domain. 
 In the context of a BACTH assay, full length CT009 interacted with itself while 
the cytoplasmic domain alone did not (Fig. 4.11).  Therefore, dimerization of CT009 is 
likely mediated in part by its transmembrane region and/or the short periplasmic tail.  It is 
also possible that other, as of yet unidentified, protein partners of CT009 may contribute 
to its dimerization, but only if it is localized properly.  Interestingly, the cytoplasmic 
domain of CT009 fails to interact with MreB (Fig. 4.11).  Therefore, it is possible that 
proper localization of CT009 by its transmembrane anchor is required for its interaction 
with MreB.  It is also possible that dimerization of CT009 is required for MreB 
interaction; removal of the transmembrane helix and the predicted short periplasmic tail 
abolished CT009 self-interactions as well.  The dimerization interface of RodZ is not well 
characterized and it is possible that dimerization may put CT009 in a configuration 
required for proper interaction with MreB.  However, this possibility is not well 
supported by the sole crystal structure of RodZ, which shows interaction between a 
monomer of RodZ and MreB (van den Ent et al., 2010). 
 It has been shown in other bacteria that MreB interacts with several proteins other 
than RodZ, including RodA, MreC, and MreD, forming a morphogenic complex.  RodA 
is an integral membrane protein and is predicted to be a flippase involved in cell wall 
elongation.  CT726 has been annotated as a chlamydial RodA homolog although no 
published experimental work has been done on this protein.  MreD is an integral 
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membrane protein with 4-6 membrane-spanning helices.  While its precise function is 
unclear, it has been shown to interact with MreB and is required for the maintenance of 
proper cell shape.  Importantly, there is no apparent chlamydial homolog to MreD.  MreC 
spans the inner membrane with a single helix and possesses a large C-terminal domain 
localized to the periplasm.  Its presence in Chlamydiae is somewhat unclear.  Although 
there was no annotated MreC gene in the initially sequenced chlamydial genome, more 
recent annotations list CT638 as an MreC homolog.  An analysis of CT638 protein 
sequence by HMMTOP reveals a single predicted transmembrane helix, consistent with 
the topology of MreC (data not shown).  However, CT638 has only very weak homology 
to MreC and there exists no experimental evidence for the function of CT638 as an MreC 
homolog.  Further investigation into these other members of the MreB morphogenic 
complex could give deeper insight into the function of this complex in Chlamydiae. 
 The process of cell division in chlamydial species is poorly understood due to the 
lack of apparent homologs to well-conserved bacterial cell division components.  The 
most notable cell division protein absent in chlamydial genomes is FtsZ, which forms the 
Z ring and acts as the central coordinator for cell division.  It was recently proposed that 
chlamydial MreB may play a role in cell division, possibly as a functional replacement 
for FtsZ (Ouellette et al., 2012).  While FtsZ is a major component of the cell division 
machinery, it does not function alone; many other proteins are involved in both 
stabilizing the Z ring and ensuring that it forms in an appropriate location.  More 
specifically, nucleoid occlusion factors such as SlmA prevent Z-ring formation from 
disrupting the bacterial chromosome while negative regulators of FtsZ polymerization, 
such as the MinCDE proteins, prevent Z-ring formation at the cell poles.  These are 
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critical functions in cell division and are their absence would lead to division defects.  
Importantly, homologs to these proteins are not apparent in chlamydial species by 
genome annotation.  In this study, we have identified a chlamydial homolog to the protein 
RodZ; the foundation of this discovery was based on structural studies.  In the future, 
structural information (computationally and/or experimentally derived) may be 
instrumental in the identification of these factors and will, in turn, lead to a better 
understanding of the fundamental process of chlamydial cell division. 
 The majority of the support for the hypothesis that chlamydial species utilize cell-
shape determining proteins (specifically MreB) for mediating cell division comes from a 
recent report in which chemical inhibition of MreB lead to a non-dividing state in 
chlamydial cells (Ouellette et al., 2012).  Non-experimental support for this hypothesis 
lies in the observation that chlamydial genomes encode only three apparent cell division 
genes (out of the ~20 cell division genes conserved in other bacteria) and encode several 
cell shape determining genes while possessing a coccoid morphology.  Members of the 
phylum Chlamydiae have particularly small genomes (~1 megabase) and are unlikely to 
encode proteins that do not serve a necessary function, implying that these morphogenic 
proteins have a key function in the biology of Chlamydia.  In concept, the process of 
directing sidewall-specific peptidoglycan synthesis (the function of cell shape 
determining proteins) is similar to the process of directing cell division; both processes 
must ensure that polymerization of peptidoglycan occurs at a specific site.  Of course, 
there are many differences between these two processes.  Nonetheless, the use of shape 
determining proteins for mediating cell division is an intriguing hypothesis, which bears 
more investigation.  For example, what prevents MreB-controlled septation from 
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contacting (and damaging) the chromosome?  What role does peptidoglycan synthesis 
play in chlamydial cell division and what is the molecular structure of chlamydial 
peptidoglycan?  What are the precise molecular functions of proteins such as MreB, 
RodZ, RodA and FtsK in Chlamydia?  Clearly we have only just begun to understand cell 
division in chlamydia. 
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Chapter V 
Discussion 
 
Utility and Limitations of the use of Structural Information in Functional 
Characterization of Proteins 
 
 Historically, the use of experimentally derived structural information has been 
reported to be successful in informing function among hypothetical proteins (Dey et al., 
2013).  Large structural genomics consortia have demonstrated this on a genome-wide 
scale, studying organisms such as Mycoplasma genitalium, Mycoplasma pneumoniae, 
Thermotoga maritima, and Mycobacterium tuberculosis (da Fonseca et al., 2012, 
Sacchettini, 2013, Shin et al., 2007, Wilson, 2013).  These bacteria were focused on due 
to their small genome size, impact on public health or utility as a model system for 
structure determination.  However, despite its significant impact on public health, its 
relatively small genome and its large number of annotated proteins of unknown function, 
species of Chlamydia have not been the subject of a structural genomics project.  The 
scope of the research presented in this document is on scale much smaller than these 
projects but the relationships between structure and function in three chlamydial proteins 
can be discussed. 
  CT296 was annotated as a protein of unknown function, but initial experimental 
studies on the protein demonstrated a functional relationship to the Fur protein.  Our 
structural studies on this protein were successful in some ways and unsuccessful in others.  
Both computational and experimental structural studies were unsuccessful simply 
	   158	  
because they ultimately did not lead to the identification of a possible function for the 
CT296 protein.  The structure of the CT296 protein contains a partial cupin barrel fold, 
which is widely used by many different classes of proteins, and therefore identification of 
a putative function for CT296 was not possible.  However, the overall fold of CT296 is 
structurally similar to several Fe(II) and 2-oxoglutarate-dependent enzymes (of diverse 
enzymatic function).  A cursory analysis of the structure would have therefore lead to the 
conclusion that CT296 is an enzyme that requires these cofactors.  However, further 
analysis of the protein lead to a more accurate conclusion: upon examining the sequence 
and structure of CT296 for amino acid sidechains capable of coordinating these two 
enzymatic cofactors, it was found that such residues are not apparent in CT296.  
Therefore, because CT296 does not appear to be able to coordinate these molecules on its 
own, it is likely not an enzyme of this class.  This illustrates a limitation of the protein 
structure-function relationship; namely, that many proteins of different functions share a 
common global fold and that the presence of this global fold does relatively little to 
inform function.  This also highlights the necessity of going beyond merely correlating 
global fold to function and using other structural details (such as the coordination of 
cofactors) to make an assessment of protein function. 
  However, the structure of the CT296 protein was not without merit.  Previously 
demonstrated by another group to bind to DNA as a putative transcription factor, the 
structure of CT296 revealed an absence of any conserved DNA-binding structural motif.  
This finding lead to a re-examination of the studies that showed its DNA binding 
properties.  Upon close examination, it was found that these published studies lacked key 
controls.  Therefore, the structure of CT296 lead to a change in the putative function of 
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the protein.  Although a putative function was not clearly identified, its function as a 
DNA-binding protein was called into question.  Being one of very few transcription 
factors identified in chlamydial species, CT296 has been used as a control transcription 
factor in several experiments by other groups and therefore it was important to the 
chlamydial field as a whole to report the lack of DNA-binding capabilities of the CT296 
protein.  Another important observation regarding the structural analysis of CT296 was 
that the computationally modeled structure was remarkably similar to the experimentally 
determined structure, an illustration of the effectiveness of the I-TASSER server, even on 
proteins with low sequence homology to proteins of known function. 
  Ultimately, the function of the CT296 protein is not clear.  It is likely not 
functioning as a transcription factor and it does not appear to be able to bind Fe(II) or 2-
oxoglutarate, like its closest structural homologs.  However, it may be speculated that the 
function of CT296 involves another protein.  The crystal structure of CT296 revealed an 
incomplete cupin barrel fold, lacking several necessary opposing beta sheets to complete 
the fold; therefore, it is possible that a protein partner to CT296 might complete this fold.  
Although this does not point to a definitive function for CT296, the structure of such a 
binding partner (or perhaps a co-crystal structure with both proteins) could be more 
informative.  The technique of co-immunoprecipitation, using antibodies against CT296 
applied to a chlamydial cell lysate could potentially identify such a binding partner. 
  Another example of a chlamydial protein of unknown function with a solved 
structure is CT584.  The story behind this protein is interesting because X-ray 
crystallography was not the only technique used to explore the structure of CT584.  
Initially, the secondary structure characteristics of CT584 were examined, particularly the 
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changes in secondary structure in response to changes in pH and temperature (Markham 
et al., 2009).  While the secondary structure characteristics of a protein are generally 
much less informative regarding a protein’s putative function, these studies were carried 
out with a hypothesis concerning the function of CT584 already proposed: namely, that it 
is a chlamydial T3SS needle tip protein.  Even with a hypothesized function, these 
secondary structure experiments were only worth performing because of previous 
structural studies of the same nature performed on other known T3SS needle tip proteins.  
Ultimately, the secondary structure characterization of CT584 supported the hypothesis 
that it is a T3SS needle tip protein.  However, further studies, both functional and 
structural, were needed to more solidly support this hypothesis. 
  The structure of CT584 (its closely related Chlamydia pneumoniae ortholog, 
Cpn0803) was solved by another group while my functional studies of the protein were 
ongoing (Stone et al., 2012).  The structure of this protein was less than illuminating, 
however, and a function for the protein was not made clear by the elucidation of its 
structure.  Like, CT296, the structure of CT584 called into question its previously 
purported function; in this case, the chlamydial T3SS needle tip protein.  This was 
primarily due to an overall structure with little similarity to known needle tip proteins.  
However, the investigators also assessed protein features beyond global fold: they 
examined the features of its multimeric form and found that such a multimer did not 
possess an inner diameter capable of allowing proteins through for secretion.  
Additionally, they found identified the residues in the CT584 ortholog responsible for 
interaction with the needle protein and found that they would be buried in a hexamer, 
suggesting that an oligomer of the protein (found in T3SS needle tips) would not be 
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capable of binding to the tip of the needle.  Although the global structure alone suggested 
a non-needle tip function for the protein, these further studies on the detailed structural 
elements and oligomerization characteristics suggested this more strongly.  Therefore, 
although a function cannot be assigned to CT584, these structural studies have not leant 
support to the hypothesis that it is a T3SS needle tip protein.  This is in line with my own 
functional studies of CT584, which also do not support this hypothesis.  Importantly, I 
have also generated crystals of CT584; the structure of this protein, solved by Scott 
Lovell, is very similar to that of Cpn0803 and all the same functional conclusions could 
be drawn from it.  Overall, these studies on CT584 illustrate how the three dimensional 
structure of a protein ultimately gives more credible information than information 
regarding its secondary structure alone.  Additionally, they demonstrate how structural 
information can sometimes be at odds with other information regarding a protein’s 
function. 
  Importantly, the structure of CT584 was also modeled computationally.  Unlike 
CT296, this model did not suggest a clear function for the protein; closest structural 
homologs to the model were transcriptional regulators of diverse family and function.  
Additionally, the CT584 model lacks structural similarity to the experimentally 
determined structure of the C. pneumonia ortholog, Cpn0803.  Therefore, the case of 
CT584 is an example by which computational structural modeling was wholly 
unsuccessful in proving useful information for functional assignment. 
  Regarding the function of CT584, neither the crystal structure nor my functional 
analyses point toward a definitive function for this protein.  However, a very recent report 
showed that CT584 interacts with the putative T3SS substrate CT082 and increases its 
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secretion (Pais et al., 2013).  This suggests that CT584 is functioning as a T3SS 
chaperone.  This role is supported by my localization studies, showing a primarily 
cytoplasmic localization of the protein.  Further studies would be aimed at the 
identification of additional proteins chaperoned by CT584 and/or the identification of a 
molecular function for its known partner, CT082. 
  The third and final example of the protein structure-function paradigm involves 
the chlamydial protein CT009.  Annotated as a protein of unknown function, the primary 
sequence for CT009 did give some clue to its function by the presence of a putative helix-
turn-helix motif, primarily found in DNA binding proteins.  Due to its low solubility, the 
structure of CT009 was analyzed computationally long before it was crystallized.  This 
initial computational model of full-length CT009 showed structural similarity to the cI 
and cro transcriptional repressors, leading to studies on the DNA binding properties of 
CT009.  However, a single transmembrane helix was eventually identified at the C-
terminus of the CT009 protein.  Removal of this transmembrane helix lead to increased 
protein solubility but, importantly, it also lead to a significantly different model.  When 
the structure of the cytoplasmic domain of CT009 alone was modeled, the resulting 
structure resembled the protein RodZ as well as the proteins cI or cro. Importantly, the 
crystal structure of the cytoplasmic domain of CT009 very closely resembled the model 
of this domain. 
  However, these structures of CT009 were about as similar to RodZ about as they 
were to cI or cro and therefore the overall structure of CT009, on its own, was not very 
conclusive.  In formulating a hypothesis regarding the function of CT009, information 
outside of the global fold of the protein was leveraged.  In examining published reports 
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concerning RodZ, cI and cro, it was found that RodZ, like CT009, possesses a single-pass 
transmembrane helix while cI and cro do not.  Additionally, although RodZ, cI and cro all 
possess helix-turn-helix motifs, RodZ does not use this motif for DNA binding; given the 
failed attempts at getting CT009 to bind to DNA, this observation suggests that CT009 
might be more functionally related to RodZ.  Furthermore, all analyzed sequences of 
RodZ possess two conserved hydrophobic residues, involved in protein-protein 
interactions.  Although the overall sequence similarity between CT009 and RodZ is low, 
these two residues are conserved in CT009 are in a similar orientation in the two 
structures.  Therefore, based on these further analyses of the CT009 sequence and 
structure, CT009 was hypothesized to be a functional homolog to RodZ and not to cI or 
cro.  This underlines the importance of utilizing all bioinformatics tools available for the 
analysis of a protein’s sequence and structural properties and not just its global fold when 
forming hypotheses regarding its function.  In many ways, CT009 proved to be an ideal 
example of the protein structure-function paradigm because the structure of the protein, 
as well as these other characteristics, lead clearly to a hypothesis regarding its function. 
 
Chlamydial Structural Genomics 
 
 As discussed above, several bacteria have been the focus of structural genomics 
projects in efforts to elucidate the structures of all proteins in their respective proteomes.  
Importantly, despite their relatively small genome size, their significant impact on public 
health and their abundance of proteins of unknown function, no chlamydial species have 
been selected for study by structural proteomics. 
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  Despite the relative success of these groups in solving the crystal structures of a 
large number of proteins from a single organism, the process of structural genomics is 
still challenging and expensive.  A less costly alternative to the experimental solution of 
these structures is the computationally modeling of all identified proteins in a genome.  
While considerably less costly than an experimental approach, computational structural 
genomics is less effective simply because the accurate modeling of proteins, particularly 
proteins with no homologs by primary sequence, is challenging.  Despite this difficulty, 
the computational protein structure modeling illustrated in this report underlines the 
overall effectiveness of this technique. 
  As discussed above, the crystal structure of CT296 did not clearly point to a 
potential function for the protein.  However, the computationally generated model of 
CT296 was remarkably like the crystal structure, despite the lack of sequence homologs 
with known structures.  In contrast, the modeled structure of CT584 was entirely 
dissimilar to the crystal structure of the C. pneumoniae ortholog.  The sequence similarity 
between these two related proteins is very high and so this is likely not a reason for this 
discrepancy.  CT584 simply lacks significant sequence homology to proteins of known 
structure, causing the chances for its successful modeling to be relatively low.  Finally, 
the modeled structure of the cytoplasmic domain of CT009 was very similar to the crystal 
structure of this protein and suggested the same functional role in the cell.  Importantly, 
an accurate structure was only possible when the cytoplasmic domain of the protein was 
analyzed.  The accurate modeling of membrane helices and integral membrane proteins is 
not as developed as the algorithms for modeling soluble domains of proteins and this 
limits the number of proteins in the chlamydial genome that can be confidently modeled.  
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Despite their shortcomings, these three examples of computational modeling of 
chlamydial proteins illustrate the potential effectiveness of applying computational 
structure modeling to the entire chlamydial proteome.  As shown with CT296, CT584 
and CT009, such an approach could give important insights into the biological roles and 
functions of the many hypothetical proteins in the chlamydial genomes. 
 
CT584 is a poor potential chlamydial vaccine target 
 
  Although chlamydial infections can be effectively treated with antibiotics, 
infections are frequently asymptomatic.  Consequently, infected individuals may not only 
forgo treatment but may unwittingly pass their infection on to others, due to lack of 
detection.  Additionally, chlamydial resistance to commonly used antibiotics has already 
been reported in C. suis, a species that infects pigs.  Therefore, strategies that lead to the 
prevention of infection by chlamydial species are of particular interest. 
  One such strategy for prevention of chlamydial infection is the development of an 
effective vaccine against C. trachomatis in humans.  Although research to this end has 
been intense, a vaccine against human chlamydial infection has yet to be developed.  
Vaccination using whole, inactivated organisms is a commonly used strategy for vaccines 
against other pathogens.  However, vaccines composed primarily of inactivated EBs have 
been shown in the past to actually enhance disease rather than prevent it (Grayston et al., 
1961, Nichols et al., 1966, Woolridge et al., 1967).  For this reason, subsequent research 
has focused on the development of protein subunit vaccines. 
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  Antigens to be used to these subunit vaccines can be categorized into four classes: 
antigens that are exposed on the surface of chlamydial organisms, antigens that are 
exposed on the surface of chlamydial inclusions, antigens that are in the chlamydial 
cytoplasm and antigens that are secreted into the host cytoplasm (Murthy & Arulanandam, 
2012).  The majority of research has focused on antigens exposed on the surface of 
chlamydia as these antigens are expected to induce neutralizing antibodies that could 
prevent initial attachment and entry of organisms.  Surface-exposed chlamydial antigens 
tested for vaccine efficacy include MOMP, OmcB, PorB and the PmP proteins, to name a 
few. 
  One category of surface-exposed antigens that has yet to be examined for efficacy 
in Chlamydia is proteins associated with the external portion of the Type III Secretion 
System (T3SS).  The exposed components of this system include the needle protein and 
the needle tip protein.  The T3SS needles and needle tip proteins of other pathogenic 
bacteria have displayed immunogenic behavior and are therefore attractive vaccine 
candidates (Overheim et al., 2005, Barrett et al., 2010).  Therefore, identification of the 
chlamydial T3SS needle tip protein is on high importance for its potential use in a protein 
subunit vaccine. 
  Current studies regarding CT584 do not support its role as a chlamydial T3SS 
needle tip protein.  Although CT584 has some characteristics of a T3SS needle protein, it 
ultimately lacks a primary surface localization on either EBs or RBs.  Additionally, 
neutralization studies, utilizing anti-CT584 antibodies to neutralize the infective 
capabilities of C. trachomatis EBs were not successful (Ichie Osaka, personal 
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communication).  Therefore, it is likely poorly immunogenic and therefore a poor 
candidate for a vaccine component. 
 
Genetic Exchange in Chlamydia 
 
  The development of a robust system for genetic exchange in chlamydiae has been 
of high priority for many years now.  These organisms have resisted attempts at classical 
genetic manipulation techniques such as transformation, likely due to the inherent 
characteristics of chlamydial biology.  The proteins of the outer membranes of EBs are 
highly crosslinked, thereby making the passage of DNA through this membrane by heat 
shock or electroporation largely unsuccessful.  Purified RBs are less impermeable, but 
they are not infectious and because the chlamydial developmental cycle relies on 
infection of a host cell for its completion, any transformed RBs would therefore not be 
able to replicate.  A robust system for culturing chlamydia axenically has also been a 
challenge to the field.  Finally, attempts to introduce DNA into RBs in their natural state 
(in the context of an infection) would prove difficult because and DNA would have to 
cross the host cell membrane, the inclusion membrane and then the inner and outer 
membranes of the RBs themselves.  Clearly, the biology of chlamydial organisms is not 
conducive to genetic manipulation. 
  Despite these challenges, there have been recent successes in the field of 
chlamydial genetics.  Different species of chlamydia apparently recombine their DNA 
with one another in the context of a co-infection; an observation that was utilized to 
transfer an antibiotic resistance gene from C. suis to C. trachomatis (Suchland et al., 
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2009).  However, this usefulness of this technique is limited because genetic information 
can only be transferred from one species of Chlamydia to another and therefore new 
genes cannot be introduced.  Additionally, forward genetics approaches have had some 
success in identifying genes involved in glycogen accumulation (Nguyen & Valdivia, 
2012).  This involves chemical mutagenesis of chlamydial organisms followed by 
isolation of clones, screening for a phenotype, and finally whole genome sequencing.  
However, this is not a targeted approach and can only identify genes with a non-lethal 
and easily identifiable phenotype. 
  The most promising report in the field of chlamydial genetic exchange has been 
the recent description of a shuttle vector and a transformation protocol that has allowed 
for the stable transformation of EBs with a plasmid that encodes GFP (Wang et al., 2011).  
While GFP was used merely as a proof of concept, this technology can theoretically 
allow for stable transformation of chlamydia with plasmids encoding any protein. 
  While supplying chlamydia with exogenous protein or overexpressed quantities of 
an endogenous protein could give insight into protein function, a system for targeted, 
temporally controlled gene knockout could have wider-reaching consequences.  There are 
many ways in which a target gene knockout could be achieved.  For example, antisense 
RNA could be encoded on a plasmid, preventing translation of a target gene.  
Alternatively, DNA binding proteins with designable DNA target sequences could be 
employed to block gene expression of desired genes at the transcriptional level.  Finally, 
dominant negative versions of proteins (if the function of these protein are well-known) 
could be overexpressed, leading to a loss of function post-translationally.  Temporal 
control of the expression of these plasmid-encoded factors could be achieved by the use 
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of inducible promoters.  Regardless of the exact mechanisms used, the discovery of a 
technique for stable transformation of chlamydia opens up possibilities for further 
discoveries. 
 The applications for the technique of chlamydial transformation and the possible 
technique of targeted gene knock-down can be imagined for virtually every aspect of 
chlamydial research, including the three proteins of unknown function described in this 
report.  CT296, in its role as DcrA, could be examined by knocking down expression of 
the protein and assessing the phenotype.  If it plays a role in regulating the iron response, 
a phenotype for a CT296 deficient strain might only be seen in response to iron limitation.  
However, our findings point to a different function for CT296, a function that is less clear.  
Knocking down of CT296 expression at different timepoints during the developmental 
cycle could give insight into its function by determining when (if at all) it is required for 
cellular function. 
  Recent studies suggest that CT584 is involved in the T3SS function, likely not as 
a needle tip protein but rather as a chaperone for T3SS effectors (Stone et al., 2012).  If 
this is true, its knockdown could have consequences on infection, inclusion maintenance 
or immune evasion.  By examining the exact phenotype associated with CT584 
knockdown, a more precise role for it could be elucidated.  Importantly, if it is critical for 
EB invasion of the host cell, stable strains of CT584 knockout would not be viable, 
making it paramount to employ temporally regulated gene knockdown for such 
experiments.  However, our findings regarding the localization of CT584 do not support 
its role in T3S.  In this case, targeted gene disruption of CT584 could point to a different 
function by this protein by showing a unique phenotype for cells lacking it. 
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  As a homolog to RodZ, the role of CT009 in the biology of Chlamydia is not 
entirely clear.  In other bacteria, RodZ is associated with rod shape determination and its 
knockout results in spherically shaped bacteria.  However, chlamydiae are not rod shaped 
and the need for a RodZ homolog is therefore not apparent.  Recent evidence implicates 
another rod-shape determining protein in the process of cell division, leading to the 
hypothesis that CT009 is also involved in this process.  Targeted knockdown of CT009 
expression in dividing RBs could test this hypothesis; if CT009 is involved in cell 
division, CT009 deficient cells would show no defects in growth or infection, but an 
inability to divide.  Additionally, if CT009 and other rod-shape determining proteins have 
a role in RB-EB conversion, this would also become apparent through a phenotype in 
which RBs grow but do not convert to EBs. 
	   171	  
References 
 
Abdelrahman, Y. M. & R. J. Belland, (2005) The chlamydial developmental cycle. FEMS 
microbiology reviews 29: 949-959. 
Adams, D. W. & J. Errington, (2009) Bacterial cell division: assembly, maintenance and 
disassembly of the Z ring. Nature reviews. Microbiology 7: 642-653. 
Adams, M. A., M. D. Suits, J. Zheng & Z. Jia, (2007) Piecing together the structure-
function puzzle: experiences in structure-based functional annotation of 
hypothetical proteins. Proteomics 7: 2920-2932. 
Adams, P. D., P. V. Afonine, G. Bunkoczi, V. B. Chen, I. W. Davis, N. Echols, J. J. 
Headd, L. W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. 
Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. 
Terwilliger & P. H. Zwart, (2010) PHENIX: a comprehensive Python-based 
system for macromolecular structure solution. Acta Crystallogr D Biol 
Crystallogr 66: 213-221. 
Aggarwal, A. K., D. W. Rodgers, M. Drottar, M. Ptashne & S. C. Harrison, (1988) 
Recognition of a DNA operator by the repressor of phage 434: a view at high 
resolution. Science 242: 899-907. 
Akers, J. C., H. Hodac, R. H. Lathrop & M. Tan, (2011) Identification and functional 
analysis of CT069 as a novel transcriptional regulator in Chlamydia. J Bacteriol. 
Albrecht, M., C. M. Sharma, R. Reinhardt, J. Vogel & T. Rudel, (2010) Deep 
sequencing-based discovery of the Chlamydia trachomatis transcriptome. Nucleic 
Acids Res 38: 868-877. 
	   172	  
Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller & D. J. 
Lipman, (1997) Gapped BLAST and PSI-BLAST: a new generation of protein 
database search programs. Nucleic acids research 25: 3389-3402. 
Alyahya, S. A., R. Alexander, T. Costa, A. O. Henriques, T. Emonet & C. Jacobs-
Wagner, (2009) RodZ, a component of the bacterial core morphogenic apparatus. 
Proc Natl Acad Sci U S A 106: 1239-1244. 
Andrews, N. C., (2000) Iron homeostasis: insights from genetics and animal models. 
Nature reviews. Genetics 1: 208-217. 
Aravind, L., V. Anantharaman, S. Balaji, M. M. Babu & L. M. Iyer, (2005) The many 
faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS 
microbiology reviews 29: 231-262. 
Bailey, R. L., P. Arullendran, H. C. Whittle & D. C. Mabey, (1993) Randomised 
controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 342: 
453-456. 
Barrett, B. S., A. P. Markham, R. Esfandiary, W. L. Picking, W. D. Picking, S. B. Joshi 
& C. R. Middaugh, (2010) Formulation and immunogenicity studies of type III 
secretion system needle antigens as vaccine candidates. Journal of 
pharmaceutical sciences 99: 4488-4496. 
Barrientos, L. G., J. M. Louis, I. Botos, T. Mori, Z. Han, B. R. O'Keefe, M. R. Boyd, A. 
Wlodawer & A. M. Gronenborn, (2002) The domain-swapped dimer of 
cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR 
structures. Structure 10: 673-686. 
	   173	  
Batteiger, B. E., W. Tu, S. Ofner, B. Van Der Pol, D. R. Stothard, D. P. Orr, B. P. Katz & 
J. D. Fortenberry, (2010) Repeated Chlamydia trachomatis genital infections in 
adolescent women. The Journal of infectious diseases 201: 42-51. 
Battey, J. N., J. Kopp, L. Bordoli, R. J. Read, N. D. Clarke & T. Schwede, (2007) 
Automated server predictions in CASP7. Proteins 69 Suppl 8: 68-82. 
Beeckman, D. S. & D. C. Vanrompay, (2010) Bacterial secretion systems with an 
emphasis on the chlamydial Type III secretion system. Current issues in 
molecular biology 12: 17-41. 
Belland, R. J., G. Zhong, D. D. Crane, D. Hogan, D. Sturdevant, J. Sharma, W. L. Beatty 
& H. D. Caldwell, (2003) Genomic transcriptional profiling of the developmental 
cycle of Chlamydia trachomatis. Proceedings of the National Academy of 
Sciences of the United States of America 100: 8478-8483. 
Bendezu, F. O., C. A. Hale, T. G. Bernhardt & P. A. de Boer, (2009) RodZ (YfgA) is 
required for proper assembly of the MreB actin cytoskeleton and cell shape in E. 
coli. EMBO J 28: 193-204. 
Bennett, M. J., S. Choe & D. Eisenberg, (1994) Domain swapping: entangling alliances 
between proteins. Proc Natl Acad Sci U S A 91: 3127-3131. 
Betts, H. J., L. E. Twiggs, M. S. Sal, P. B. Wyrick & K. A. Fields, (2008) Bioinformatic 
and biochemical evidence for the identification of the type III secretion system 
needle protein of Chlamydia trachomatis. J Bacteriol 190: 1680-1690. 
Betts-Hampikian, H. J. & K. A. Fields, (2010) The Chlamydial Type III Secretion 
Mechanism: Revealing Cracks in a Tough Nut. Frontiers in microbiology 1: 114. 
	   174	  
Blasiak, L. C., F. H. Vaillancourt, C. T. Walsh & C. L. Drennan, (2006) Crystal structure 
of the non-haem iron halogenase SyrB2 in syringomycin biosynthesis. Nature 
440: 368-371. 
Blocker, A. J., J. E. Deane, A. K. Veenendaal, P. Roversi, J. L. Hodgkinson, S. Johnson 
& S. M. Lea, (2008) What's the point of the type III secretion system needle? 
Proceedings of the National Academy of Sciences of the United States of America 
105: 6507-6513. 
Bosnjak, Z., S. Dzijan, D. Pavlinic, M. Peric, N. Ruzman, I. R. Krizan, G. Lauc, A. 
Antolovic-Pozgain, J. Burazin & D. Vukovic, (2012) Distribution of Chlamydia 
trachomatis serotypes in clinical urogenital samples from north-eastern Croatia. 
Curr Microbiol 64: 552-560. 
Brown, W. J. & D. D. Rockey, (2000) Identification of an antigen localized to an 
apparent septum within dividing chlamydiae. Infect Immun 68: 708-715. 
Byrne, G. I. & J. W. Moulder, (1978) Parasite-specified phagocytosis of Chlamydia 
psittaci and Chlamydia trachomatis by L and HeLa cells. Infect Immun 19: 598-
606. 
Caldwell, H. D., J. Kromhout & J. Schachter, (1981) Purification and partial 
characterization of the major outer membrane protein of Chlamydia trachomatis. 
Infect Immun 31: 1161-1176. 
Carey, A. J., W. M. Huston, K. A. Cunningham, L. M. Hafner, P. Timms & K. W. 
Beagley, (2013) Characterization of In Vitro Chlamydia muridarum Persistence 
and Utilization in an In Vivo Mouse Model of Chlamydia Vaccine. Am J Reprod 
Immunol. 
	   175	  
Carlson, J. H., S. F. Porcella, G. McClarty & H. D. Caldwell, (2005) Comparative 
genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. 
Infect Immun 73: 6407-6418. 
CDC, (2007) Biosafety in Microbiological and Biomedical Laboratories (BMBL). U. S. 
D. o. H. a. H. Services (ed). Washington, DC. 
Cecil, J. A., M. R. Howell, J. J. Tawes, J. C. Gaydos, K. T. McKee, Jr., T. C. Quinn & C. 
A. Gaydos, (2001) Features of Chlamydia trachomatis and Neisseria gonorrhoeae 
infection in male Army recruits. The Journal of infectious diseases 184: 1216-
1219. 
Centers, (2010) Sexually Transmitted Disease Surveillance 2009. D. o. H. a. H. Services 
(ed). Atlanta, U.S. 
Chai, C., Z. Xie & E. Grotewold, (2011) SELEX (Systematic Evolution of Ligands by 
EXponential Enrichment), as a powerful tool for deciphering the protein-DNA 
interaction space. Methods Mol Biol 754: 249-258. 
Chatterjee, S., D. Zhong, B. A. Nordhues, K. P. Battaile, S. Lovell & R. N. De Guzman, 
(2011) The crystal structures of the Salmonella type III secretion system tip 
protein SipD in complex with deoxycholate and chenodeoxycholate. Protein 
science : a publication of the Protein Society 20: 75-86. 
Chellas-Gery, B., K. Wolf, J. Tisoncik, T. Hackstadt & K. A. Fields, (2011) Biochemical 
and localization analyses of putative type III secretion translocator proteins CopB 
and CopB2 of Chlamydia trachomatis reveal significant distinctions. Infect Immun 
79: 3036-3045. 
	   176	  
Chen, V. B., W. B. Arendall, 3rd, J. J. Headd, D. A. Keedy, R. M. Immormino, G. J. 
Kapral, L. W. Murray, J. S. Richardson & D. C. Richardson, (2010) MolProbity: 
all-atom structure validation for macromolecular crystallography. Acta 
Crystallogr D Biol Crystallogr 66: 12-21. 
Chopra, I., C. Storey, T. J. Falla & J. H. Pearce, (1998) Antibiotics, peptidoglycan 
synthesis and genomics: the chlamydial anomaly revisited. Microbiology 144 ( Pt 
10): 2673-2678. 
Choroszy-Krol, I. C., M. Frej-Madrzak, A. Jama-Kmiecik, T. Bober & J. Jolanta 
Sarowska, (2012) Characteristics of the Chlamydia trachomatis species - 
immunopathology and infections. Advances in clinical and experimental 
medicine : official organ Wroclaw Medical University 21: 799-808. 
Chowdhury, R., M. A. McDonough, J. Mecinovic, C. Loenarz, E. Flashman, K. S. 
Hewitson, C. Domene & C. J. Schofield, (2009) Structural basis for binding of 
hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure 17: 
981-989. 
Clifton, D. R., K. A. Fields, S. S. Grieshaber, C. A. Dooley, E. R. Fischer, D. J. Mead, R. 
A. Carabeo & T. Hackstadt, (2004) A chlamydial type III translocated protein is 
tyrosine-phosphorylated at the site of entry and associated with recruitment of 
actin. Proceedings of the National Academy of Sciences of the United States of 
America 101: 10166-10171. 
Clifton, I. J., M. A. McDonough, D. Ehrismann, N. J. Kershaw, N. Granatino & C. J. 
Schofield, (2006) Structural studies on 2-oxoglutarate oxygenases and related 
double-stranded beta-helix fold proteins. J Inorg Biochem 100: 644-669. 
	   177	  
Cochrane, M., C. W. Armitage, C. P. O'Meara & K. W. Beagley, (2010) Towards a 
Chlamydia trachomatis vaccine: how close are we? Future microbiology 5: 1833-
1856. 
Cooksey, C. M., E. K. Berggren & J. Lee, (2010) Chlamydia trachomatis Infection in 
minority adolescent women: a public health challenge. Obstetrical & 
gynecological survey 65: 729-735. 
Cozzetto, D., A. Kryshtafovych, K. Fidelis, J. Moult, B. Rost & A. Tramontano, (2009) 
Evaluation of template-based models in CASP8 with standard measures. Proteins 
77 Suppl 9: 18-28. 
D'Autreaux, B., L. Pecqueur, A. Gonzalez de Peredo, R. E. Diederix, C. Caux-Thang, L. 
Tabet, B. Bersch, E. Forest & I. Michaud-Soret, (2007) Reversible redox- and 
zinc-dependent dimerization of the Escherichia coli fur protein. Biochemistry 46: 
1329-1342. 
da Fonseca, M. M., A. Zaha, E. R. Caffarena & A. T. Vasconcelos, (2012) Structure-
based functional inference of hypothetical proteins from Mycoplasma 
hyopneumoniae. Journal of molecular modeling 18: 1917-1925. 
Daruzzaman, A., I. J. Clifton, R. M. Adlington, J. E. Baldwin & P. J. Rutledge, (2006) 
Unexpected oxidation of a depsipeptide substrate analogue in crystalline 
isopenicillin N synthase. Chembiochem 7: 351-358. 
de Lorenzo, V., S. Wee, M. Herrero & J. B. Neilands, (1987) Operator sequences of the 
aerobactin operon of plasmid ColV-K30 binding the ferric uptake regulation (fur) 
repressor. J Bacteriol 169: 2624-2630. 
	   178	  
Dey, F., Q. Cliff Zhang, D. Petrey & B. Honig, (2013) Toward a "Structural BLAST": 
Using structural relationships to infer function. Protein science : a publication of 
the Protein Society. 
Diederichs, K. & P. A. Karplus, (1997) Improved R-factors for diffraction data analysis 
in macromolecular crystallography. Nat Struct Biol 4: 269-275. 
Doublie, S., (2007) Production of selenomethionyl proteins in prokaryotic and eukaryotic 
expression systems. Methods Mol Biol 363: 91-108. 
Dunwell, J. M., A. Purvis & S. Khuri, (2004) Cupins: the most functionally diverse 
protein superfamily? Phytochemistry 65: 7-17. 
Emsley, P. & K. Cowtan, (2004) Coot: model-building tools for molecular graphics. Acta 
Crystallogr D Biol Crystallogr 60: 2126-2132. 
Emsley, P., B. Lohkamp, W. G. Scott & K. Cowtan, (2010) Features and development of 
Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501. 
Englund, S., C. H. af Segerstad, F. Arnlund, E. Westergren & M. Jacobson, (2012) The 
occurrence of Chlamydia spp. in pigs with and without clinical disease. BMC 
veterinary research 8: 9. 
Erickson, H. P., D. E. Anderson & M. Osawa, (2010) FtsZ in bacterial cytokinesis: 
cytoskeleton and force generator all in one. Microbiology and molecular biology 
reviews : MMBR 74: 504-528. 
Escolar, L., J. Perez-Martin & V. de Lorenzo, (1999) Opening the iron box: 
transcriptional metalloregulation by the Fur protein. J Bacteriol 181: 6223-6229. 
Espina, M., A. J. Olive, R. Kenjale, D. S. Moore, S. F. Ausar, R. W. Kaminski, E. V. 
Oaks, C. R. Middaugh, W. D. Picking & W. L. Picking, (2006) IpaD localizes to 
	   179	  
the tip of the type III secretion system needle of Shigella flexneri. Infect Immun 
74: 4391-4400. 
Eswar, N., B. Webb, M. A. Marti-Renom, M. S. Madhusudhan, D. Eramian, M. Y. Shen, 
U. Pieper & A. Sali, (2006) Comparative protein structure modeling using 
Modeller. Current protocols in bioinformatics / editoral board, Andreas D. 
Baxevanis ... [et al.] Chapter 5: Unit 5 6. 
Evans, P., (2006) Scaling and assessment of data quality. Acta Crystallogr D Biol 
Crystallogr 62: 72-82. 
Evans, P., (2012) Biochemistry. Resolving some old problems in protein crystallography. 
Science 336: 986-987. 
Evans, P. R., (2011) An introduction to data reduction: space-group determination, 
scaling and intensity statistics. Acta Crystallogr D Biol Crystallogr 67: 282-292. 
Falk, L., H. Fredlund & J. S. Jensen, (2005) Signs and symptoms of urethritis and 
cervicitis among women with or without Mycoplasma genitalium or Chlamydia 
trachomatis infection. Sexually transmitted infections 81: 73-78. 
Ferrer-Costa, C., H. P. Shanahan, S. Jones & J. M. Thornton, (2005) HTHquery: a 
method for detecting DNA-binding proteins with a helix-turn-helix structural 
motif. Bioinformatics 21: 3679-3680. 
Fields, K. A. & T. Hackstadt, (2002) The chlamydial inclusion: escape from the 
endocytic pathway. Annual review of cell and developmental biology 18: 221-245. 
Fukushi, H. & K. Hirai, (1993) Chlamydia pecorum--the fourth species of genus 
Chlamydia. Microbiology and immunology 37: 516-522. 
	   180	  
Ghosh, P., (2004) Process of protein transport by the type III secretion system. 
Microbiology and molecular biology reviews : MMBR 68: 771-795. 
Gouet, P., X. Robert & E. Courcelle, (2003) ESPript/ENDscript: Extracting and 
rendering sequence and 3D information from atomic structures of proteins. 
Nucleic acids research 31: 3320-3323. 
Grayston, J. T., (1992) Infections caused by Chlamydia pneumoniae strain TWAR. 
Clinical infectious diseases : an official publication of the Infectious Diseases 
Society of America 15: 757-761. 
Grayston, J. T., R. L. Woolridge, C. W. Chen, F. A. Assaad, S. Maffei, C. H. Yen & C. Y. 
Yang, (1961) Bacterial conjunctivitis caused by an eye ointment base used as a 
placebo in therapeutic trials. American journal of ophthalmology 52: 251-256. 
Hammerschlag, M. R., (2000) Chlamydia pneumoniae and the lung. The European 
respiratory journal : official journal of the European Society for Clinical 
Respiratory Physiology 16: 1001-1007. 
Hammerschlag, M. R. & S. A. Kohlhoff, (2012) Treatment of chlamydial infections. 
Expert opinion on pharmacotherapy 13: 545-552. 
Harkinezhad, T., T. Geens & D. Vanrompay, (2009) Chlamydophila psittaci infections in 
birds: a review with emphasis on zoonotic consequences. Veterinary microbiology 
135: 68-77. 
Hefty, P. S. & R. S. Stephens, (2007) Chlamydial type III secretion system is encoded on 
ten operons preceded by sigma 70-like promoter elements. J Bacteriol 189: 198-
206. 
	   181	  
Hickey, J. M., L. Weldon & P. S. Hefty, (2011) The atypical OmpR/PhoB response 
regulator ChxR from Chlamydia trachomatis forms homodimers in vivo and binds 
a direct repeat of nucleotide sequences. J Bacteriol 193: 389-398. 
Holm, L., S. Kaariainen, P. Rosenstrom & A. Schenkel, (2008) Searching protein 
structure databases with DaliLite v.3. Bioinformatics 24: 2780-2781. 
Holm, L. & J. Park, (2000) DaliLite workbench for protein structure comparison. 
Bioinformatics 16: 566-567. 
Holm, L. & P. Rosenstrom, (2010) Dali server: conservation mapping in 3D. Nucleic 
acids research 38: W545-549. 
Holm, L. & C. Sander, (1993) Protein structure comparison by alignment of distance 
matrices. J Mol Biol 233: 123-138. 
Hsia, R. C., Y. Pannekoek, E. Ingerowski & P. M. Bavoil, (1997) Type III secretion 
genes identify a putative virulence locus of Chlamydia. Mol Microbiol 25: 351-
359. 
Hu, V. H., E. M. Harding-Esch, M. J. Burton, R. L. Bailey, J. Kadimpeul & D. C. Mabey, 
(2010) Epidemiology and control of trachoma: systematic review. Tropical 
medicine & international health : TM & IH 15: 673-691. 
Hueck, C. J., (1998) Type III protein secretion systems in bacterial pathogens of animals 
and plants. Microbiology and molecular biology reviews : MMBR 62: 379-433. 
Hvidsten, T. R., A. Laegreid, A. Kryshtafovych, G. Andersson, K. Fidelis & J. 
Komorowski, (2009) A comprehensive analysis of the structure-function 
relationship in proteins based on local structure similarity. PLoS One 4: e6266. 
	   182	  
Hybiske, K. & R. S. Stephens, (2007) Mechanisms of host cell exit by the intracellular 
bacterium Chlamydia. Proceedings of the National Academy of Sciences of the 
United States of America 104: 11430-11435. 
Jagelska, E., V. Brazda, S. Pospisilova, B. Vojtesek & E. Palecek, (2002) New ELISA 
technique for analysis of p53 protein/DNA binding properties. Journal of 
immunological methods 267: 227-235. 
Janowski, R., S. Panjikar, A. N. Eddine, S. H. Kaufmann & M. S. Weiss, (2009) 
Structural analysis reveals DNA binding properties of Rv2827c, a hypothetical 
protein from Mycobacterium tuberculosis. J Struct Funct Genomics 10: 137-150. 
Jewett, T. J., E. R. Fischer, D. J. Mead & T. Hackstadt, (2006) Chlamydial TARP is a 
bacterial nucleator of actin. Proceedings of the National Academy of Sciences of 
the United States of America 103: 15599-15604. 
Kabsch, W., (1988) Automatic indexing of rotation diffraction patterns. Journal of 
Applied Crystallography 21: 67-72. 
Kabsch, W., (1993) Automatic processing of rotation diffraction data from crystals of 
initially unknown symmetry and cell constants. J. Appl. Cryst. 26: 795-800. 
Kapoor, S., (2008) Re-emergence of lymphogranuloma venereum. Journal of the 
European Academy of Dermatology and Venereology : JEADV 22: 409-416. 
Karimova, G., N. Dautin & D. Ladant, (2005) Interaction network among Escherichia 
coli membrane proteins involved in cell division as revealed by bacterial two-
hybrid analysis. J Bacteriol 187: 2233-2243. 
	   183	  
Karimova, G., J. Pidoux, A. Ullmann & D. Ladant, (1998) A bacterial two-hybrid system 
based on a reconstituted signal transduction pathway. Proceedings of the National 
Academy of Sciences of the United States of America 95: 5752-5756. 
Karplus, P. A. & K. Diederichs, (2012) Linking crystallographic model and data quality. 
Science 336: 1030-1033. 
Kehrer, J. P., (2000) The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 
149: 43-50. 
Kemege, K. E., J. M. Hickey, S. Lovell, K. P. Battaile, Y. Zhang & P. S. Hefty, (2011) 
Ab initio structural modeling of and experimental validation for Chlamydia 
trachomatis protein CT296 reveal structural similarity to Fe(II) 2-oxoglutarate-
dependent enzymes. J Bacteriol 193: 6517-6528. 
Khare, D., B. Wang, L. Gu, J. Razelun, D. H. Sherman, W. H. Gerwick, K. Hakansson & 
J. L. Smith, (2010) Conformational switch triggered by alpha-ketoglutarate in a 
halogenase of curacin A biosynthesis. Proceedings of the National Academy of 
Sciences of the United States of America 107: 14099-14104. 
Khuri, S., F. T. Bakker & J. M. Dunwell, (2001) Phylogeny, function, and evolution of 
the cupins, a structurally conserved, functionally diverse superfamily of proteins. 
Mol Biol Evol 18: 593-605. 
Kim, H. S., H. L. Kim, K. H. Kim, J. Kim do, S. J. Lee, J. Y. Yoon, H. J. Yoon, H. Y. 
Lee, S. B. Park, S. J. Kim, J. Y. Lee & S. W. Suh, (2010) Crystal structure of 
Tpa1 from Saccharomyces cerevisiae, a component of the messenger 
ribonucleoprotein complex. Nucleic acids research 38: 2099-2110. 
	   184	  
Kleinschnitz, E. M., A. Heichlinger, K. Schirner, J. Winkler, A. Latus, I. Maldener, W. 
Wohlleben & G. Muth, (2011) Proteins encoded by the mre gene cluster in 
Streptomyces coelicolor A3(2) cooperate in spore wall synthesis. Mol Microbiol 
79: 1367-1379. 
Koo, I. C., D. Walthers, P. S. Hefty, L. J. Kenney & R. S. Stephens, (2006) ChxR is a 
transcriptional activator in Chlamydia. Proc Natl Acad Sci U S A 103: 750-755. 
Koski, M. K., R. Hieta, M. Hirsila, A. Ronka, J. Myllyharju & R. K. Wierenga, (2009) 
The crystal structure of an algal prolyl 4-hydroxylase complexed with a proline-
rich peptide reveals a novel buried tripeptide binding motif. J Biol Chem 284: 
25290-25301. 
Kraus, E. & U. Femfert, (1976) Proteinase K from the mold Tritirachium album Limber. 
Specificity and mode of action. Hoppe-Seyler's Zeitschrift fur physiologische 
Chemie 357: 937-947. 
Krug, M., M. S. Weiss, U. Heinemann & U. Mueller, (2012) XDSAPP: a graphical user 
interface for the convenient processing of diffraction data using XDS. Journal of 
Applied Crystallography 45: 568-572. 
Kruse, T., J. Bork-Jensen & K. Gerdes, (2005) The morphogenetic MreBCD proteins of 
Escherichia coli form an essential membrane-bound complex. Mol Microbiol 55: 
78-89. 
Kumar, S. & M. R. Hammerschlag, (2007) Acute respiratory infection due to Chlamydia 
pneumoniae: current status of diagnostic methods. Clinical infectious diseases : 
an official publication of the Infectious Diseases Society of America 44: 568-576. 
	   185	  
Larkin, M. A., G. Blackshields, N. P. Brown, R. Chenna, P. A. McGettigan, H. 
McWilliam, F. Valentin, I. M. Wallace, A. Wilm, R. Lopez, J. D. Thompson, T. J. 
Gibson & D. G. Higgins, (2007) Clustal W and Clustal X version 2.0. 
Bioinformatics 23: 2947-2948. 
Laroucau, K., A. Di Francesco, F. Vorimore, S. Thierry, J. L. Pingret, C. Bertin, H. 
Willems, G. Bolske & R. Harley, (2012) Multilocus variable-number tandem-
repeat analysis scheme for chlamydia felis genotyping: comparison with 
multilocus sequence typing. Journal of clinical microbiology 50: 1860-1866. 
Lau, C. Y. & A. K. Qureshi, (2002) Azithromycin versus doxycycline for genital 
chlamydial infections: a meta-analysis of randomized clinical trials. Sexually 
transmitted diseases 29: 497-502. 
Lee, J., S. Wu & Y. Zhang, (2009) Ab Initio Protein Structure Prediction In: From 
Protein Structure to Function with Bioinformatics. J. D. Rigden (ed). Springer 
Netherlands, pp. 3-25. 
Lewis, R. J., J. A. Brannigan, W. A. Offen, I. Smith & A. J. Wilkinson, (1998) An 
evolutionary link between sporulation and prophage induction in the structure of a 
repressor:anti-repressor complex. Journal of molecular biology 283: 907-912. 
Li, Z., M. J. Trimble, Y. V. Brun & G. J. Jensen, (2007) The structure of FtsZ filaments 
in vivo suggests a force-generating role in cell division. EMBO J 26: 4694-4708. 
Lorenzini, E., A. Singer, B. Singh, R. Lam, T. Skarina, N. Y. Chirgadze, A. Savchenko & 
R. S. Gupta, (2010) Structure and protein-protein interaction studies on 
Chlamydia trachomatis protein CT670 (YscO Homolog). J Bacteriol 192: 2746-
2756. 
	   186	  
Mariotti, S. P., D. Pascolini & J. Rose-Nussbaumer, (2009) Trachoma: global magnitude 
of a preventable cause of blindness. Br J Ophthalmol 93: 563-568. 
Markham, A. P., Z. A. Jaafar, K. E. Kemege, C. R. Middaugh & P. S. Hefty, (2009) 
Biophysical characterization of Chlamydia trachomatis CT584 supports its 
potential role as a type III secretion needle tip protein. Biochemistry 48: 10353-
10361. 
Mathews, S. A., K. M. Volp & P. Timms, (1999) Development of a quantitative gene 
expression assay for Chlamydia trachomatis identified temporal expression of 
sigma factors. FEBS Lett 458: 354-358. 
Matthews, B. W., (1968) Solvent content of protein crystals. J Mol Biol 33: 491-497. 
McCoy, A. J., R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni & R. J. 
Read, (2007a) Phaser crystallographic software. J Appl Crystallogr 40: 658-674. 
McCoy, A. J., R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni & R. J. 
Read, (2007b) Phaser crystallographic software. J. Appl. Cryst. 40: 658-674. 
McDonough, M. A., K. L. Kavanagh, D. Butler, T. Searls, U. Oppermann & C. J. 
Schofield, (2005) Structure of human phytanoyl-CoA 2-hydroxylase identifies 
molecular mechanisms of Refsum disease. The Journal of biological chemistry 
280: 41101-41110. 
McDonough, M. A., V. Li, E. Flashman, R. Chowdhury, C. Mohr, B. M. Lienard, J. 
Zondlo, N. J. Oldham, I. J. Clifton, J. Lewis, L. A. McNeill, R. J. Kurzeja, K. S. 
Hewitson, E. Yang, S. Jordan, R. S. Syed & C. J. Schofield, (2006) Cellular 
oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase 
	   187	  
(PHD2). Proceedings of the National Academy of Sciences of the United States of 
America 103: 9814-9819. 
Meng, X., M. H. Brodsky & S. A. Wolfe, (2005) A bacterial one-hybrid system for 
determining the DNA-binding specificity of transcription factors. Nature 
biotechnology 23: 988-994. 
Meng, X., R. M. Smith, A. V. Giesecke, J. K. Joung & S. A. Wolfe, (2006) Counter-
selectable marker for bacterial-based interaction trap systems. BioTechniques 40: 
179-184. 
Meng, X. & S. A. Wolfe, (2006) Identifying DNA sequences recognized by a 
transcription factor using a bacterial one-hybrid system. Nature protocols 1: 30-
45. 
Michaud-Soret, I., A. Adrait, M. Jaquinod, E. Forest, D. Touati & J. M. Latour, (1997) 
Electrospray ionization mass spectrometry analysis of the apo- and metal-
substituted forms of the Fur protein. FEBS Lett 413: 473-476. 
Mihalik, S. J., J. C. Morrell, D. Kim, K. A. Sacksteder, P. A. Watkins & S. J. Gould, 
(1997) Identification of PAHX, a Refsum disease gene. Nat Genet 17: 185-189. 
Miller, J. H., (1972) Experiments in molecular genetics, p. 466. Cold Spring Harbor 
Laboratory Press, Plainview, NY. 
Minezaki, Y., K. Homma & K. Nishikawa, (2005) Genome-wide survey of transcription 
factors in prokaryotes reveals many bacteria-specific families not found in 
archaea. DNA research : an international journal for rapid publication of reports 
on genes and genomes 12: 269-280. 
	   188	  
Misaghi, S., Z. R. Balsara, A. Catic, E. Spooner, H. L. Ploegh & M. N. Starnbach, (2006) 
Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells 
during infection. Mol Microbiol 61: 142-150. 
Murthy, A. K. & B. P. Arulanandam, (2012) Chlamydia vaccines: progress and 
challenges. In: Intracellular Pathogens I: Chlamydiales. M. Tan & P. Bavoil (eds). 
Washington, D.C.: ASM Press, pp. 311-333. 
Nguyen, B. D. & R. H. Valdivia, (2012) Virulence determinants in the obligate 
intracellular pathogen Chlamydia trachomatis revealed by forward genetic 
approaches. Proceedings of the National Academy of Sciences of the United States 
of America 109: 1263-1268. 
Nichols, R. L., S. D. Bell, Jr., E. S. Murray, N. A. Haddad & A. A. Bobb, (1966) Studies 
on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine 
at three dosage levels in Saudi Arabia. The American journal of tropical medicine 
and hygiene 15: 639-647. 
Noyes, M. B., X. Meng, A. Wakabayashi, S. Sinha, M. H. Brodsky & S. A. Wolfe, 
(2008) A systematic characterization of factors that regulate Drosophila 
segmentation via a bacterial one-hybrid system. Nucleic acids research 36: 2547-
2560. 
Ochman, H. & E. A. Groisman, (1996) Distribution of pathogenicity islands in 
Salmonella spp. Infect Immun 64: 5410-5412. 
Ouellette, S. P., G. Karimova, A. Subtil & D. Ladant, (2012) Chlamydia Co-Opts the 
Rod-Shape Determining Proteins MreB and Pbp2 for Cell Division. Mol 
Microbiol. 
	   189	  
Overheim, K. A., R. W. Depaolo, K. L. Debord, E. M. Morrin, D. M. Anderson, N. M. 
Green, R. R. Brubaker, B. Jabri & O. Schneewind, (2005) LcrV plague vaccine 
with altered immunomodulatory properties. Infect Immun 73: 5152-5159. 
Pais, S. V., C. Milho, F. Almeida & L. J. Mota, (2013) Identification of novel type III 
secretion chaperone-substrate complexes of Chlamydia trachomatis. PLoS One 8: 
e56292. 
Pavelka, M. S., Jr., (2007) Another brick in the wall. Trends Microbiol 15: 147-149. 
Pennella, M. A. & D. P. Giedroc, (2005) Structural determinants of metal selectivity in 
prokaryotic metal-responsive transcriptional regulators. Biometals : an 
international journal on the role of metal ions in biology, biochemistry, and 
medicine 18: 413-428. 
Perara, E., D. Ganem & J. N. Engel, (1992) A developmentally regulated chlamydial 
gene with apparent homology to eukaryotic histone H1. Proceedings of the 
National Academy of Sciences of the United States of America 89: 2125-2129. 
Peters, J., D. P. Wilson, G. Myers, P. Timms & P. M. Bavoil, (2007) Type III secretion a 
la Chlamydia. Trends Microbiol 15: 241-251. 
Potterton, L., S. McNicholas, E. Krissinel, J. Gruber, K. Cowtan, P. Emsley, G. N. 
Murshudov, S. Cohen, A. Perrakis & M. Noble, (2004) Developments in the 
CCP4 molecular-graphics project. Acta Crystallogr D Biol Crystallogr 60: 2288-
2294. 
Qu, X., R. Swanson, R. Day & J. Tsai, (2009) A guide to template based structure 
prediction. Curr Protein Pept Sci 10: 270-285. 
	   190	  
Rau, A., S. Wyllie, J. Whittimore & J. E. Raulston, (2005) Identification of Chlamydia 
trachomatis genomic sequences recognized by chlamydial divalent cation-
dependent regulator A (DcrA). J Bacteriol 187: 443-448. 
Raulston, J. E., (1997a) Iron and Micronutrients. In: Chlamydia: Genomics and 
Pathogenesis. P. M. Bavoil & P. B. Wyrick (eds). Wymondham, UK: Horizon 
Bioscience, pp. 171-194. 
Raulston, J. E., (1997b) Response of Chlamydia trachomatis serovar E to iron restriction 
in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 65: 
4539-4547. 
Read, T. D., G. S. Myers, R. C. Brunham, W. C. Nelson, I. T. Paulsen, J. Heidelberg, E. 
Holtzapple, H. Khouri, N. B. Federova, H. A. Carty, L. A. Umayam, D. H. Haft, J. 
Peterson, M. J. Beanan, O. White, S. L. Salzberg, R. C. Hsia, G. McClarty, R. G. 
Rank, P. M. Bavoil & C. M. Fraser, (2003) Genome sequence of Chlamydophila 
caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in 
the evolution of the Chlamydiaceae. Nucleic acids research 31: 2134-2147. 
Resnikoff, S., D. Pascolini, D. Etya'ale, I. Kocur, R. Pararajasegaram, G. P. Pokharel & S. 
P. Mariotti, (2004) Global data on visual impairment in the year 2002. Bulletin of 
the World Health Organization 82: 844-851. 
Reuter, K., M. Pittelkow, J. Bursy, A. Heine, T. Craan & E. Bremer, (2010) Synthesis of 
5-hydroxyectoine from ectoine: crystal structure of the non-heme iron(II) and 2-
oxoglutarate-dependent dioxygenase EctD. PLoS One 5: e10647. 
Rohde, G., E. Straube, A. Essig, P. Reinhold & K. Sachse, (2010) Chlamydial zoonoses. 
Deutsches Arzteblatt international 107: 174-180. 
	   191	  
Roy, A., A. Kucukural & Y. Zhang, (2010) I-TASSER: a unified platform for automated 
protein structure and function prediction. Nat Protoc 5: 725-738. 
Sacchettini, J., (2013) webTB. 
Saier, M. H., Jr., (2006) Protein secretion and membrane insertion systems in gram-
negative bacteria. The Journal of membrane biology 214: 75-90. 
Schmitt, M. P., E. M. Twiddy & R. K. Holmes, (1992) Purification and characterization 
of the diphtheria toxin repressor. Proceedings of the National Academy of 
Sciences of the United States of America 89: 7576-7580. 
Schoborg, R. V., (2011) Chlamydia persistence -- a tool to dissect chlamydia--host 
interactions. Microbes and infection / Institut Pasteur 13: 649-662. 
Schuck, P., (2000) Size-distribution analysis of macromolecules by sedimentation 
velocity ultracentrifugation and lamm equation modeling. Biophysical journal 78: 
1606-1619. 
Scidmore, M. A., (2005) Cultivation and Laboratory Maintenance of Chlamydia 
trachomatis. Current protocols in microbiology Chapter 11: Unit 11A 11. 
Shin, D. H., J. Hou, J. M. Chandonia, D. Das, I. G. Choi, R. Kim & S. H. Kim, (2007) 
Structure-based inference of molecular functions of proteins of unknown function 
from Berkeley Structural Genomics Center. J Struct Funct Genomics 8: 99-105. 
Shiomi, D., M. Sakai & H. Niki, (2008) Determination of bacterial rod shape by a novel 
cytoskeletal membrane protein. EMBO J 27: 3081-3091. 
Sievers, F., A. Wilm, D. Dineen, T. J. Gibson, K. Karplus, W. Li, R. Lopez, H. 
McWilliam, M. Remmert, J. Soding, J. D. Thompson & D. G. Higgins, (2011) 
	   192	  
Fast, scalable generation of high-quality protein multiple sequence alignments 
using Clustal Omega. Molecular systems biology 7: 539. 
Sim, D. W., Y. S. Lee, J. H. Kim, M. D. Seo, B. J. Lee & H. S. Won, (2009) HP0902 
from Helicobacter pylori is a thermostable, dimeric protein belonging to an all-
beta topology of the cupin superfamily. BMB Rep 42: 387-392. 
Spaargaren, J., H. S. Fennema, S. A. Morre, H. J. de Vries & R. A. Coutinho, (2005) 
New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam. 
Emerging infectious diseases 11: 1090-1092. 
Spaeth, K. E., Y. S. Chen & R. H. Valdivia, (2009) The Chlamydia type III secretion 
system C-ring engages a chaperone-effector protein complex. PLoS pathogens 5: 
e1000579. 
Srivastava, D., W. Zhu, W. H. Johnson, Jr., C. P. Whitman, D. F. Becker & J. J. Tanner, 
(2010) The structure of the proline utilization a proline dehydrogenase domain 
inactivated by N-propargylglycine provides insight into conformational changes 
induced by substrate binding and flavin reduction. Biochemistry 49: 560-569. 
Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. Marathe, L. Aravind, W. Mitchell, L. 
Olinger, R. L. Tatusov, Q. Zhao, E. V. Koonin & R. W. Davis, (1998) Genome 
sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. 
Science 282: 754-759. 
Stone, C. B., S. Sugiman-Marangos, D. C. Bulir, R. C. Clayden, T. L. Leighton, J. W. 
Slootstra, M. S. Junop & J. B. Mahony, (2012) Structural characterization of a 
novel Chlamydia pneumoniae type III secretion-associated protein, Cpn0803. 
PLoS One 7: e30220. 
	   193	  
Suchland, R. J., K. M. Sandoz, B. M. Jeffrey, W. E. Stamm & D. D. Rockey, (2009) 
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro. 
Antimicrobial agents and chemotherapy 53: 4604-4611. 
Taylor, H. R., (2008) Trachoma: A Blinding Scourge from the Bronze Age to the Twenty-
first Century. Haddington Press, Australia. 
Terwilliger, T. C., P. D. Adams, R. J. Read, A. J. McCoy, N. W. Moriarty, R. W. Grosse-
Kunstleve, P. V. Afonine, P. H. Zwart & L. W. Hung, (2009) Decision-making in 
structure solution using Bayesian estimates of map quality: the PHENIX AutoSol 
wizard. Acta Crystallogr D Biol Crystallogr 65: 582-601. 
Terwilliger, T. C., R. W. Grosse-Kunstleve, P. V. Afonine, N. W. Moriarty, P. H. Zwart, 
L. W. Hung, R. J. Read & P. D. Adams, (2008) Iterative model building, structure 
refinement and density modification with the PHENIX AutoBuild wizard. Acta 
Crystallogr D Biol Crystallogr 64: 61-69. 
Thompson, C. C., S. S. Nicod, D. S. Malcolm, S. S. Grieshaber & R. A. Carabeo, (2012) 
Cleavage of a putative metal permease in Chlamydia trachomatis yields an iron-
dependent transcriptional repressor. Proceedings of the National Academy of 
Sciences of the United States of America 109: 10546-10551. 
Thompson, J. D., T. J. Gibson & D. G. Higgins, (2002) Multiple sequence alignment 
using ClustalW and ClustalX. Current protocols in bioinformatics / editoral 
board, Andreas D. Baxevanis ... [et al.] Chapter 2: Unit 2 3. 
Thomson, N. R., M. T. Holden, C. Carder, N. Lennard, S. J. Lockey, P. Marsh, P. Skipp, 
C. D. O'Connor, I. Goodhead, H. Norbertzcak, B. Harris, D. Ormond, R. Rance, 
M. A. Quail, J. Parkhill, R. S. Stephens & I. N. Clarke, (2008) Chlamydia 
	   194	  
trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. 
Genome research 18: 161-171. 
Thornton, J. M., A. E. Todd, D. Milburn, N. Borkakoti & C. A. Orengo, (2000) From 
structure to function: approaches and limitations. Nat Struct Biol 7 Suppl: 991-
994. 
Timms, P., D. Good, C. Wan, C. Theodoropoulos, S. Mukhopadhyay, J. Summersgill & 
S. Mathews, (2009) Differential transcriptional responses between the interferon-
gamma-induction and iron-limitation models of persistence for Chlamydia 
pneumoniae. Journal of microbiology, immunology, and infection = Wei mian yu 
gan ran za zhi 42: 27-37. 
Tsuchiya, Y., K. Kinoshita & H. Nakamura, (2005) PreDs: a server for predicting 
dsDNA-binding site on protein molecular surfaces. Bioinformatics 21: 1721-1723. 
Tusnady, G. E. & I. Simon, (2001) The HMMTOP transmembrane topology prediction 
server. Bioinformatics 17: 849-850. 
Unemo, M., H. M. Seth-Smith, L. T. Cutcliffe, R. J. Skilton, D. Barlow, D. Goulding, K. 
Persson, S. R. Harris, A. Kelly, C. Bjartling, H. Fredlund, P. Olcen, N. R. 
Thomson & I. N. Clarke, (2010) The Swedish new variant of Chlamydia 
trachomatis: genome sequence, morphology, cell tropism and phenotypic 
characterization. Microbiology 156: 1394-1404. 
Valdivia, R. H., (2008) Chlamydia effector proteins and new insights into chlamydial 
cellular microbiology. Current opinion in microbiology 11: 53-59. 
	   195	  
Valegard, K., A. C. Terwisscha van Scheltinga, A. Dubus, G. Ranghino, L. M. Oster, J. 
Hajdu & I. Andersson, (2004) The structural basis of cephalosporin formation in a 
mononuclear ferrous enzyme. Nat Struct Mol Biol 11: 95-101. 
van den Ent, F., C. M. Johnson, L. Persons, P. de Boer & J. Lowe, (2010) Bacterial actin 
MreB assembles in complex with cell shape protein RodZ. EMBO J 29: 1081-
1090. 
Van Lent, S., J. R. Piet, D. Beeckman, A. van der Ende, F. Van Nieuwerburgh, P. Bavoil, 
G. Myers, D. Vanrompay & Y. Pannekoek, (2012) Full genome sequences of all 
nine Chlamydia psittaci genotype reference strains. J Bacteriol 194: 6930-6931. 
van Staalduinen, L. M., C. S. Park, S. J. Yeom, M. A. Adams-Cioaba, D. K. Oh & Z. Jia, 
Structure-based annotation of a novel sugar isomerase from the pathogenic E. coli 
O157:H7. J Mol Biol 401: 866-881. 
Voigt, A., G. Schofl & H. P. Saluz, (2012) The Chlamydia psittaci genome: a 
comparative analysis of intracellular pathogens. PLoS One 7: e35097. 
Vonrhein, C., C. Flensburg, P. Keller, A. Sharff, O. Smart, W. Paciorek, T. Womack & G. 
Bricogne, (2011) Data processing and analysis with the autoPROC toolbox. Acta 
Crystallogr D Biol Crystallogr 67: 293-302. 
Wang, Y., S. Kahane, L. T. Cutcliffe, R. J. Skilton, P. R. Lambden & I. N. Clarke, (2011) 
Development of a transformation system for Chlamydia trachomatis: restoration 
of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS 
pathogens 7: e1002258. 
Warshakoon, N. C., S. Wu, A. Boyer, R. Kawamoto, J. Sheville, S. Renock, K. Xu, M. 
Pokross, S. Zhou, C. Winter, R. Walter, M. Mekel & A. G. Evdokimov, (2006) 
	   196	  
Structure-based design, synthesis, and SAR evaluation of a new series of 8-
hydroxyquinolines as HIF-1alpha prolyl hydroxylase inhibitors. Bioorg Med 
Chem Lett 16: 5517-5522. 
Weiss, D. S., (2004) Bacterial cell division and the septal ring. Mol Microbiol 54: 588-
597. 
Weiss, M. S., (2001) Global indicators of X-ray data quality. Journal of Applied 
Crystallography 34: 130-135. 
White, C. L., A. Kitich & J. W. Gober, (2010) Positioning cell wall synthetic complexes 
by the bacterial morphogenetic proteins MreB and MreD. Mol Microbiol 76: 616-
633. 
Wilmouth, R. C., J. J. Turnbull, R. W. Welford, I. J. Clifton, A. G. Prescott & C. J. 
Schofield, (2002) Structure and mechanism of anthocyanidin synthase from 
Arabidopsis thaliana. Structure 10: 93-103. 
Wilson, I. A., (2013) The Joint Center for Structural Genomics. 
Wolf, K., G. V. Plano & K. A. Fields, (2009) A protein secreted by the respiratory 
pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with 
human Act1. Cellular microbiology 11: 769-779. 
Wong, C., D. G. Fujimori, C. T. Walsh & C. L. Drennan, (2009) Structural analysis of an 
open active site conformation of nonheme iron halogenase CytC3. J Am Chem 
Soc 131: 4872-4879. 
Woolridge, R. L., J. T. Grayston, I. H. Chang, C. Y. Yang & K. H. Cheng, (1967) Long-
term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. 
American journal of ophthalmology 63: Suppl:1650-1655. 
	   197	  
Workowski, K. A. & S. Berman, (2010) Sexually transmitted diseases treatment 
guidelines, 2010. MMWR. Recommendations and reports : Morbidity and 
mortality weekly report. Recommendations and reports / Centers for Disease 
Control 59: 1-110. 
Wu, S., J. Skolnick & Y. Zhang, (2007) Ab initio modeling of small proteins by iterative 
TASSER simulations. BMC Biol 5: 17. 
Wu, S. & Y. Zhang, (2007) LOMETS: a local meta-threading-server for protein structure 
prediction. Nucleic Acids Res 35: 3375-3382. 
Wyllie, S. & J. E. Raulston, (2001) Identifying regulators of transcription in an obligate 
intracellular pathogen: a metal-dependent repressor in Chlamydia trachomatis. 
Mol Microbiol 40: 1027-1036. 
Wyrick, P. B., (2010) Chlamydia trachomatis persistence in vitro: an overview. The 
Journal of infectious diseases 201 Suppl 2: S88-95. 
Xu, J. & Y. Zhang, (2010) How significant is a protein structure similarity with TM-score 
= 0.5? Bioinformatics 26: 889-895. 
Yakunin, A. F., A. A. Yee, A. Savchenko, A. M. Edwards & C. H. Arrowsmith, (2004) 
Structural proteomics: a tool for genome annotation. Curr Opin Chem Biol 8: 42-
48. 
You, Z., S. Omura, H. Ikeda, D. E. Cane & G. Jogl, (2007) Crystal structure of the non-
heme iron dioxygenase PtlH in pentalenolactone biosynthesis. The Journal of 
biological chemistry 282: 36552-36560. 
Zhang, J. P. & R. S. Stephens, (1992) Mechanism of C. trachomatis attachment to 
eukaryotic host cells. Cell 69: 861-869. 
	   198	  
Zhang, Y., (2008) Progress and challenges in protein structure prediction. Curr Opin 
Struct Biol 18: 342-348. 
Zhang, Y., (2009) I-TASSER: fully automated protein structure prediction in CASP8. 
Proteins 77 Suppl 9: 100-113. 
Zhang, Y. & J. Skolnick, (2004) SPICKER: a clustering approach to identify near-native 
protein folds. J Comput Chem 25: 865-871. 
Zhang, Y. & J. Skolnick, (2005) TM-align: a protein structure alignment algorithm based 
on the TM-score. Nucleic acids research 33: 2302-2309. 
Zhong, G., (2009) Killing me softly: chlamydial use of proteolysis for evading host 
defenses. Trends Microbiol 17: 467-474. 
Zhou, P. & G. Wagner, (2010) Overcoming the solubility limit with solubility-
enhancement tags: successful applications in biomolecular NMR studies. Journal 
of biomolecular NMR 46: 23-31. 
 
 
